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Thesis Abstract 
 
Introduction: This thesis explored Chronic Neuropathic Pain (CNP) 
patients' experiences of the treatment journey of Spinal Cord 
Stimulation (SCS) surgery, considering life prior to, and after the 
surgery. Previous SCS literature has predominantly focused on 
technology, SCS efficacy, and the role of psychological factors in 
SCS patient selection and outcomes. Whilst research highlights SCS 
as an effective treatment for various CNP conditions, it predominantly 
employs quantitative outcome measures, thereby reducing the depth 
of information yielded about the experience of SCS surgery and 
patient satisfaction. There is a dearth of in-depth understanding of 
the lived experience of the SCS surgery treatment journey. 
 
Objectives: The aim of this thesis was to explore participant 
experiences of the SCS surgery treatment journey considering life 
prior to and after the surgery. 
 
Methods: Ethical and NHS trust approval were obtained. A 
purposive sample of seven CNP patients who had undergone SCS 
surgery 2-8 months previously were recruited. Each participant took 
part in a face-to-face semi-structured interview which was audio 
recorded. Interviews were transcribed verbatim and analysed using 
Interpretative Phenomenological Analysis (IPA). 
 
Results: Three super-ordinate themes were generated: Diminished 
control and coping, identity transitions and SCS conflict. The themes 
were interpreted as being interconnected with each other. To 
demonstrate the treatment journey, all themes were included in the 
journal paper and further details of convergences and divergences 
between participants were included in the extended paper.   
 
  
Discussion: In line with previous research, patients’ expectations of 
SCS surgery were significant in patient satisfaction with the 
outcomes, reinforcing the importance of identifying and addressing 
expectations in pre-surgery preparation. Given SCS is often the last 
treatment option; the current study found post-SCS participants were 
going through a process of acceptance of lost identities and of 
current pain relief and capabilities. Simultaneously, participants were 
adjusting to living with the stimulator, indicating the significance of 
offering psychological treatments adjunct to SCS treatment to 
support participants through these processes. Difficulties in 
acceptance of identity changes and adjustment to SCS could 
negatively impact on mood and sense of control which can have 
adverse effects on pain perception. 
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Abstract 
 
 Object. To review Health Related Quality of Life (HRQoL) 
following Spinal Cord Stimulation (SCS) surgery as measured by 
generic HRQoL measures in chronic neuropathic pain patients. 
 
 Methods. Electronic databases and reference list searches 
were conducted to ascertain articles related to HRQoL following SCS 
surgery in patients experiencing chronic neuropathic pain. Two 
randomized controlled trials consisting of 7 studies and 2 case series 
were reviewed and assessed for methodological quality. 
 
 Results. SCS surgery resulted in significant pain reductions 
for Failed Back Surgery Syndrome (FBSS) and Complex Regional 
Pain Syndrome (CRPS) patients. However, significant improvements 
in HRQoL that were sustained over time were restricted to FBSS 
patients.   
 
 Conclusions. SCS is effective at reducing neuropathic pain in 
FBSS and CRPS. However, more robust, long term trials, using a 
combination of generic and specific HRQoL measures are required to 
further understand the impact of SCS surgery on HRQoL with 
different neuropathic pain conditions.  
 
Key Words: Spinal Cord Stimulation • Health Related Quality of 
Life • Outcomes • Chronic neuropathic pain • Systematic review  
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Introduction 
Chronic Neuropathic Pain (CNP) 
Neuropathic pain is initiated or caused by a primary lesion or 
dysfunction in the peripheral or central nervous system37. It is 
characterized by a constant burning pain, intermittent shooting pains 
and spontaneous paresthesias which manifests as abnormal 
sensations including numbness, itching and tingling14. It is termed 
chronic if the pain persists for at least 6 months, or if the symptoms 
last longer than would be expected for tissue healing36. Chronic pain 
has a negative impact on a person’s quality of life (QoL) affecting 
their emotional, psychological, social and physical functioning44. It is 
a significant burden to health care systems and the worldwide 
economy 8. The prevalence rates for neuropathic pain are estimated 
at 1-8% in the United Kingdom (UK)4,53 and 1.5% in the United 
States4. CNP is most commonly located in the back and legs14. 
However, it is associated with a number of different medical 
conditions that are etiologically heterogeneous such as Failed Back 
Surgery Syndrome (FBSS), Complex Regional Pain Syndrome 
(CRPS) Type I and II, diabetic neuropathy, postherpetic neuralgia 
and spinal cord injury36 (see appendix A for descriptions of 
conditions). There are a range of treatments for neuropathic pain 
including; anticonvulsants, antidepressants, oral medications with 
local anaesthetic properties, opioids, regional analgesics (injections 
to numb the painful area) and surgical procedures. Simple analgesics 
are ineffective for neuropathic pain18, this type of pain is termed 
intractable and individuals suffering from this are often offered more 
invasive treatments such as Spinal Cord Stimulation (SCS) surgery.  
 
SCS 
The therapeutic application of electrical stimulation to the spinal cord 
has been used to treat various pain disorders since 1967, however 
advances in surgical techniques and technology have increased its 
popularity over recent years17. SCS involves surgically implanting a 
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small, battery powered stimulator into a patient. It delivers electricity 
to the spinal cord through an electrode which changes some of the 
pain messages the body sends to the brain51. Patients often undergo 
a trial electrical stimulation under local anaesthetic prior to the full 
implantation to determine whether effective pain relief of at least 50% 
is achieved12. Literature on the clinical effectiveness of SCS surgery 
demonstrates it is effective at reducing neuropathic pain as well as 
increasing quality of life, decreasing analgesic consumption and 
helping patients to return to work46. However, it is not effective for all 
types of pain; such as pain resulting from tissue damage, known as 
nociceptive pain43 and pain due to insufficient blood flow for the 
metabolic needs of organs known as ischaemic pain44. In 2008, The 
National Institute of Health and Clinical Excellence (NICE) 
recommended SCS as a treatment option for CNP, however more 
robust research studies are required before recommending SCS for 
ischaemic pain38. This recommendation is likely to increase funding 
and opportunities for neuropathic patients to access this treatment in 
the UK.  
 
SCS is associated with high costs; therefore evaluating cost 
effectiveness of the intervention has been a current focus in the 
literature3,47-49. Systematic reviews of cost effectiveness of SCS 
surgery report the initial high costs associated with the device 
implantation and the maintenance are offset by a reduction in the use 
of healthcare resources post implant47. Therefore, in the long term it 
is deemed less costly3.  
 
Research suggests the presence and severity of CNP is associated 
with greater impairments in a number of important Health Related 
Quality of Life (HRQoL) domains including physical, emotional, and 
social functioning which impacts on life roles24. Therefore, cost 
effectiveness studies have examined costs in relation to HRQoL35. 
The evidence suggests the initial outlay costs of SCS surgery are 
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justified as there are substantial HRQoL gains in comparison to 
patients only receiving Conventional Medical Management (CMM) 
who experienced little or no benefits35.  
 
Health related quality of life 
The term health related quality of life is used in many different 
contexts for a number of purposes resulting in there being no 
consensus of a definition41. Therefore, for the purpose of this article, 
health related quality of life will be understood in terms of the 
domains identified in a globally used standardised generic HRQoL 
measure. This is called the EQ-5D which was designed by the 
EuroQoL group1. In the development of the measure, authors drew 
on existing domains in HRQoL measures and consulted lay persons 
to ascertain appropriate terminology9. In this measure, HRQoL is 
understood in terms of an individual’s mobility, their ability to carry 
out usual activities (work, study, housework, family, and leisure 
activities), their experience of pain/discomfort, feelings of 
depression/anxiety and self care (part of physical functioning21).  
Neuropathic pain patients have been noted to score considerably 
lower on the EQ-5D in comparison to other populations with severe 
illnesses such as chronic heart failure34 and stroke35. This highlights 
the devastating impact of neuropathic pain. Evidence suggests SCS 
increases various aspects of HRQoL in many neuropathic pain 
conditions. Such evidence has identified improvements in activities of 
daily living and functioning in CRPS patients22, improvements in 
mood, activities and quality of sleep with patients with chronic back 
and extremity pain
10
 and improvements in exercise tolerance in 
diabetic peripheral neuropathy50. 
 
Research on SCS surgery employs either generic and/or specific 
measures when evaluating HRQoL. The latter refers to measures 
specifically designed to measure a disease/condition (e.g. 
diabetes/neuropathic pain); a population of patients (e.g. the elderly) 
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or a certain function (e.g. sleep, mobility). There are advantages and 
disadvantages of the use of both types of measures. Generic 
measures permit comparisons across interventions and different 
conditions and have been argued to be as responsive as disease 
specific measures40. Although, some authors propose specific 
measures are more sensitive to conditions21. Disease-specific 
measures have been criticised for trying to identify clinical 
information relevant to the condition rather than determine the impact 
of the condition on general function25. Furthermore, difficulties in 
interpreting batteries of measures have resulted in inaccurate 
conclusions about efficacy of treatment interventions40. For the 
purpose of this paper the focus will be on generic measures so direct 
comparisons can be made across different neuropathic pain 
conditions. 
 
In conclusion, given the strong relationship between neuropathic pain 
severity and lower HRQoL and the improvements in HRQoL following 
SCS surgery, it seems pertinent to review the literature in this area. 
Previous reviews have included HRQoL when reviewing clinical 
effectiveness of SCS surgery; however they have failed to consider 
this important outcome independently, nor have they included recent 
evidence published since it was recommended as a treatment of 
choice for neuropathic pain38. The primary aim of this systematic 
review is to examine the evidence from available literature on HRQoL 
following SCS as evaluated by generic HRQoL measures. Pain 
intensity following SCS surgery as measured by Visual Analogue 
Scale (VAS) scores will also be included in the review because 
reducing neuropathic pain is the primary aim of SCS and higher 
levels of pain are associated with lower levels of HRQoL24. 
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Method 
Searching 
A systematic review of literature pertaining to HRQoL following SCS 
Surgery in neuropathic pain patients was conducted using six main 
electronic databases: Cochrane Library (1991 – July 2010), PsycInfo 
(1806 – July 2010), Medline (1950 – July 2010), EMBASE (1980 – 
July 2010), Intute (2006 – July 2010), and Web of Science (1900 – 
July 2010). Grey literature was searched using the electronic 
resources to reduce publication bias. The system for Information on 
Grey Literature in Europe (SIGLE) and DART-Europe Etheses and 
Dissertations were used. Searches were not restricted by language, 
date or publication type. The Cochrane Database of Systematic 
Reviews was used to identify recent systematic reviews conducted in 
this area. Furthermore, a scoping review was conducted using initial 
search terms to identify relevant systematic reviews on SCS surgery 
and neuropathic pain (see appendix B for reviews) and for generic 
HRQoL measures. From this information, more specific search terms 
were identified. Four primary search concepts were used, which 
covered the intervention, outcomes and population of interest: Spinal 
cord stimulation, QoL, outcomes, and neuropathic pain. Search 
terms for QoL were informed by terms used in generic HRQoL 
measures such as the EQ-5D, the Short Form-36 (SF-36)57 and the 
Nottingham Health Profile (NHP)23 as terminology in articles was 
observed to often correspond with these measures. An example of 
the MEDLINE search strategy is provided (see appendix C), which 
was modified for other databases. The scoping review demonstrated 
that very few HRQoL studies had been conducted for SCS surgery 
prior to the 1990’s, with majority of clinical effectiveness studies only 
measuring pain outcomes, therefore hand searches were not 
completed. 
 
Following electronic searches, 379 article’s titles and abstracts were 
reviewed and 43 relevant articles retrieved. Reference lists from 
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systematic reviews and relevant articles were hand searched to 
identify a further 166 potentially relevant articles for abstract 
screening as titles tended not to specify whether HRQoL was 
measured. Duplicates were removed identifying 61 articles for further 
analysis, 42 of which were reviews. The inclusion and exclusion 
criteria were then applied (see below).  There were 7 references from 
2 trials accepted for the review and 2 case series. Although, these 
two trials were using the same participants, they were treated as 
separate studies as they were each investigating different 
hypotheses (e.g. SCS effectiveness at different time periods or a 
completely different hypothesis not related to SCS efficacy). 
 
Selection 
 Inclusion and exclusion criteria 
Types of studies  
It is widely accepted that Random Controlled Trials (RCTs) are the 
‘gold standard’ on the hierarchy of evidence for quality of study 
designs, followed by other controlled clinical trials and observational 
studies such as case series20. The initial scoping review of the 
literature revealed a range of methodological approaches in this area 
with few RCTs; therefore all of the above study designs were 
included to explore HRQoL following SCS surgery. Studies excluded 
were those at the bottom of the hierarchy such as single case 
studies, case reports or practice commentaries where results are 
difficult to generalise20. Studies were also excluded if they were; 
reviews or guidance papers that did not present original research; 
economic evaluations/ cost effectiveness articles and studies only 
published in languages that were not English. 
 
Intervention 
All SCS devices were included (e.g. rechargeable and non-
rechargeable implantable pulse generator systems or stimulators 
with radiofrequency receiver systems). No restriction was imposed 
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on whether SCS was a single therapy or was used in combination 
with other therapies/medications. Studies were excluded when the 
neurostimulation intervention was on other parts of the nervous 
system such as deep brain stimulation. 
 
Population 
Studies identifying their patient population as adults experiencing 
chronic neuropathic pain were included. Studies were excluded if 
participants were pregnant, children or in a chronic unconscious state 
(e.g. a long-term coma). Studies were also excluded if they failed to 
state participants’ origin of pain as chronic neuropathic pain or if they 
did not specify that their pain met the classification criteria for a 
neuropathic pain condition. This was important as some syndromes 
(e.g. FBSS) can be the result of pain of different origins such as 
neuropathic and/or nociceptive44, and as previously stated SCS is 
less effective for nociceptive pain39 which could bias HRQoL 
outcomes. 
 
Outcomes 
Studies including a generic HRQoL measure to evaluate outcomes 
were included. Measures included in the review were required to 
meet the operational definition of HRQoL, which included covering 
areas similar to the following domains: mobility, pain, mood, activities 
and self care (i.e. functional abilities). Studies were excluded if they 
did not examine HRQoL.  
 
A meta-analysis was not conducted due to the different 
methodologies employed. Therefore, the results will be presented 
descriptively.  
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Data abstraction 
Data was abstracted by using a standardised form modified from 
Torgerson52 (see appendix D). A summary of the studies main 
characteristics is provided in appendix E and a summary of the key 
findings related to HRQoL and pain intensity is provided in appendix 
F. Although, not all of the outcome measures used in each study will 
be discussed to achieve the objectives of this review, descriptions of 
their function are provided to contextualise and synthesise the key 
findings (see appendix G). The quality of studies was assessed 
according to the criteria detailed in the NHS CRD Report No. 429 (see 
appendix H), with the aim of providing a descriptive account of the 
studies methodological quality. A numerical system was not 
employed. There is currently no ‘gold standard’ numerical scoring 
system for quality of studies31 and there are inconsistencies in 
interpretation and application of criteria, which raises questions about 
the reliability and validity of such scoring in practice2. 
 
Results 
In total, there were 4 studies from a Prospective Randomised Control 
Trial of Effectiveness of SCS (PROCESS)16,32-34, 3 studies from a 
Dutch prospective trial26-28 and 2 case series45,56. The results section 
will be structured according to methodological design of the studies 
and information previously extracted in the tables.  
 
RCTs 
General characteristics 
Objectives  
All RCTs provided clear, specific objectives; five assessed the 
efficacy of SCS as a treatment for neuropathic pain compared with a 
control group. Follow ups ranged from 6-60 months. In contrast, 
study A3 used the PROCESS trial data to assess the extent to which 
disease-specific measures on pain and disability translated to 
improvements in HRQoL on generic measures. Lastly, study A4 used 
12 
 
the PROCESS data to analyse the sub-dimensions of both the 
disease-specific and generic HRQoL measures.    
   
Participants 
Sample sizes ranged from 54-100 participants. Both sets of trials 
included basic participant demographics such as average age, 
gender, and information on pain type, location, and treatment history. 
However, neither trial provided age ranges, ethnicity or marital 
status. Kemler and colleagues26-28 did not specify employment 
status. Age and gender were specified for both the intervention and 
control groups in both trials at baseline, however at follow up when 
numbers depleted changes in demographic data were not detailed in 
study B6 and B7. 
 
The PROCESS trial employed FBSS patients with neuropathic pain 
of radicular origin, which was predominantly located in the leg 
(exceeding back pain). The nature of the neuropathic pain was 
checked as per routine practice through clinical investigations and 
supporting tests such as X-ray and Magnetic Reasoning Imagery 
(MRI). In contrast, the Kemler trial failed to identify whether such 
procedures had been completed, but stated all patients met the 
diagnostic criteria for Reflex Sympathetic Dystrophy (RSD) 
established by the International Association for the study of Pain37.  
RSD is now more commonly referred to as Complex Regional Pain 
Syndrome (CRPS) type I, which is the term used in the last paper of 
the trial.  
 
Setting, country and treatment period 
Both trials provided details of participant recruitment and the 
treatment period. The Kemler trial recruited participants from the 
authors neurosurgery department, a single site in the Netherlands, 
whereas the PROCESS trial recruited from 12 sites based in 
Australia, Belgium, Canada, Israel, Italy, Spain, Switzerland, and the 
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UK. The PROCESS trial did not provide specific percentages of 
participants from each country.   
 
Study design  
Both were prospective RCTs and eligible patients were required to 
have a pain intensity VAS score of at least 50mm (5cm). In line with 
the literature suggesting psychological factors can negatively impact 
on SCS efficacy12, the Kemler trial also screened for psychological 
distress using the Symptom Check List-90 (SCL-90). Any SCL-90 
scores of 200 or more resulted in further examination by a 
psychologist. Any substance abuse or major psychiatric diagnosis 
excluded participants from the trial. Conversely, the PROCESS trials 
did not screen for psychological distress but noted patients with 
evidence of an active psychiatric disorder were excluded.   
 
Test stimulation was performed in both trials. Effectiveness was 
judged by patients achieving at least a 50% reduction in pain 
intensity on the VAS. In the Kemler trial no participants failing test 
stimulation were implanted, however five of the nine participants 
(17%) who failed test stimulation in the PROCESS trial received 
permanent implants.  
 
As evident in the study characteristics (appendix E), there was 
heterogeneity in comparators. The PROCESS trial used SCS and 
CMM as the intervention, and CMM alone as the comparator. CMM 
consisted of using oral medication (such as opioids, non-steroidal 
anti-inflammatory drugs, antidepressant, anti-convulsants/ 
antiepileptic and other analgesic therapies), nerve blocks, epidural 
corticosteroids, physical and psychological rehabilitative therapy, 
and/or chiropractic care. In contrast, Kemler et al employed SCS and 
Physical Therapy (PT) as the intervention and PT alone as the 
comparator. The PT was a standardised program of graded 
exercises which aimed to improve strength, mobility, and function of 
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the affected hand or foot. The therapy was administered for 30 
minutes, twice a week, with a minimum of two days between 
sessions. The program lasted for six months. Selected physical 
therapists were specifically trained to run the program to ensure 
standardisation. 
 
Outcome measures 
Both trials measured HRQoL as a secondary outcome to pain, 
employing both generic and specific measures to form a battery of 
tests. Sub-dimensions of the measures were intermittently reported. 
Both trials employed VAS scores to quantify pain and used the EQ-
5D as a generic HRQoL measure. However, study A1 did not report 
EQ-5D results with no explanation of why this was omitted from the 6 
months analysis. The SF-36, EQ-5D and NHP met the operational 
definition for HRQoL as generic measures; however the Sickness 
Impact Profile (SIP) did not due to lacking a pain scale. Furthermore, 
authors note this is to be used with a battery of other measures, not 
in isolation19. Other measures employed varied across trials (a 
description of all measure employed in the studies has been included 
in appendix G). There were numerous studies investigating the 
reliability and validity of the generic HRQoL measures (see Table 1); 
however estimates for a neuropathic pain population could not be 
located. Results were inconsistent, but generally showed adequate 
reliability and validity other than for VAS for chronic pain; however 
this study had an extremely small sample size. 
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TABLE 1 
Reliability and Validity of Measures 
Outcome 
Measure 
Type of 
Measure 
Reliability 
 
Validity 
Visual 
Analogue 
Scale 
(VAS)11,42 
Pain By averaging responses 
from three 100mm VAS 
pain ratings assessing 
current, average and 
worse pain, it is 
suggested adequate 
internal consistency was 
gained (alpha coefficient 
0.77). It was more 
normally distributed 
than individual VAS 
scores in a sample of 
320 individuals with 
temporomandibular 
disorder (TMD) pain15.  
Validity 
estimates for 
VAS have been 
reported as 
unsatisfactory for 
chronic pain11. 
However, this 
was based on an 
extremely small 
sample.  
 
Nottingham 
Health 
Profile 
(NHP)23 
HRQoL Test-retest reliability on 
a group of patients with 
PVD2 suggested high 
correlation co-efficients 
for sub-dimensions of 
both parts of the 
questionnaire: 
Spearman’s Rho 
ranging between, 
 r = 0.75-0.88 (p<0.01). 
Part two = Cramers o 
ranging between o = 
0.55-0.89 (p<0.01)23.  
Face, content 
and criterion 
validity were 
reported to be 
satisfactory and 
the measure was 
able to 
discriminate 
between ill and 
well people5. 
                                                 
2
 = Peripheral Vascular Disease (PVD) 
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EuroQoL 
5D  
(EQ-5D)30 
HRQoL Test re-test reliability for 
the five domains has 
been calculated using a 
Kappa co-efficient in a 
group of stroke patients. 
Results suggested co-
efficients between 0.63-
0.8013. 
Validation in a 
neuropathic pain 
population could 
not be found. 
However, 
construct validity 
has been 
reported in a 
number of 
clinical 
applications13. 
Some support for 
its convergent 
validity was 
obtained when 
comparing the 
EQ-5D to the SF-
6D across a 
range of patients 
group; however a 
number of 
discrepancies 
were also 
identified across 
the patient group 
and severity of 
illness6. 
 
Short Form 
36 
(SF36)57 
HRQoL Studies estimate each 
scale reliability co-
efficients as exceeding 
a median of 0.76. 
SF-36 is 
suggested to 
include 8 of the 
most frequently 
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Internal consistency 
estimates of the 8 
scales ranged from 0.73 
to 0.96 and test re-test 
reliability estimates on 
the 8 scales ranged 
from 0.60 to 0.817 
 
 
presented health 
concepts58. 
 
Weak to strong 
correlations have 
been reported 
between the SF-
26 and other 
measures. 
Strong 
correlations were 
obtained 
between the 
physical 
functioning 
subscale of the 
SIP, the AIMS 
and the NHP 
(0.52 to 0.85) 
and strong 
correlations were 
reported 
between the 
mental health 
sub-scales of the 
SF-36 and other 
psychological 
subscales 
(ranging from 
r=0.51 to r= 
0.82)5. 
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Statistical analyses were identified in both trials and data was 
provided on participants treatment allocation as opposed to the 
actual treatment received in line with the Intention-to-treat (ITT) 
principle. Both trials reported per treatment analyses, which is the 
actual treatment received. Both trial employed independent t-tests to 
compare baseline data between groups and study B5 used non-
parametric tests when data was not normally distributed. Both used 
different types of multivariate regressions/logistic regressions 
(depending on if data was continuous or dichotomous) to assess the 
potential influences of baseline differences between the groups and 
outcome variables on the size of treatment effects.  
 
Follow ups 
Details of withdrawals and losses at follow ups were explicitly stated 
in both trials and at least 80% of the samples were retained at the 6 
month follow up. However, at 24 months study A2 retained 
approximately 50% and study B6 retained approximately 70% of their 
sample.    
 
Key findings 
Primary pain outcomes as measured by VAS scores and HRQoL 
evaluated by generic measures are presented (see appendix F). 
 
Both trials suggest SCS surgery was effective at achieving at least 
50% pain relief at 6 months and provided more pain relief in 
comparison to the control group. Study A1 showed significantly 
greater reduction in leg pain (p<0.001) and back pain (p<0.008) 
compared with CMM alone and study B5 showed significant 
reduction in pain in the SCS group, whereas the PT alone group 
mean scores increased (SCS = decreased by 2.4, PT increased by 
0.2, p<0.001).  
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Improvements in HRQoL as measured by generic HRQoL measures 
varied across the two neuropathic pain conditions (FBSS and 
CRPS). At 6 months, the PROCESS trial which employed FBSS 
patients showed significant improvements on HRQoL on seven of the 
eight SF-36 domains excluding ‘role-emotional’ (mean = 51.3, 
p=0.02). Whereas the CMM group only achieved significant 
improvement on the General Health domain of the SF-36 (mean = 
41.3, p<0.007). Significant differences between groups were 
obtained in seven out of the eight domains p≤0.02, however not in 
the ‘role-physical’ domain.  
 
In contrast, the Kemler trial ITT analysis on CRPS patients at 6 
months showed no differences between SCS + Physical Therapy 
(PT) group on HRQoL as measured by the NHP and EQ-5D. 
Therefore, no values were presented. However, per treatment 
received analyses (PTRA) showed the SCS group (n=24) 
experienced significant improvements in comparison to the PT group 
on the pain index of the NHP, for patients with hand (p=0.02) and 
foot (p=0.008) pain. The results from the two generic HRQoL 
measures (EQ-5D and NHP) and the specific measures (SIP and 
SRDS) were not presented; one value of HRQoL was tabulated. It is 
unclear how this single value was calculated from these measures.  
 
At 24 months, study A2 completed a comparison with baseline 
results showing the SCS+CMM group reported significant reductions 
in leg pain (p<0.0001), but not back pain (p=0.21). Study B5 did not 
report within group comparisons, however found the SCS and PT 
group reported more pain reductions than the PT alone group 
(SCS+PT = 2.1cm, PT alone = 0cm, p<0.01).  
 
The variations in HRQoL results between the different neuropathic 
pain patients employed in each trial were sustained at 24 months. 
When compared with baseline results, study A2 SCS+CMM group 
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again reported improvements on seven out of the eight domains of 
the SF-36 (p≤0.01), apart from the role emotion domain (p=0.11). In 
contrast, study B6 reported no within group data and there were still 
no significant differences between groups.  
 
There were inconsistencies across the studies in whether or not they 
reported the sub-dimensions of the generic HRQoL measures. 
Although all 9 studies used the EQ-5D as a generic HRQoL 
measure, only study A4 drawing on the PROCESS Trial data to 
specifically analyse the sub-dimensions of the measures presented 
the sub dimensions of the EQ-5D. 
 
In studies where the sub-dimensions were presented (A1&2 = SF-36, 
A4 = SF-36 & EQ-5D, B5&6 = NHP), they highlight the relationship 
between the level of pain and the patient’s perception of their 
HRQoL. Studies B5 and B6 demonstrated improvements in HRQoL 
were indicated by the pain dimension of the NHP at 6 and 24 
months. Study A3 demonstrated higher levels of pain and disability 
was associated with lower level of quality of life. Likewise, study A4 
highlighted a proportion of patients still experiencing HRQoL 
problems were related to pain and discomfort, with 34% reporting 
extreme pain problems.  
 
At 6 months, study A4 indicated the SCS group showed greater 
scores on the physical component summary (PCS) and mental 
component summary (MCS) of the SF-36 (PCS mean = 32.4, MCS 
mean = 44.5) in comparison to the CMM alone group (PCS mean = 
28.1, MCS = 37.7). Significant improvements were evident from 
baseline till the 24 months follow up (p≤0.01). The SCS group also 
showed greater improvements compared to baseline and the CMM 
alone group on 4 of the 5 dimensions of the EQ-5D (not mobility) 
which was also sustained over 24 months.  
  
21 
 
Quality and methodological issues 
Both trials completed baseline assessments prior to randomisation 
and detailed adequate randomisation assignment using computer 
generated tables32 or blocks26. Both concealed the randomisation 
process from investigators one trial by electronically locking details 
until the patient entered the trial32 and the other via telephone by a 
research assistant stating the number of patients randomised26 (see 
appendix H). Due to the paresthesia that accompanies stimulation, 
patients were not blinded and it was difficult to blind investigators. 
Therefore, this cannot rule out the risk of a placebo effect, which is 
noted to be highly prevalent amongst surgical procedures55. Authors 
in both trials argue the consistency of pain relief across 1, 3, & 6 
months follow up suggest the results are not due to a placebo 
response26. 
 
Baseline characteristics of the intervention and control groups in both 
trials were comparable, excluding back pain in the PROCESS trial 
which was slightly higher in the control group. Although, authors 
argue leg pain is the primary outcome where no differences were 
evident, this cannot rule out the potential effects of greater back pain 
on the controls responses in other measures such as the HRQoL 
questionnaires given the evidence suggesting neuropathic pain 
severity is associated with lower HRQoL24. 
 
Although using a homogenous population is desirable when 
employing questionnaires to measure outcomes, as demonstrated 
there appears to be specific differences in HRQoL after SCS surgery 
between neuropathic pain conditions. Therefore, this limits the 
generalisability of the results to patients were the predominant 
neuropathic pain is located in other areas and other pain conditions.  
 
Participants recruited in the Kemler study were severely disabled, 
many of whom required crutches or wheelchairs to move, and 
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therefore the impact on HRQoL may have been very different with 
patients in the earlier stages of the condition.   
 
The neurostimulators used in the PROCESS trial were provided by 
the company Medtronic who funded the trial. The trial was designed 
and managed by a committee that included four external 
representatives and two from Medtronic and the manuscript was 
written by the independent members of the committee. Research 
suggests industry funded studies report more favourable results than 
independent studies54.    
 
Case series 
General characteristics 
Objectives 
Study 8 specified a specific primary and secondary objective, to 
ascertain if patients could use the neurostimulator and evaluation of 
clinical effectiveness of SCS on a range of outcome measures. 
However, study 9 failed to state an objective in the abstract or the 
main text. Authors stated a goal ‘to build a quality system for 
neuromodulation’ (p.185), which is broad and unclear.  
   
Participants 
Sample sizes ranged from 45-105 participants. Both case series 
included basic participant demographics such as average age, 
gender, and information on pain type, location, and treatment history. 
Unlike the RCTs, they both included average pain duration (study 8 = 
86 months; study 9 = 134 months) and Study 9 included an age 
range (31.1 to 69.4 years). However, again neither study provided 
ethnicity or marital status and only Study 9 included employment 
details. Changes in demographics after drop outs and withdrawals 
were not recorded in either study. 
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Similar to the RCTs, both studies employed representative samples 
of common neuropathic pain conditions. Study 8 employed patients 
of mixed diagnoses, predominantly post-operative back or leg pain 
(55%); radicular pain (27%) and CRPS type I (7%) and type II (7%). 
However, authors referred to the last 4% as ‘other’. Therefore, it is 
unclear what type of neuropathic pain the remaining participants 
experienced. Study 9 recruited FBSS patients with predominantly 
Neuropathic Limb Pain (NLP) Type III which manifests in one leg with 
some back pain (87.6%) and NLP Type II, which manifests only in 
the leg (12.4%).  
 
Setting, country and treatment period 
Study 8 provided limited details of participant recruitment and the 
study settings. It reported it was a multicentre study with participants 
recruited from 12 sites, however failed to specify the specific 
countries and percentages of how many participants came from each 
site. In contrast, study 9 stated it was undertaken in the Netherlands. 
Both studies stated the study treatment period, which meant all 
studies reviewed stated this information.     
 
Study design  
Study 9 eligibility criteria identified only patients with pain intensity 
VAS score of 5 or above and employed the SCL-90 checklist to 
screen psychological distress (scores 225 or above). In contrast, 
study 8 did not provide a VAS cut off score nor did they screen for 
psychological factors. The study provided limited exclusion criteria 
without mentioning whether patients with psychiatric disorders were 
accepted into the study.   
 
Test stimulation was performed in both studies. In contrast to all 
other studies in this review, study 8 did not use the 50% pain 
intensity reduction as a judge of effectiveness. Instead effectiveness 
was judged by patient and physician satisfaction.  
24 
 
Outcome measures 
Both studies employed outcome measures for the patient to provide 
evaluation of their experience; however study 8 included the 
physician’s satisfaction of the stimulator also. Both studies employed 
generic and specific HRQoL measures, which were different but 
covered similar constructs appropriate for the pain condition 
(functionality, pain and HRQoL). Both used the EQ-5D. 
 
Statistical analyses employed to compare baseline scores to follow 
up were different in studies 8 and 9. Study 8 used t-tests to compare 
VAS and the EQ-5D data, whereas study 9 used a non-parametric 
test the Wilcoxon Signed rank Test. 
  
Follow ups 
Both studies had a 12 month follow up and clearly identified changes 
in sample size and reasons for participant leaving or being excluded 
from the study. 
 
Key findings 
Primary pain outcomes as measured by VAS scores and HRQoL 
evaluated by generic measures are presented (see appendix F). 
 
Following SCS treatment both studies showed significant and similar 
improvements in pain from baseline to the 12 months follow up 
(study 8 = 7.2 to 4.4, study 9 = 7.3 to 3.0).  
 
Both studies indicate significant improvements in HRQoL as 
measured by the EQ-5D. Study 8 showed a mean increase in VAS 
scores from 0.21 to 0.46 at 12 months. Study 9 showed a mean 
decrease from 55.2 to 38.2 using the same measure. As evident from 
the scores, both studies employed a different method to calculate the 
scores that is not consistent with the user guide. There are a number 
of ways to score the EQ-5D, however there are relevant papers 
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identifying these methods that can be referenced. Although, Study 9 
acknowledges not following the user guide, it does not refer the 
reader to the scoring system adopted or explain it. This lack of 
consistency in scoring makes it difficult to make accurate 
comparisons between studies.  
 
Quality and methodological issues 
Both studies included an inclusion and exclusion criteria, although 
study 8 only briefly states participants were required to be adults, 
meet a neuropathic pain condition criteria and were excluded if they 
had previously been implanted with an SCS system. It failed to clarify 
what other treatment patients implanted were undergoing at the time 
of evaluation and whether individuals with psychiatric disorders were 
excluded. 
 
Neither study explicitly specified whether patients were entered into 
the study at a similar point in their condition progression; however 
this would have been difficult for Study 8 with the mixed diagnoses. 
Both studies completed 12 months follow ups therefore allowing 
sufficient time before evaluating the impact of SCS on levels of pain 
and HRQoL.  
 
In the discussion of study 9, it provided comparisons of results with a 
study completed by Burchiel et al10 which demonstrated comparable 
results. However, no explicit conclusions were stated about 
outcomes of pain and HRQoL used in the study.  
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Discussion 
The aim of this review was to systematically examine the literature on 
HRQoL as measured by generic measures after SCS surgery. Pain 
relief as measured by VAS scores was also considered in this review 
due to this being the primary aim of SCS to reduce neuropathic pain 
and the strong relationship between neuropathic pain severity and 
lower levels of HRQoL previously identified24. The literature reviewed 
suggests that SCS results in improvements in pain relief and HRQoL 
as measured by generic measures. However, there are distinct 
differences between pain conditions and whether changes are 
sustained over time.   
 
Improvements in pain intensity as measured by VAS scores were 
evident in both FBSS and CRPS patients. However, improvements in 
HRQoL were only demonstrated in FBSS patients. FBSS patients 
scores on HRQoL generic measures improved when compared to 
baseline and a CMM alone control group. These results were 
sustained at 6 months (study A1), 12 months (study 9) and 24 
months (study A2). When the measures were broken down into 
component parts, improvements were evident across all domains of 
the SF-36 and EQ-5D apart from mobility (study A4). Results 
generally highlighted the significance impact of pain on individuals 
HRQoL which supports previous research24. 
 
Conversely, the Kemler RCT demonstrated no significant changes in 
HRQoL in patients with CRPS and improvements were not sustained 
over time. However, study 8 results showed improvements in HRQoL 
with their sample which included CRPS patients. Additionally, other 
prospective clinical studies that employed CRPS patients with severe 
disabilities found significant improvements in pain intensity and 
HRQoL using different more specific measures of functionality, 
activities of daily living and pain22. Although the quality of these 
studies was lower than the Kemler RCTs, it highlights that using 
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different measures can yield different results for the same conditions. 
Of note, despite the Kemler trial not achieving statistically significant 
gains in HRQoL through outcome measures, patient satisfaction 
suggested 90% felt they had responded positively to the treatment 
and 95% reported they would undergo the treatment again with the 
same outcomes. This contrast in statistical results from self report 
measures and reported satisfaction reinforces the importance of 
establishing more robust measurements of HRQoL.     
 
Clinical implications 
Neuropathic pain is a severe, chronic condition resistant to regular 
treatment18 which is associated with high costs for health services 
across the globe8. Therefore, a strong clinical implication is providing 
an effective treatment that decreases pain and increases HRQoL to 
avoid economic burden. As previously identified, the initial outlay cost 
of SCS surgery are reported to be justified by the reduction of health 
resources consumption post implant making it a desirable treatment 
option both economically and clinically due to the HRQoL gains for 
certain neuropathic pain patients. However, only one study appears 
thus far to have investigated the relationship between HRQoL, cost 
and resource consumption at 6 months follow up; therefore further 
longer term research is required. A combination of the NICE 
recommendations and extra cost effectiveness research could 
provide more opportunities for this hard to treat patient group to 
access SCS surgery.  
 
Limitations 
Although rigorous methods were undertaken to reduce bias, this 
review is not without limitations. The search terms used may not 
have been broad enough, particularly for neuropathic pain. This was 
kept generic in order to prevent restricting the search to specific 
neuropathic pain conditions, however specifying a range of 
conditions as search terms may have resulted in more articles. A 
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further limitation is failing to examine specific measures of different 
aspects of HRQoL that formed a battery of tests. The current results 
indicate it is becoming more common practice for clinical studies to 
employ both generic and specific measures to produce more 
comprehensive results, which is important in light of growing 
evidence suggesting different measures of HRQoL are differentially 
sensitive to effects of neuropathic pain24.  
  
Future research 
Therefore, future systematic reviews could consider a two-tier review 
using generic and specific measures to examine HRQoL after SCS 
surgery. Furthermore, more robust, high quality, long term RCTs are 
required in the various neuropathic pain conditions before generating 
conclusions about HRQoL after SCS surgery, especially its 
effectiveness over time. There is a distinct lack of consistency in the 
measures employed in studies, how measures are scored, and how 
results are interpreted and presented. It is imperative that 
consistency is achieved to create a stronger, higher quality body of 
evidence for this difficult to treat patient group whose quality of life is 
so poor.  
 
Furthermore, this review highlighted the dearth in the literature of any 
in depth qualitative studies exploring the patient’s experience of pain 
and HRQoL following SCS surgery. Categorising outcomes has been 
suggested as over-simplistic given that pain can vary over time, 
place and circumstances43, which is also likely to impact on an 
individual’s quality of life. Therefore, future qualitative studies should 
be conducted to complement the existing evidence base.   
 
In conclusion, the quality and quantity of quantitative SCS research is 
growing. Evidence suggests that most HRQoL domains improve 
following SCS surgery in certain neuropathic pain conditions such as 
FBSS which can be sustained over time. However, it highlighted that 
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CRPS patients with more severe functional difficulties have not 
consistently achieved the same HRQoL gains. Therefore, further 
more robust studies are required in CRPS and other neuropathic 
pain conditions. It is important that a variety of specific and generic 
measures are employed to provide a more comprehensive and 
sensitive battery of measures. Furthermore, other methodologies 
such as qualitative studies could provide more breadth and depth to 
the existing literature.    
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Abstract 
Object. Existing research has focused on spinal cord 
stimulation (SCS) efficacy, technology, and patient selection and 
suitability. In contrast, this study aimed to explore the lived 
experience of the treatment journey of SCS, with regard to how 
patients made sense of their life of chronic neuropathic pain prior to, 
and following, the SCS implant.  
Methods. The study employed a qualitative methodology. 
Seven participants were interviewed face-to-face using a semi-
structured interview schedule. These were digitally audio-recorded 
and transcribed verbatim. The transcripts were then analysed using 
Interpretative Phenomenological Analysis.   
Results. Three super-ordinate themes were generated from 
the analysis: diminished control and coping, identity transitions and 
SCS conflict.  
Conclusions. In line with past research, patient expectations 
appeared to impact on SCS treatment satisfaction, reinforcing the 
importance of addressing these in pre-surgery preparation. The study 
provides novel insights into the experience of accessing SCS. It 
highlights that emotional support may be useful for those 
experiencing complications in obtaining their SCS to reduce feelings 
of powerlessness. Also, as SCS was often the last treatment option, 
these participants described a process of acceptance of their lost 
identities, levels of pain relief and current capabilities. 
Simultaneously, participants were adjusting to the presence of the 
stimulator and living with the device. Therefore, post-surgical 
psychological support could be offered in conjunction with SCS to 
assist in coping with these processes. Increasing acceptance of 
identity changes and adjustment to SCS could positively impact on 
mood, pain perception and subsequent SCS treatment satisfaction. 
 Key words • Spinal cord stimulation • Chronic neuropathic pain 
• Patient perspective • Qualitative research • Interpretative 
phenomenological analysis • Lived experience  
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Introduction 
Neuropathic pain (NP) is caused by a primary lesion or dysfunction in 
the nervous system24 and is one of the most challenging conditions 
to treat in neurological practice32. It is termed chronic if the pain 
persists for at least six months, or if symptoms last longer than would 
be expected for tissue healing23. NP is debilitating and can have a 
negative impact on a person’s quality of life (QoL), affecting their 
psychological, social and physical functioning31. There are various 
treatments available including anticonvulsants, antidepressants, 
opioids, regional analgesics, surgical procedures, and psychological 
therapies27. For more intractable conditions, individuals are offered 
Spinal Cord Stimulation (SCS) surgery.  
 
SCS is a surgically implanted device that delivers electricity to the 
spinal cord, changing the pain messages sent to the brain 43. Prior to 
full implantation, patients undergo trial stimulation to determine 
whether effective pain relief of at least 50% is achieved9. Recent 
randomised controlled trials (RCTs) indicate SCS is effective in 
reducing pain and medication use, improving QoL, functional 
capacity, and patient satisfaction in carefully selected patients18,20. 
There is also evidence of a reduction in emotional distress following 
SCS implantation17. Although, SCS is beneficial to certain NP 
conditions31, there is a substantial subset of patients who do not 
benefit10 or who experience loss of efficacy over time4,30. 
 
Literature suggests psychological factors may partially explain these 
differences3, with reviews indicating that psychological factors (e.g. 
depression, anxiety, somatisation and poor coping) can predict SCS 
outcomes5. The European Federation of the International Study of 
Pain Chapter’s (EFIC) guidelines recommend that psychological 
evaluation is undertaken as part of the SCS screening process to 
rule out contraindications, such as an unresolved major psychiatric 
disorder (e.g. psychosis, severe depression), substance misuse, or 
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lack of social support12. However, currently there are no ‘gold 
standard’ measures proposed for such assessment42. Also, as 
psychological evaluation was originally largely driven by medical 
insurance requirements in the United States (US), it is still not 
consistently applied within the UK1.  
 
The SCS literature provides valuable knowledge on patient suitability, 
SCS technology and treatment effectiveness using a range of 
outcome measures. However, there is a dearth of in-depth qualitative 
analysis of what it means to have SCS surgery from a patient 
perspective. Exploratory qualitative research has provided 
psychological insights into the experience of chronic pain and other 
surgical procedures7,39. The qualitative literature on chronic pain 
describes a discrepancy between patients’ painful bodies and their 
preferred selves as a barrier to therapeutic rehabilitation; specifically, 
it impedes progress towards acceptance of this changed identity39. 
Additionally, qualitative studies have provided insights into NP 
patients’ experiences of accessing pain relief treatments, although 
not SCS. Research indicated that patients felt insignificant, poorly 
understood and dismissed, whilst being referred from service to 
service46. Therefore, patients not only felt let down by their bodies40 
but also by services, leaving them feeling “trapped”46. Researching 
the experience of the SCS journey therefore could be particularly 
important in understanding how patients came to have SCS, their 
experience of the surgery, and the outcome.  
  
Previous qualitative literature on the experience of patients who have 
had surgically implanted devices has offered valuable insights into 
patient experiences of Implantable Cardioverter Defibrillator (ICD) 
and how they adjust physically and psychologically7. Although the 
purpose of the device is different to SCS, such research 
demonstrates the depth of information gained about adapting to this 
device. Prior to implant, patients in the study had experienced 
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misdiagnosis, hopelessness, loss of functioning and felt dismissed by 
healthcare professionals. This is consistent with the chronic pain 
literature. Post-implantation patients gained control of their symptoms 
and felt independent as they no longer had to heavily rely on 
healthcare professionals. Furthermore, despite experiencing anxiety 
associated with the internal shocks, externally they felt that some 
normality had been restored. The specific qualitative analysis 
employed for this study was unclear. However, it allowed a richer, 
more detailed exploration of patients’ experience of the ICD pre- and 
post-surgery. Such insights on SCS could provide important 
information currently missing in the SCS literature.  
 
In summary, there is a lack of in-depth analysis of the lived 
experience of the SCS surgery treatment journey. This research is 
the first qualitative study to systematically analyse SCS patient 
experiences from a phenomenological perspective. Using 
Interpretative Phenomenological Analysis (IPA)35, the aim of the 
current research was to gain a patient perspective of the lived 
experience of the SCS treatment journey, providing further insights 
for SCS teams and prospective patients; specifically, how patients 
make sense of their life of chronic NP prior to, and after implantation 
of the stimulator .  
 
Method 
Design 
As informed by the literature review and research objective, the 
researchers employed a retrospective qualitative design. IPA
35
 was 
used to explore the participants’ experiences of their treatment 
journey of SCS surgery. To achieve this, the first author (AT) 
attempted to understand how participants made sense of their 
experience33. In contrast to quantitative research which uses 
representative groups or populations to make probabilistic claims and 
generalisations, IPA studies take an idiographic approach34, which 
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entails completing a detailed, nuanced analysis of the experience of 
a small sample of participants38.  
 
Participants  
Seven participants were purposively selected from a neurosurgery 
department. The participants were homogeneous in that they had all 
undergone SCS surgery to treat chronic NP; however, the specific 
origin of their pain and other demographic information varied. The 
sample consisted of four females and three males, aged 43-68 years. 
All participants were identified as White British, and had experienced 
back and/or leg pain for 6-21 years. All had chosen to have SCS 
surgery following the failure of alternative pain treatments to provide 
adequate pain relief and/or due to negative medication side-effects. 
Two participants had previously undergone SCS surgery, but due to 
complications the SCS had to be removed and replaced. All 
identifying information has been changed to protect participants’ 
anonymity.  
 
Procedure 
Following approval from the Regional Ethics Committee and the R&D 
department, the neurosurgery department sent information packs to 
all patients meeting the inclusion criteria. Participants had to have 
undergone SCS surgery within the past 2-8 months, were aged 18 or 
over, spoke English, and consented to take part. The time scale 
allowed for a period of post-surgery recovery, but interviews were 
undertaken soon enough after the surgery for participants to recall 
life leading up to and after the surgery. AT obtained written consent 
alongside demographic information, and interviewed the participants 
in their homes. All interviews were audio recorded and lasted 
between 43 - 96 minutes. Following the interview, participants were 
debriefed and offered information on support services available. 
Initial reflections on the interview content were recorded and notes 
were made in a research journal.  
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In accordance with IPA methodology, a semi-structured interview 
schedule was developed to guide the interview (see Table 2). This 
provided flexibility through the use of prompts allowing exploration 
of interesting claims or concerns that arose. The schedule followed 
a chronological sequence to capture experiences before and after 
SCS. As SCS is only considered after standard treatments have 
failed27, it was important to include life prior to pain and previous 
pain treatments to understand what life had been like for patients to 
bring them to consider SCS. 
TABLE 2 
Interview Schedule 
Interview Questions 
 
1. To begin with, describe what life was like before your surgery?  
2. Prior to the surgery, did experiencing pain change the way 
you thought or felt about yourself?  
3. How did you feel when the surgery was suggested to you? 
4. How would you describe living with the device implanted in 
you? 
5. Having had the surgery, describe how life has been? 
6. Having had the surgery, how would you describe yourself 
now?  
7. Having had the surgery, how do you see yourself in the 
future? 
8. Additional prompts:  
Can you tell me more about that? What sense did you make of 
that? 
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Data analysis  
AT transcribed the audio recordings verbatim to provide the raw data 
for analysis. IPA does not provide a single method to analyse data, 
but offers flexible guidelines which can be modified to meet the 
research objectives34. This study drew on the most recent guidelines 
by Smith and colleagues33, which involved employing specific 
techniques to identify patterns in the data at different stages of the 
analysis. The first transcript was read and re-read and initial 
exploratory coding including descriptive, linguistic and conceptual 
comments were noted. Initial themes were generated to reflect a 
summarised understanding of the exploratory coding. The initial 
themes were then listed and similar themes were collapsed together. 
From this data, super-ordinate and sub-ordinate themes were 
generated. The same procedure was adopted for subsequent 
transcripts, completing an individual case-by-case analysis34. 
Patterns across the cases were then examined and themes were 
organised and combined. 
 
Quality assurance  
To ensure research credibility and quality assurance, Yardley’s 
guidelines were adhered to8,48. AT sought a critical voice from a 
member of the research team (RdN) to enhance the credibility of the 
interpretative process. Gaining convergence of ideas was not the 
focus, as accuracy and objectivity are not in line with the critical 
realist epistemological position the authors took, pertaining to 
multiple perspectives on reality. However, the aim was to ensure that 
all interpretation was clearly embedded in the data which can also be 
seen explicitly by the use of direct quotes presented. Trustworthiness 
was achieved through using a reflective diary to document all 
decision making, creating an audit trail from interviews to write-up.  
This provided transparency and a coherent narrative throughout the 
research process contributing to the rigour of the findings8. It also 
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allowed for recognition of prior knowledge and ideas that might 
influence the process.  
 
Results 
Three interrelated super-ordinate themes were generated from the 
analysis: diminished control and coping, identity transitions, and SCS 
conflict, each of which contained sub-themes (see Table 3). The 
themes included either information from before or after the SCS 
surgery, or information from both. This was contextualised by 
participants’ quotes. It is recommended that three quotes be 
presented for each theme36. However, in order to present a snapshot 
of the treatment journey, only one or two quotes are presented to 
exemplify a sub-theme.  
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TABLE 3 
IPA Analysis: Super-ordinate and Sub-themes 
Super-ordinate Theme Sub-themes 
 
Diminished control and coping Battling the system and managing 
expectations 
Multiple levels of powerlessness 
Coping with symptoms of 
depression 
Impact of pain and the non-able 
body  
Identity transitions Identity loss 
Managing the unwanted pain 
identity 
SCS conflict Positive change 
Disappointment, adaptation and 
acceptance 
 
Diminished control and coping 
This super-ordinate theme encapsulates the diminished sense of 
control experienced by participants both prior to and after SCS 
surgery as they attempted to cope with the impact of their chronic 
NP. Four sub-themes were identified.  
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Battling the system and managing expectations 
This reflects participants’ arduous journey through various treatments 
and associated hopes and disappointments. All participants were 
persistent in attending pain clinics, despite numerous treatment 
failures including previous surgical procedures. Devastation at the 
lack of progress permeated these stories, often leaving participants 
feeling desperate by the time they were offered SCS. Nicole 
poignantly reflects this when she described attending the panel that 
assessed her suitability for SCS: 
 
Nicole: ‘I got called up to the panel (pause), which is where I learnt a 
little bit more about it [SCS], but at that point I’d had tried 
anything...Because I was at the point...I was ready to drive into a 
brick wall I had had enough, errr, er, pain levels were, there was no 
sort of respite, at all’ 
 
Due to such desperation, managing expectations of treatments was a 
key part of this journey. All participants described faith in SCS; for 
two participants their hopes were increased by the SCS trial, but for 
the others it seemed to be a faith based on a persistent hope for 
something better. Specific expectations of SCS differed amongst 
participants. Some participants reported maintaining low 
expectations of SCS due to previous treatment disappointments and 
explanations about what to expect, whereas others had higher 
expectations: 
 
Maya: ‘they did sort of say, y-you know, it may work for you, it may 
not work for ya...you do go into it thinking, you know I’ll be able to do 
this, that and the other [after SCS]...you have to accept you can’t do 
that, erm, but the expectations, I wanted more’. 
 
Such expectations were linked to participants’ subsequent 
satisfaction with their SCS as illustrated in the theme SCS conflict. 
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This faith in SCS motivated two participants to persist in their fight to 
get a stimulator despite numerous barriers related to funding. This 
resulted in anger and upset as they tried to gain some control of this 
pursuit. Sally progressed from bargaining ‘let me have it done, and I’ll 
walk away’ to pleading ‘let me have this one chance’ to pestering ‘I 
kept pestering’ in desperation for her SCS, perceiving this as her 
‘final chance of getting some pain relief’. Yet simultaneously, she 
tried to retain an open-mind about the outcome as her previous SCS 
malfunctioned. Within this was a sense of powerlessness as 
captured in the next theme.  
 
Multiple levels of powerlessness 
Multiple levels of powerlessness were interwoven throughout six 
participants’ experiences, overlapping with all other themes. All 
participants alluded to a sense of powerlessness to their pain due to 
it dictating what they could and could not do. This powerlessness 
was also experienced in relation to the side-effects of the medication, 
negative hospital experiences, in relation to fighting for a stimulator, 
adapting to it, or simply fate. This powerlessness to the system was 
present in the majority of Sally’s and Sarah’s account. Sally’s initial 
loss of control was when her first SCS had to be removed. However, 
she was then denied a replacement due to her not getting the 
required 50% pain relief. As she expressed her anger at her 
subjective experience not being valued, she likened SCS to a 
commodity to be traded to convey her sense of injustice.  
 
Sally: ‘I’m kind of piggy in the middle, it’s my body your cutting open, 
stuffing an implant in, surely if I’m happy with 10, 15 percent then it 
should be done, if you brought a product from anywhere and it was 
faulty, you would take it back, you would either get your money back 
or you’d get another one’ 
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Sally was unable to comprehend this disparity in opinions about what 
constituted ‘adequate pain relief’ leaving her feeling devoid of 
agency. In contrast, Jack and Pete alluded to a higher sense of 
powerlessness that nobody could control.  
 
Pete: ‘Describe myself now (pause)...Um (pause), cheated...Not by 
the NHS but by some, you know, some act of God, or some fate that 
suddenly changes your life from this (points to legs) to this (points to 
stimulator) in one phuff (noise with mouth)’.     
 
This external locus of control exhibited by participants had a negative 
impact on thought processes and mood. Participants described a ‘no 
win situation’ (Jack), with little control over their lives, contributing 
further to their desperation for some positive change. 
 
Coping with symptoms of depression 
All but one participant described an ongoing struggle with 
experiencing and coping with depressive symptoms prior to SCS. 
One participant reported these ceased following surgery, however for 
the others they persisted. There was variation in participants’ specific 
symptoms (e.g. low mood, ruminative thinking and loss of 
motivation), and their coping strategies. However, all six participants 
experienced feelings of hopelessness at some point in their journey. 
Jack coped by challenging his negative thinking, whereas Mike and 
Pete talked about ensuring they had a purpose in their day to break 
the cycle of feeling low.   
 
Pete: ‘you’ve gotta have a reason to get up in the 
morning...otherwise, you’ll just drift into this, this state of...‘I’ll not 
have a shave today, I’ll not have a wash today, cos I’m not going 
anywhere’. 
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Participants’ symptoms were exacerbated by challenging situations 
like Sarah’s difficulties in obtaining her stimulator. In her desperation 
for pain relief, she feared being denied SCS for exhibiting low mood 
and distress, so began concealing her emotions from healthcare 
professionals. She described feeling emotionally unsupported during 
this process, leaving her feeling angry:   
 
Sarah: ‘I should have been able to be emotional, I should have been 
able to talk to someone that helped me be ok for the spinal cord 
stimulator, and help me be ok if it didn’t work’. 
 
The lack of emotional support at different points in the SCS treatment 
journey was echoed by other participants, particularly post-operation 
during the adaptation process. Pete reported the benefits of being 
able to talk about his SCS experience in the interview: ‘it’s been nice 
to get it out, and in fact I might feel a lot different [about his SCS] 
now, I’ve actually sat down and phuff (noise with mouth) and brought 
it out’. This quote highlights the positive release Pete achieved and 
the potential it had to change to his perceptions. 
 
Impact of pain and the non-able body  
All participants described activity limitations, participation restrictions, 
multiple losses and dependence as a result of their pain. Social 
losses were most prevalent due to the physical restrictions as 
illustrated by Nicole:  
 
Nicole: ‘I don’t have a social life anymore... if you can’t keep up with 
the people, ermm, they just don’t want to know (pause), erm, after a 
while, er everything you do, ends up, to able-bodied people in a way, 
as a hindrance’.  
 
Nicole felt like a burden to others; a sentiment also expressed by 
Sarah, who coped by withdrawing from social situations:  
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Sarah: ‘The reason I’d be saying no [to social event], maybe wasn’t 
so much about the pain, as to (pause) why would they want me 
there, cos I’m just a burden (pause, tears rolling down face) so I’d 
say no cos of that’. 
 
The feeling of being a burden reduced Sarah’s sense of self and 
desire to interact socially. The burden of the non-able body was 
peppered through accounts alongside the inherent powerlessness 
that accompanies it. Participants’ bodies prevented them from fully 
engaging in the world, a rupture resulting in social exclusion, reduced 
mood, and low self-esteem. Understanding this restrictive pain reality 
helps to contextualise participants’ desire for SCS. However, in this 
group of participants the level of change from SCS on these aspects 
of their lives varied as is discussed in the ‘SCS conflict’ theme.   
 
Identity transition 
This theme represents identity loss and changes in participants’ 
sense of self as a result of their pain. This consisted of two sub-
themes: 
 
Identity loss 
All participants described loss of identities. The loss of the pre-pain, 
active self was predominant in all accounts, which often resulted in 
loss of social contacts and associated social identities: 
 
Mike: ‘I was fairly active, well very active, I use to like easy sports, 
tennis and stuff like that...and then things slowed down...cos of the 
pain, I couldn’t do as much’ 
 
Pete: ‘I use to be part of a walking club, we used to do hill walking, I 
don’t see any of them anymore, because I don’t go walking’. 
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There was a sense of mourning these lost selves, with participants 
making comparisons to who they were and who they had become, 
consequently leaving a void in their sense of who they are. For most 
participants, the gains from SCS left them with a sense of needing to 
accept their losses, what had and had not changed, and adapt to this 
unwanted pain identity.  
 
Managing the unwanted pain identity 
The ‘pain identity’ included both personal characteristics of what 
participants are like when in pain and how they manage pain socially. 
Every account included reflections of managing an unwanted pain 
identity, both prior to, and after SCS surgery. Pain persistence and 
severity underpinned all accounts which contributed to an 
understanding of this as a stable identity like gender, ethnicity or 
race, as depicted by Sally ‘It [pain] were just, just part of me I 
suppose’. The way the pain identity manifested differed across 
participants but broadly fell into two categories: Anger (demanding, 
aggressive)/shame or quiet and withdrawn. For Pete, his ‘personality 
change’ was too painful to accept. This is reflected in the content of 
his account and his inconsistent use of pronouns which may provide 
distance for him from this undesirable aspect of himself:   
 
Pete: ‘I get aggressive a lot...it isn’t me, this person from the last 10 
years isn’t me....you don’t want to be like that, you don’t want to, you 
don’t want to treat other people like because you know they’re are 
trying to help you but you just want to be left alone, you just want to 
be (hesitates), packed away into your own life’. 
 
This sense of shame of his pain identity was echoed in other 
accounts in relation to emotional expression. Participants masked 
their pain identity by suppressing emotions or concealing their 
experience of pain from others, often due to the fear of social 
consequences of revealing this. It seemed the process of accepting 
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this part of their identity prevented talk of future identities for most 
participants. 
 
SCS conflict  
This theme represents what the SCS outcome meant to participants. 
All participants, apart from Sally, experienced conflicting feelings 
about their stimulator. Five participants weighed up the positive and 
negative aspects of SCS. In contrast, Pete felt grateful for it, but felt 
his life was no different. These are documented as two sub-themes: 
 
Positive change 
‘Positive change’ encompasses the multiple ways in which SCS 
positively influenced participants on an individual and interpersonal 
level. All participants, apart from Pete, reported that the reduction in 
pain made them happier and provided some with optimism for the 
future. Such change was pivotal for some who had previously felt 
hopeless about their future. This is reflected in Nicole’s statement 
summarising how SCS broke her cycle of hopelessness: 
 
Nicole: ‘It’s [SCS] probably the best thing that’s happened in the last 
eight years...I suppose in the long run, it’s probably saved my 
life...it’s given me the chance to start looking forward’. 
 
Participants described small but significant changes to activities of 
daily living. Being able to sit or stand for longer periods helped them 
at work, in home life, or socially. However, one of the most prevalent 
positive outcomes for participants was looking forward to reducing 
their medication use, and ultimately the negative side-effects. SCS 
instilled a sense of control for Sally, Maya and Jack; which for Jack 
was a contrast to the perceived loss of control he experienced after 
taking medication: 
 
52 
 
Jack: ‘I think I’d rather use the stimulator [not medication] because 
even though it’s taking, it’s only taking part of it [pain] off, I feel like I 
am in control of that’. 
 
These changes were weighed up with other less desirable aspects of 
the SCS, leaving most participants feeling ambivalent, or as Sarah 
described, feeling ‘in limbo’. 
 
Disappointment, adaptation and acceptance 
All participants apart from Sally conveyed disappointment with 
certain aspects of their SCS, predominantly related to adapting to its 
presence and using the stimulator. This was coupled with a process 
of acceptance of their current pain relief and capabilities. All six 
participants alluded to adapting to the attention required by the 
stimulator, due to the visibility or discomfort of the battery, side-
effects, or as a result of having to frequently change the settings on 
the device depending on what they were doing. Four participants 
described experiencing unpredictable side-effects (e.g. shocks, loss 
of leg control, or feeling off-balance) which added to the 
powerlessness they already experienced. This contrasted to the 
sense of control some participants experienced following the implant. 
Jack felt particularly paranoid about the shocks and anxious about 
when they would happen:  
 
Jack: ‘you get the shocks depending on what you’re doing, so I do 
get a little paranoid as to what I’m doing and sometimes I just think 
I’m turning it off, cos I, having a break from it almost, you know, yet I 
do think it has been a god sent’. 
 
This example illustrates not only the adaptation to SCS, but also his 
SCS conflict. Jack alluded to not only using SCS for pain respite, but 
also needing a break from his SCS, yet he still was keen to express 
how positive he feels about it. There is a sense that despite these 
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effects, he still has choice and control over whether to have the SCS 
switched on, unlike the medication, which once taken, it is out of his 
control. 
 
Participants’ expectations of SCS were closely linked to subsequent 
disappointment. Although, three of these six participants reported an 
increase in mobility/functioning, the others experienced no 
improvement in their functioning, or less than they expected. 
Therefore the rupture between their bodies and the world continued 
to exist. For Sarah, her freedom from pain and improved mood failed 
to free her from her non-able body and its implications: 
 
Sarah: ‘I can’t do much more...so financially I’m screwed anyway, I 
can’t go out, so still stuck in ‘ere, although I’m not in as much pain, I 
mean the walls start crawling in on you regardless. You could be the 
happiest person in the world, but eventually you’d go stir crazy’. 
 
Therefore, participants were experiencing a process of acceptance of 
their level of pain relief and capabilities. This process could be the 
start of the end of their battle. Having tried most, if not all treatment 
options, it represented an opportunity to stop trying and accept life as 
it is. However, the gravity of this task in reality was a daunting 
prospect ‘I feel like I’m just, I-I feel like this is rest of me life to be 
honest’ (Jack).  
 
Discussion 
The current research aimed to explore seven individuals’ experience 
of the SCS treatment journey considering life prior to and after SCS 
surgery. The data analysis revealed three super-ordinate themes: 
diminished control and coping, identity transitions and SCS conflict. 
These themes link to existing literature on SCS surgery preparation 
and outcome, as well as the constructs described in the chronic pain 
literature (e.g. identity) and the impact of pain.  
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The current study highlights how the experience of SCS cannot be 
considered in isolation from coping with the journey that precedes it. 
Participants persisted with experimenting with various treatments and 
experiencing associated hope and disappointment. This was 
consistent with existing research6, suggesting chronic NP patients 
cope with their pain through proactive attempts to seek help, and 
despite disappointment they show a willingness to try any possibility6. 
This has been suggested to be a means to gain control21 due to the 
sense of powerlessness and consequent desperation evoked by the 
pain experience3.  However, this desperation for a ‘cure’ could have 
implications for the success of SCS surgery, or perceptions of 
success42. Certainly, participants discussed expectations and faith in 
SCS which appeared to impact on their satisfaction with the clinical 
outcomes. Research indicates the extent to which pre-operative 
expectations are fulfilled, influences post-operative satisfaction in 
lumbar and cervical spine patients41. Furthermore, Kumar and 
colleagues20 in their PROCESS study reported that only 55% of the 
patients using the SCS found it (50% or above) beneficial at 6 
months and 40% at 24months. This significant drop in reported 
efficacy could be caused by mismanagement of expectations which 
is consistent with the current findings. This reinforces 
recommendations to address patient beliefs and expectations prior to 
SCS surgery3,9. In addition to this, for two participants this process 
was further complicated by difficulties in accessing SCS. There is a 
dearth of literature on patients’ experiences of attaining SCS. Initial 
insights from the current study suggest emotional support may be 
helpful during this process when complications arise, as the 
consequent powerlessness and associated anxiety could further 
exacerbate patients’ pain experience45.   
 
The physical restrictions and activity limitations associated with 
participants’ pain resulted in loss of roles and social identities, as well 
as the presence of depressive symptoms. This is consistent with the 
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chronic pain literature14,25-26. All but one of the participants reported 
feeling more positive, whether due to a reduction in their pain and/or 
improvements in activities of daily living (e.g. sitting/standing longer). 
This is consistent with research indicating SCS can reduce emotional 
distress17, improve pain-associated depression28, and QoL19. It 
seemed the positive effects of the stimulator disrupted feelings of 
persistent low mood, lack of successful pain relief and hopelessness. 
However, when discussing the broader context of their lives post-
surgery, participants continued to allude to coping with depressive 
symptoms. Although pain relief was the primary goal, the findings 
suggest SCS also represented hope to make changes to social 
circumstances through increasing functioning. This is supported by 
research investigating patients’ hopes of improvement in relation to 
QoL prior to SCS which suggested functional status was the most 
important benefit patients hoped to gain from SCS2. The diversity of 
outcomes to SCS in the current study meant certain expectations 
were met, and some were not. This left most participants unable to 
reclaim pre-pain identities or losses, and instead they were going 
through a process of acceptance. Illness can threaten identity: first 
there is the loss; then comes the redefining and rediscovering of 
identities16. Given that most participants saw SCS as their last option, 
they appeared to be experiencing this process of acceptance with 
less reference to re-discovering roles at this point. Being able to 
accept identity loss and their pain identity is important as not doing 
so may impede rehabilitation39.  
 
Furthermore, being able to accept pain levels and give up 
unproductive attempts to control pain can lower pain intensity, 
decrease depression and physical and psychosocial disability21-22. 
Therefore, some SCS patients may benefit from additional 
physiological and psychological interventions to improve 
functioning26,44 and to assist with associated emotions and 
behaviours during this acceptance process. A suggested treatment 
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for chronic pain is Acceptance and Commitment Therapy (ACT) 
which aims to increase functioning and reduce interference of pain by 
changing individuals’ relationship with pain, by focusing on achieving 
value-driven goals and acceptance as oppose to trying to control 
pain15. A recent RCT (n=114) comparing ACT and Cognitive 
Behavioural Therapy (CBT) in treating chronic pain indicated ACT 
participants showed improvements on pain interference, depression, 
pain-related anxiety, and reported higher levels of treatment 
satisfaction than the CBT group47. Such a treatment could be used 
adjunctively to SCS, alongside behavioural treatments encouraging 
patients to incrementally increase activity levels with their new level 
of pain relief gained from the stimulator44. 
  
The current study highlighted that participants were simultaneously 
adapting to living with their SCS and the associated side-effects 
during this acceptance process. The occurrence of side-effects is 
clearly documented in literature28. However, there is a paucity of 
literature about patients’ perspective about the side-effects, or how to 
assist patients to adapt and cope with their new devices, medication 
reduction and associated anxieties. The unpredictable nature of the 
side-effects further induced a sense of powerlessness and left 
participants with conflicting feelings about their positive gains and 
more negative aspects of the device. Wider literature on ICDs 
discussed patients’ adaptation to the psychological and physical 
impact of the device and the shocks delivered to regulate their heart 
beat7,11,13. Whilst the function of an ICD is very different to SCS, the 
experience of adapting to an internal device, and the associated 
shocks, is comparable to participants’ narratives in the current study. 
The significance here is the reported feelings of loss of control have 
been associated with helplessness and high levels of depression11. 
This is important when considering patients’ adjustment to the 
stimulator and further research into factors facilitating and impeding 
control of, and adjustment to SCS is required.  
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Clinical implications 
The findings from this analysis contribute to existing literature by 
providing an in-depth understanding of the experience of the SCS 
treatment journey. This included coping with pre-surgery 
expectations, the process of accepting SCS outcomes and 
subsequent losses alongside the challenges of adapting to the 
stimulator.  
 
Some literature recommends pre-surgery preparations for SCS 
implantation including psychological assessment, psycho-education 
and supporting patients with beliefs and expectations about the 
surgery44. In light of patient willingness to try any treatment, attention 
should be given to patients’ ability to take in significant information 
during the SCS assessment. Information should be provided in a 
number of formats, and adequate time should be spent exploring the 
meaning of patients’ pain experience, and gaining specific details 
about expectations and goals in order to address any overly 
optimistic expectations3,9,44. Furthermore, it has previously been 
suggested that providing potential SCS patients with the opportunity 
to talk to patients already implanted may help prepare patients for the 
surgery and post-surgery adjustment44. One study suggested 
patients with health difficulties find ‘counsellors’ with similar problems 
more credible information providers than healthy trained 
professionals29. 
 
The literature recommends postsurgical psychological support and 
monitoring44. Postsurgical support in the UK often includes meetings 
with the surgeon and nursing staff to adjust the stimulator settings; 
however, it remains unclear how frequently psychological support is 
provided during the SCS adaptation process. The current findings 
suggest multidisciplinary support including psychological input should 
be offered to patients adapting to the presence, or use of their SCS. 
This can allow evaluation of whether patients’ expectations have 
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been met, their current levels of mood and functioning, and may also 
assist with the psychological effects of reduced opioid medication 
usage.  For relevant patients, SCS could be combined with 
physiotherapy and psychological therapies (e.g. ACT) to restore 
functional capacity, to work through losses and facilitate pain 
acceptance, providing more holistic postsurgical pain management. 
This could assist in reducing feelings of powerlessness by helping 
patients feel less isolated and more emotionally contained.  
 
Limitations 
A limitation of the study is the retrospective nature of the accounts, 
as the detail of events may be subject to memory recall and it 
assumes participants have the ability to articulate relevant 
information37. However, non-verbal cues, metaphors and emotions 
during the interview provided other forms of communication of 
participants’ experiences. Also, the purpose of the study was to 
capture the participants’ meaning-making in the here-and-now, with 
the understanding that their perception of events may alter if 
conducted in a different time or place. The findings are specific to this 
group of individuals and the study did not intend to make 
generalisations about the results to all SCS patients as this is not in 
line with the idiographic approach of IPA33. Instead, the finding of the 
study can inform current practice in neurosurgery departments and 
pain management multidisciplinary teams working with SCS patients 
experiencing similar challenges.  
   
Future research 
Future research could undertake longitudinal qualitative research, 
collecting data throughout the treatment journey (i.e. prior to surgery, 
a month post-surgery and then a follow up at six month, then a year). 
This would provide more in-depth information about surgery 
expectations, outcomes, and coping processes relating to accepting 
any lack of change and adapting to the living with the stimulator. It 
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also may provide further insights into the loss of analgesia reported 
over time4,30. More qualitative research on specific parts of the SCS 
treatment journey could provide further insights into the assessment 
process and coping with adjusting to the SCS.  
 
Furthermore, a future RCT could compare a treatment group with 
SCS and conventional medical treatments (CMT; medication) with 
consistent psychological support during assessment and post-
surgery interventions, to another group with SCS and CMT only. This 
could help determine if SCS was more effective with additional 
psychological support.  
 
Conclusion 
The current research supports previous research in the importance of 
identifying and addressing expectations of SCS during pre-surgical 
preparations. High expectations may reduce patient satisfaction with 
the outcomes of the stimulator. Additionally, if there are 
complications in accessing a stimulator, emotional support may be 
beneficial to prevent patients feeling powerless and anxious, which 
can exacerbate the pain experience. Lastly, in line with previous 
research, the current research indicates that psychological 
interventions may be useful for some patients as an adjuvant to SCS 
post-surgery. Patients may experience a process of acceptance of 
current pain levels and capabilities as well as having to 
simultaneously adjust to living with the stimulator on a psychological 
and practical level. Psychological support could, when appropriate, 
focus on mitigating remaining interference in functioning, assisting 
with identity transitions and pain acceptance, and to aid adjustment 
to the internal presence of the stimulator and living with the device.  
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1.0 Extended Paper 
I have written the extended paper to be read in conjunction with the 
journal paper. This will provide additional information on the 
background of the research and rationale for the study. It will also 
provide further details about the methodology, analysis and an 
expansion on the discussion. Lastly, I will present a critical reflection 
of the research process, the decision making and conclusions drawn. 
 
1.1 Rationale for journal choice 
I have written my journal paper to be submitted to the Journal of 
Neurosurgery4. This journal has previously published qualitative 
studies and articles on spinal cord stimulation (SCS). I felt that 
submission to this journal would reach the intended audience, as I 
hoped my research would provide insights to the pain management 
multidisciplinary teams working with SCS patients. This often 
includes neurosurgeons, nurses, clinical psychologists, 
physiotherapists and representatives of the stimulator manufacturers. 
However, I felt this was particularly important for the neurosurgeons 
for two main reasons. Firstly, I aimed to add to their understanding of 
what it means to the patients to go through the SCS treatment 
journey. Secondly, with SCS, the relationship between the surgeon 
and patient involves frequent and long lasting contact (Gybels et al., 
1998). The patients often require battery changes for their stimulator 
every few years and the surgeons will also assist with any 
complications, which are often reported with SCS (Deer, 2010).  
Medical journals prefer the use of the third person and the active 
voice. Therefore, I adhered to this in the journal paper. However, for 
the extended paper I have used first person in line with how 
qualitative research is often written.  
 
                                                 
4 see http://jns.msubmit.net/html/Instructions_to_Authors.pdf for instructions for 
authors. 
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1.2 Extended Introduction 
I reviewed the neuropathic pain (NP), chronic pain (CP) and SCS 
literature in order to gain a thorough understanding of the topics 
relevant to my research. The literature reviewed will be discussed 
and finally my rationale for the current research objective.  
 
1.2.1 Neuropathic pain  
NP represents a heterogeneous group of pain conditions (Jensen, 
Gottrup, Sindrup, & Bach, 2001). It is defined by the International 
Association for the Study of Pain (IASP) as being ‘initiated or caused 
by a primary lesion or dysfunction in the nervous system’ (Merskey & 
Bogduk 1994, p. 212). The inclusion of the term ‘dysfunction’ has 
been critiqued for being too vague (Max, 2002) and alternative 
definitions have been suggested (e.g. Backonja, 2003), however for 
the purpose of this paper I shall use this definition as it is accessible 
and fit for the purpose of this paper.  
 
1.2.2 Chronic pain 
Pain is a multifaceted, subjective experience, which involves 
physiological, affective, motivational and cognitive processes (Gybels 
et al., 1998). Acute pain may temporarily interrupt activities, however 
CP whether intermittent or continuous interferes with functioning 
(British Pain Society [BPS], 2009). Pain becomes termed as chronic 
when it has been experienced for six months or beyond what is 
expected for the course of normal healing (National Institute of 
Health and Clinical Excellence [NICE], 2008). Pain under this 
definition is perceived as a significant medical condition as opposed 
to a symptom (NICE, 2008). However, the research on CP does not 
always differentiate between chronic nociceptive pain (pain in 
response to an injury or tissue damage) and NP symptoms as a 
result of disrupted nerve functioning (Closs, Staples, Reid, Bennett & 
Briggs, 2009). Therefore, relevant research from the broader CP 
literature will need to be drawn upon which will include the NP 
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population. However, when I am referring specifically to NP research, 
this will be explicitly stated.  
 
1.2.3 Epidemiology of Chronic Neuropathic Pain (CNP) 
A recent review conducted for the epidemiology of CP suggested that 
there continues to be no accurate estimate for the prevalence of NP 
in the United Kingdom (UK) population (Smith & Torrance, 2010). 
Prevalence rates have been difficult to estimate due to there not 
being a well validated and reliable measure to identify the 
characteristics of NP (Bouhassira, Lanteri-Minet, Attal, Laurent, & 
Touboul, 2008). In a UK primary care survey, the prevalence of pain 
of neuropathic origin was reported to be 8% in this general 
population (Torrance, Smith, Bennett, & Lee, 2006). However, the 
presence of NP is perceived to be under-diagnosed and under-
treated (Taylor, 2006). It has become clear that CP with neuropathic 
characteristics is more common in the general population than 
previously suggested (Torrance et al., 2006). Furthermore, this type 
of pain is more severe than any other forms of CP and is amongst 
one of the most challenging conditions to treat, as it is less 
responsive to analgesic drugs (Dworkin et al., 2003).   
 
1.2.4 Aetiology and clinical presentation of CNP 
NP is an umbrella term for a number of pain conditions.  The most 
common types of NP are Failed Back Surgery Syndrome (FBSS), 
Complex Regional Pain Syndrome I & II (CRPS I & II) and Diabetic 
Neuropathy (see appendix A for descriptions and other NP 
conditions). All have different aetiologies and can be experienced in 
different locations (Sindrup & Jensen, 1999); however NP is 
predominantly experienced in the back and legs (Dworkin et al., 
2003). It can be caused by infections, chemotherapy, surgeries, 
nerve compression and trauma (Dworkin et al., 2003).  A distinction 
is often made between stimulus evoked NP and spontaneous NP 
that occurs independent of a stimulus persistently or intermittently 
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(Dworkin et al., 2003; Sullivan, Lynch, & Clark, 2005). The former 
can be brief, but can persist even after the cessation of the 
stimulation, whereas the latter is characterised by shooting, cramping 
or a burning like sensation (Jensen et al., 2001). Alternatively, it can 
be an episodic type pain like an electric shock or stabbing feeling 
(Jensen et al., 2001). The unpredictability and unpleasantness of the 
pain can be extremely distressing for those who experience it which 
has a negative impact on patients’ quality of life (QoL; Closs et al., 
2009). 
 
1.2.5 Impact of chronic pain 
Health related quality of life (HRQoL) has consistently been reported 
to be reduced in people with various NP conditions (O’Connor, 2009) 
and in CP in general (Breivik, Coltett, Ventafridda, Cohen, & 
Gallacher, 2006). CNP has specifically resulted in reduced mobility 
and physical functioning, depression, and difficulties initiating and 
maintaining sleep (McCarberg & Billington, 2006). The difficulties 
with sleep are thought to exacerbate symptoms and reduce pain 
threshold which can result in anxiety and depression (Nicholson & 
Veman, 2004). However, the reverse can also occur, with anxiety 
and depression disturbing sleep, demonstrating the complex 
relationship between these variables (Nicholson & Veman, 2004). 
Consequently, many individuals experiencing CNP are less 
productive at work, become unemployed or have to take early 
retirement (McDermott, Toelle, Rowbotham, Schaefer, & Dukes, 
2006).  
 
The burden of NP goes beyond the person (O’Connor, 2009) 
impacting on families supporting them (Sofaer-Bennett, Walker, 
Lamberty, Thorp, & Dwyer, 2007) as well as wider society due to the 
burden on the economy (Brook, Georgy, & Olan, 2009). The financial 
burden is a consequence of people not being able to work 
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(McDermott et al., 2006), needing to claim benefits and having high 
healthcare costs (Manca et al., 2008). 
 
1.2.6 Psychological factors involved in CP 
Pain is a fundamental aspect of human experience; it is an 
interruptive signal to alert an organism to potential danger, drawing 
our attention away from other competing stimuli (Eccleston, 2011). 
However, repeated interruption can lead to interference such as 
reduced performance or not completing jobs and tasks which is 
associated with frustration (Price, 1999).  
 
Threat is understood to be central to the pain experience as it diverts 
individuals’ attention to the cause of the pain and encourages 
escape, which is often achieved through analgesic medication 
(Eccleston, 2001). Attention to, and vigilance of pain have been 
identified as predictors of emotional distress, psychosocial disability 
and the use of health care resources (McCracken, 1997).  This, 
alongside the beliefs about pain, particularly the appraisal of what the 
pain means has become a focus in the pain literature (Turk & Okifuji, 
2002). Specifically, catastrophic thinking about pain, whereby 
individuals over exaggerate or magnify the perceived threat of pain, 
can leave individuals feeling helpless about controlling their 
symptoms (Thorn, Boothby, & Sullivan, 2002). Catastrophic thinking 
has been associated with depressive symptoms even after 
controlling for demographic information and pain severity 
(Richardson et al., 2009). This links into cognitive-behavioural 
understanding of CP. One such model employed to understand how 
individuals cope with their pain is the fear-avoidance model (see 
Leeuw et al., 2007 for review). It suggests individuals develop fear of 
particular movements/activities due to the anticipation of harm which 
results in avoidance (Morley, 2008). Prolonged avoidance of 
activities due to this fear, has led some authors to argue it is the fear 
71 
 
of pain that is more disabling than the pain per se (Waddell, Newton, 
Henderson, Somerville, & Main, 1993).    
 
Another predominant way of coping with CP is to persist in trying to 
solve the problem. However, individuals are often faced with 
numerous failed treatments leading to disappointment (Morley, 
2008). This type of coping has been referred to as an assimilative 
coping style, whereby active attempts are made to alter 
unsatisfactory life situations and restrictions (Schmitz, Saile, & 
Nilges, 1996). The alternative is accommodative coping which 
involves adapting aspirations and re-evaluating personal goals in 
relation to the losses and changes that have happened as a result of 
pain (Schmitz et al., 1996). The latter includes flexibility and adjusting 
to goals which is suggested to be important in preventing the 
development of depressive symptoms (Schmitz et al., 1996).  
 
1.2.7 Treatment of CNP 
The first line and predominant treatment prescribed for CNP is 
pharmacological (Turk & Burwinkle, 2005). NP patients are offered a 
range of analgesics including opioid medications which can have 
debilitating side-effects and are only moderately effective (Turk & 
Burwinkle, 2005). A recent survey indicated that NP patients were 
more likely to be taking opioids alongside various other pain 
medications (Torrance et al., 2006). However, patients still reported 
inadequate pain relief (Torrance et al., 2006). The main difficulty in 
treating CNP with medication is being able to identify the specific NP 
mechanisms at play so that the most effective drug for that 
mechanism can be identified (Nicholson & Verma, 2004). Due to this 
being a difficult task, it often results in a trial and error approach with 
different medications, leaving patients feeling frustrated and 
disappointed (O’Connor, 2009).  
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An alternative form of pain relief is the use of regional analgesics, 
which involves having injections to numb the painful area for a short 
period of time (Turk & Burwinkle, 2005). Antidepressant medication 
has also been effective in providing pain relief in some people with 
NP (O’Connor, 2009). These often only provide partial relief 
(O’Connor, 2009), although they can be used to assist in treating 
depression in CP patients (Dworkin et al., 2003). Lastly, various 
anticonvulsant medications have been shown to be effective in 
treating different NP conditions (Jensen, 2002). Following these 
pharmacological treatments, corrective surgery is the next most 
common option offered to CP patients (Turk & Burwinkle, 2005). 
However, there are mixed results with some patients continuing to 
experience pain. Despite this inconclusive evidence it is still routinely 
employed and is associated with high costs to the healthcare system 
(Turk & Burwinkle, 2005).  
 
Psychological treatments such as Cognitive Behaviour Therapy 
(CBT) have been shown to be effective in treating CP (e.g. 
Eccleston, Williams, & Morley, 2009; McCracken & Turk, 2002). CBT 
focuses on reducing pain and distress through modifying negative, 
catastrophic beliefs and changing unhelpful behaviours like 
avoidance of activities (McCracken & Turk, 2002; Wetherell et al., 
2011).  In contrast, Acceptance and Commitment Therapy (ACT) 
takes a different approach. ACT focuses on changing an individual’s 
relationship to pain, encouraging them to learn to tolerate and accept 
their pain so their life values can be restored (Morley, 2008). This in 
many ways is in contrast to what we as humans instinctively want to 
do. We have not evolved to disregard signals of danger or ignore our 
pain as this would not only be counter-cultural, but counter-biological 
(Eccleston, 2011). However, equally, persistent seeking for a cure or 
trying to control pain has been argued to make it more central and 
disruptive to peoples’ lives (Hayes & Duckworth, 2005) leading to 
disappointment and frustration at HCPs (Morley, 2008). ACT does 
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not aim to eliminate pain but can free individuals from the struggle of 
avoiding or reducing pain, becoming more aware of the current 
moment to pursue goals consistent with life values (Hayes & 
Duckworth, 2005; see Hayes, Jacobson, Follette, & Dougher, 1994, 
for more detailed discussion of acceptance). There is a growing 
evidence base supporting ACT as an effective treatment for CP (e.g. 
McCracken & Eccleston, 2003; McCracken, Vowles, & Gauntlett-
Gilbert, 2007; Viane, Crombex, Eccleston, Devulder, & De Corte, 
2004; Vowles, McCracken, & Eccleston, 2007). Although at present it 
is similar groups of authors investigating this concept.  
 
The above treatments are recommended to be used simultaneously 
to treat CP in order to provide a more holistic care package treating 
sensory, affective and physiological aspects of pain (Turk & Oujiki, 
2002). For more intractable NP conditions, when standard treatments 
have failed, patients can be offered SCS which will be discussed in 
more detail next. 
 
In summary, CP has a significant impact on individuals’ personal, 
social and occupational functioning. The experience of CP involves a 
range of psychological factors which impact on the experience of 
pain and coping strategies. There are a variety of treatments 
available, however often NP is resistant to such treatments resulting 
in multiple treatments being used simultaneously. When other 
standard treatments have failed to provide pain relief, more invasive 
procedures such as surgery are considered. One such option is SCS 
surgery.  
 
1.3 Spinal cord stimulation surgery  
The therapeutic application of electrical stimulation to the spinal cord 
has been used to treat various pain disorders since 1967. However 
advances in surgical techniques and technology have increased its 
popularity over recent years (Falowski, Celii, & Sharan, 2008). The 
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goal of neurostimulation is to reduce the intensity, duration and 
frequency of pain, however not to eliminate it (Falowski et al., 2008). 
The trial prior to full implantation is an advantage of SCS. This can 
provide subjective observations from the patient in combination with 
other clinical evidence to determine suitability (North & Shipley, 
2007). When implanted, patients use a remote control to adjust the 
amount of stimulation for pain relief. Another attractive feature of 
SCS is that it can be reversed. This is in contrast to other surgical 
procedures for pain relief, as these can change the patient’s anatomy 
or rupture pain pathways (North & Shipley, 2007). SCS is currently 
recommended as an effective treatment for reducing CNP (NICE, 
2008). However evidence for pain of other origins is equivocal (NICE, 
2008). For example, the evidence is inconclusive for ischemic pain5 
with more robust studies being required (NICE, 2008).  
 
1.3.1 Efficacy of SCS 
There is an extensive evidence base of SCS efficacy studies. 
However the methodological quality varies, with it predominantly 
containing case series and examples of clinical case studies related 
to technology. In contrast, over the last decade, more robust 
randomised controlled trials (RCT) have been undertaken. Two 
RCTs investigated SCS for CNP, one with FBSS patients (Kumar et 
al., 2007, 2008) and one with CRPS patients (Kemler et al., 2000; 
Kemler et al., 2004, 2008). Results indicated that SCS was effective 
at reducing pain in both NP conditions in comparison to baseline 
results and control groups, at six and 12 month follow-ups. FBSS 
patients showed improvements in HRQoL, functional capacity, 
reduction in medication use and greater patient satisfaction at six and 
12 month follow-up (Kumar et al., 2007, 2008). Whereas CRPS 
patients showed initial improvements in pain relief and HRQoL at 6 
and 24 month follow-ups, however these were not sustained at the 
60 month follow-up (Kemler et al., 2000; Kemler et al., 2004, 2008). 
                                                 
5 Ischemic pain is pain resulting from insufficient blood flow for the metabolic needs 
of organs. 
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A more recent retrospective evaluation of SCS efficacy for CRPS I 
demonstrated SCS improved pain, HRQoL and functional status 
(Kumar, Rizvi, & Bnurs, 2011). Interestingly, although the last follow-
up scores at 88 months were lower than baseline, they were higher 
than at 12 month follow-up which is consistent with previous trials 
(e.g. Kemler et al., 2008) suggesting there is often a reduction in pain 
relief over time in patients with CPRS I. Of note, some trials were 
funded by companies who manufacturer the stimulators (e.g. Kumar 
et al., 2007, 2008). It is important to acknowledge the potential bias 
however measures were taken to reduce this. 
 
Clinical trials and case series employ a range of outcome measures 
to evaluate the different aspects of the pain experience.  The 
standard measure for pain relief is using a visual analogue scale 
(VAS) containing statements to quantify pain relief, or through 
percentages ranging from 0-100% that can be rated before and after 
the surgery (Doleys, 2006). Through evaluating studies this way, 
researchers gain a breadth of information, however they work on the 
assumption that individuals’ pain is quantifiable into a rating or 
percentage that will reflect their experience of pain (Simpson, 1997). 
Furthermore, when considering HRQoL tools used such as the 
EuroQol-5D (Kind, 1996), it provides mild, moderate or severe 
ratings for severity on five dimensions of life (mobility, self care, 
ability to undertake usual activity, pain/discomfort, and anxiety and 
depression), however it provides little detail of the meaning of 
experience to the patient, nor the influence of their social and cultural 
context on the pain experience. As Simpson (1997) proposed, the 
categorisation of outcomes can be over-simplistic given that pain can 
vary over time, place and circumstances. Certainly none of the 
methods reviewed explicitly captured any in-depth meaningful 
psychological experiences of life before or after SCS surgery. This is 
an important consideration, as Eccleston (2001) asserts ‘for all 
patients with pain, what is understood about the meaning of pain, 
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disease and/or disability will play a part in the presentation of the 
problem and the effectiveness of treatment’ (p. 144).  
 
Furthermore, measures of patient satisfaction have employed similar 
structured questions to evaluate patients’ perspective of SCS. 
Although this has yielded some interesting data, it again limits the 
response patients can provide. Interestingly, despite patients finding 
they experienced a reduction in pain in the Kemler trial, 18 of the 20 
(90%) remaining implanted patients at five years follow-up indicated 
a positive response to treatment and 19 patients (95%) expressed 
they would undergo SCS again for the same result (Kemler et al., 
2008). It would be interesting to understand exactly what the SCS 
meant to these patients given they continued to provide positive 
feedback despite the SCS not maintaining its primary function of pain 
relief. Or this raises the question of whether the values provided on 
the outcome measures were not a true reflection of their SCS 
experience. 
   
In summary, there is a lack of in-depth data about how individuals 
make sense of their SCS experience or their satisfaction with the 
treatment. Specifically, the research fails to explore psychological 
factors with alternative methods to questionnaires, therefore 
potentially limiting the depth of data yielded. There is a need for 
research in this literature to explore process as oppose to solely 
focusing on adjustment outcomes. 
 
1.3.2 Psychological factors and SCS 
The role of psychological factors in SCS surgery has been a focus 
over the last couple of decades (see Beltrutti et al., 2004; Doleys, 
2006; Sparkes et al., 2010). Research indicates the importance of 
patient preparation prior to SCS, particularly determining patients’ 
expectations and psychological stability, as both can have a negative 
impact on SCS outcomes (Doley, 2006). In light of negative emotions 
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accompanying pain, it is important to distinguish emotions associated 
with CP and those reflective of unresolved major psychiatric 
disorders (e.g. severe depression, psychosis) which are 
contraindications for SCS (Gybels et al., 1998). Psychopathology in 
terms of extreme personality characteristics that impact on general 
life functioning have also been discussed as important to recognise 
prior to SCS surgery (Beltrutti et al., 2004). Therefore, psychological 
testing during patient screening for SCS is recommended by NICE 
(2008), and the IASP Guidelines for neuromodulation (Gybels et al., 
1998). At present, there is insufficient evidence to determine whether 
psychological screening improves SCS outcomes (Celestin, 
Edwards, & Jamison, 2009). However, pre-surgical depression, 
anxiety, somatisation and poor coping have been predictive of poorer 
SCS outcomes (Celestin et al., 2009). Despite this, there is no 
standard measure for assessment (Sparkes et al., 2010) and 
psychological assessment does not appear to be consistently applied 
in practice in the UK (Ackroyd, Bush, Graves, McVey, & Horton, 
2005). A common measure employed is the Minnesota Multiphasic 
Personality Inventory which deciphers behaviours and expressions of 
pain that could be attributed to psychological distress and patient 
personality (Beltrutti et al., 2004). Predominantly, it is high scores of 
the depression scale of this measure which have been indicative of 
reduced SCS efficacy, however equally depression is a variable 
shown to improve post-SCS (Sparkes et al., 2010). Therefore, it is 
suggested depressive symptoms should not be an exclusion criterion 
for SCS (Beltrutti et al., 2004; Sparkes et al., 2010). It is the severity 
and impact of such symptoms that should be assessed with 
interviews alongside questionnaires so they can be treated prior to 
(Betrutti et al., 2004) or alongside SCS therapy (Sparkes et al., 
2010).   
 
It is hypothesised that psychological factors could account for the 
loss of analgesia in some patients, 12-24 months after SCS surgery 
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(Doleys, 2006). Monhemius and Simpson (2003) advocate the loss of 
effectiveness may be a consequence of patients underestimating the 
pain relief gained. They discovered that loss of functioning in the 
device demonstrated to some patients that their stimulator was more 
effective than appreciated. This is an important consideration as it 
highlights how much more there is to discover about the experience 
of this surgical procedure, especially given the high costs associated 
with the surgery (Turk & Burwinkle, 2005).  
 
Of note, there is a dearth in the SCS literature of qualitative analysis 
of significant psychological experiences and concepts that have been 
identified as important in the CP literature. For example, a person’s 
sense of self or identity (Smith & Osborn, 2007), the experience of 
the healthcare system (Walker, Holloway, & Sofaer, 1999), living with 
and managing NP symptoms (Closs et al., 2007) and the embodied 
experience of pain (Bullington, 2009) which could have important 
implications for subsequent rehabilitation.  
 
In summary, literature indicates certain psychological variables can 
impact on SCS outcomes providing insights for patient suitability and 
psychological assessment. However, with this predominant focus on 
psychological factors for assessment and related to outcomes, 
research has failed to capture the significance and complexity of the 
psychological processes involved in the lived experience of CNP and 
having an implantable device. 
 
1.4 The lived experience of chronic pain and implantable 
devices 
Qualitative methods exploring the experience of living with CP have 
provided rich data on individuals’ sense of self and identity (Osborn & 
Smith, 2006; Smith & Osborn, 2007), experiences of loss (Walker, 
Sofaer, & Holloway, 2006) and feeling disempowered by the 
healthcare system (Walker, Holloway, & Sofaer, 1999). Qualitative 
79 
 
methods have also provided insights into the experience of adapting 
to living with an implantable device. This section will summarise 
significant concepts that are discussed in this literature.  
 
1.4.1 The self and identity 
The literature uses terms such as self concept, sense of self and 
identity interchangeably (Osborn & Smith, 2006). However in line 
with Osborn and Smith (2006), for the purpose of this study, these 
terms will refer to a ‘stable but dynamic collection of core beliefs, 
constructs, affects, or cognitions that are utilised by the individual to 
define themselves both privately and in their presentation to the 
outside world’ (p. 216). The experience of prolonged suffering like CP 
is perceived as a challenge or threat to identity (Ecclestone, Williams, 
& Stainton-Rogers, 1997). Such experiences have been described as 
‘living with a body separate from the self’, whereby painful parts of 
the body are excluded from the preferred self and classified not as a 
part of the individual (Osborn & Smith, 2006, p. 216). This disparity 
between the painful body and preferred self is proposed to prevent 
rehabilitation and acceptance of this new part of their identity (Smith 
& Osborn, 2007). The impact of pain on patients daily functioning is 
extensively talked about in studies on chronic lower back pain 
(CLBP). This research describes patients feeling vigilant and aware 
of movements resulting in them no longer feeling capable and 
productive (Crowe et al., 2010). The losses experienced as a result 
of functional difficulties negatively impacted on individuals’ 
confidence and a divide transpired between how patients saw 
themselves and who they wanted to be (Crowe et al., 2010). These 
experiences have resulted in patients perceiving pain as an 
uncontrollable threat, associated with a loss of independence and 
social and family roles (Snelgrove & Liossi, 2009). 
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1.4.2 Being caught up in the healthcare system 
This experience of alienation and detachment from the pre-pain self 
and things that used to give the individual meaning are also apparent 
between CP patients and people without CP (Bullington, 2009). 
Themes within the literature indicate individuals seeking help from 
pain clinics, felt insignificant, poorly understood and dismissed, being 
thrown from service to service (Walker et al., 1999). Therefore, 
patients not only felt let down by their bodies (Snelgrove & Liossi, 
2009) but also by services, leaving them feeling trapped by the 
healthcare system (Walker et al., 1999). Consistent across studies 
was the desire to make sense of the origins of the pain (Osborn & 
Smith, 1998) through obtaining a diagnosis however, this did not 
always happen, leading to frustration (Walker et al., 1999). 
Furthermore, literature suggests CP patients often felt they were not 
believed by professionals (Snelgrove & Liossi, 2009) which has been 
attributed to  the lack of visibility of illness, leading them open to 
labels such as being malingers (Clarke & Iphofen, 2005).    
 
1.4.3 Living with an implant 
Exploratory qualitative research has provided significant insights into 
the psychological impact and experience of other surgically 
implanted devices such as Implantable Cardioverter Defibrillators 
(ICDs; Deacon, Dunbar, Moloney, Sear, & Ujhelyi, 2003; Hallas, 
Burke, White, & Connelly, 2010; Tagney, James, & Albarran, 2003). 
This treatment is for patients with atrial fibrillation or ventricular 
arrhythmias which is when the atria or ventricles of the heart have an 
irregular rhythm (Deacon et al., 2003). These devices issue electrical 
shocks to the heart either automatically when there is an irregular 
heart rhythm or when the patient activates the device (Deacon et al., 
2003). Although, the function of this implant is very different to SCS, 
patients with a SCS also need go through the physical and 
psychological adjustment to having an implant. Interestingly, the data 
yielded suggest a similar experience to chronic pain patients with 
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their pre-implant life consisting of misdiagnosis, minimisation of 
symptoms, distressing impact of symptoms such as activity reduction 
and continuous pursuit of treatments (Deacon et al., 2003). However, 
there were methodological limitations of the study as the 
methodology employed was unclear. In contrast, two other studies 
employed grounded theory and provided adequate information about 
the analytic procedure. One study indicated being in control of the 
illness, decision making, and ICD issues were the most significant to 
participants (Hallas et al., 2010). The other study also found issues 
relating to control, both losing it and regaining it (Morken, 
Severinsson, & Karlsen, 2009). The loss of control was due to the 
unpredictability of the shocks on the automatic devices; then 
regaining control was related to life after a shock (Morken et al., 
2009). Participants in this study also talked about adjusting to the 
device and eventually changing the way they felt about it, accepting 
the uncertainty. There was also a focus on having to seek support 
and not feeling they had received enough information about the 
impact it would have on their daily lives (Morken et al., 2009). These 
studies provided a wealth of information about what it is like for 
patient living with an ICD. Such rich data is currently absent in the 
SCS literature.   
 
1.5 Rationale 
The lack of in-depth analysis of patients’ psychological experience of 
SCS surgery highlights the importance of conducting exploratory 
qualitative research to inform existing quantitative studies. The SCS 
literature has provided insights into SCS efficacy for a number of 
different forms of CP as well as different types of NP. Recent 
systematic reviews suggest SCS can reduce pain, improve HRQoL 
and functional status in NP conditions (e.g. Simpson, Duenas, 
Holmes, Papaioannou, & Chilcott, 2009). There is also a body of 
literature on the role of psychological variables informing assessment 
processes and patient selection to improve SCS outcomes. However, 
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there is little understanding of the complex relationship between pain, 
the patients’ bodies, their sense of self and identity and general 
experience of the treatment journey of SCS surgery. Therefore, I 
aimed to contribute further to this evidence base by exploring the 
lived experience of the patient’s treatment journey of SCS with 
consideration to how they make sense of their experience of life with 
CNP prior to, and post SCS implant. This approach is in line with 
creating a more patient led National Health Service (NHS), giving a 
voice to patients who hold knowledge and understanding of the 
experience of CNP and SCS (Department of Health [DoH], 2005). I 
hope the research can increase multidisciplinary pain management 
teams’ understanding of the experience of having SCS surgery, 
informing future practice and providing information for future SCS 
candidates.  
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2.0 Extended Method 
The following information is an extension of the method section in the 
journal paper. This includes a discussion of quantitative and 
qualitative methodologies, an appraisal of different qualitative 
approaches, a comprehensive rationale for adopting Interpretative 
Phenomenological Analysis (IPA; Smith, 1996) and further details of 
the procedure, data collection and analysis.  
 
2.1 Quantitative and qualitative research 
It is beyond the scope of this paper to provide a historical account of 
the development of, and divergences between quantitative and 
qualitative modes of enquiry. However in order to contextualise the 
current research, a brief overview will be provided, detailing related 
philosophical underpinnings.  
 
A researcher’s perspective on the nature of reality (ontology) and 
what can be known (epistemology) will inform how they attempt to 
attain knowledge (methodology). At one end of the spectrum, there is 
the naive realist ontology. This perceives there is an objective reality 
that can be apprehended. This informs a positivist epistemological 
position, where the object of scientific enquiry is seen as independent 
of the researcher. Knowledge is gained through testing pre-
determined hypotheses through direct observations and 
measurement which can then be subjected to statistical analysis 
(Krauss, 2005). However, for the majority of quantitative researchers, 
the focus changed over time from verifying (positivism) to falsifying 
(post-positivism) hypotheses (Guba & Lincoln, 1994). Therefore, 
some quantitative researchers started to consider an element of 
interpretation in the production of knowledge (Madill, Jordan, & 
Shirley, 2000). This is more consistent with a critical realist stance 
which perceives there to be a reality, but that there are multiple 
perspectives of this reality (Healy & Perry, 2000). Critical realism 
lends itself well to both quantitative and qualitative methods of 
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enquiry. At the other end of the ontological spectrum6, there is the 
relativist position which advocates there is no single true reality 
(Ponterotto, 2005). Rather, there are multiple, constructed realities 
that are influenced by historical, social and cultural factors. This 
ontological position informs a range of constructivist and 
interpretative epistemologies which acknowledge the dynamic 
relationship between the researcher and participant (Ponterotto, 
2005). Qualitative methods are concerned with gaining participants’ 
perspectives and understanding phenomenon as they occur in 
particular situations (Carter & Little, 2007; Yardley, 2000). Such 
methods can be informed by various epistemological positions. 
Therefore, it is important that I am transparent about my position on 
reality and what can be known from that position in order to 
demonstrate how this informed my choice of IPA to explore my 
research objective. 
 
2.2 Epistemological position 
I adopt a critical realist position, whereby I perceive there to be stable 
and enduring features that make up an underlying reality, but 
understand there can be multiple perspectives and meanings related 
to this reality (Fade, 2004). I perceive these as being mediated by the 
thoughts, expectations and beliefs that individuals bring to it (Willig, 
2008a). Therefore, I accept that past experiences will inevitably 
influence what people say and do, applying to me as the researcher, 
as well as my participants. I think it is important to be critical of what 
we think we know and I recognise that we can only try to access 
reality.  Within critical realism, reality is perceived to be arranged on 
a number of levels. Therefore, scientific investigation must go beyond 
‘statements of regularity’, analysing the underlying processes and 
meanings that can explain the patterns generally observed (Denzin & 
Lincoln, 2011, p. 11). For this reason, and due to the existing SCS 
literature, I felt a qualitative method of enquiry was more appropriate. 
                                                 
6
 It is important to note that there are certain perspectives that propose to be a-
ontological such as functional contextualism (see Hayes, 1993, for further details).  
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These would enable me to gain an understanding of the meaning of 
the experience of SCS, whereas quantitative methods would only 
contribute to the already existing generalised patterns available 
within the SCS literature.  
 
2.3 Qualitative rationale 
Building on from the previous section, the existing SCS literature 
provides a breadth of understanding relating to SCS efficacy, 
technology and patient suitability. However this approach fails to take 
healthcare professionals (HCPs) to the core of patients’ lived 
experience (Biggerstaff & Thompson, 2008). Patient satisfaction has 
been investigated using structured questions focusing on satisfaction 
with pain relief and whether patients would have agreed to this 
treatment based on their outcome (e.g. Kemler et al., 2008; Kumar et 
al., 2007; Ohnmeiss & Rashbaum, 2001). The results of other more 
in-depth interviews have been ranked or quantified (e.g. Anderson, 
Carlson, & Shatin, 2001; Devulder, DeLaat, Bastelaere, & Rolly, 
1997). This type of research fails to account for process and is more 
focused on outcomes. Therefore, it cannot capture past experiences 
and events surrounding patients’ SCS choice.  To gain a greater 
understanding of patients’ subjective experience of SCS surgery, a 
methodology that would capture the depth of participants’ sense 
making of their experience was required. This would enable 
acknowledgement of the process, giving patients the opportunity to 
speak about what was important and meaningful to them. Therefore, 
employing a quantitative framework and issuing questionnaires 
would not have been appropriate for this objective.  
 
2.4 IPA 
Prior to providing my rationale for IPA, this section will provide details 
of the background of IPA. IPA was developed by Jonathan Smith 
(1996) with the aim of examining how individuals make sense of their 
significant life experiences. He described IPA as mediating the 
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opposing positions of social cognition, where verbal responses were 
seen as reflections of cognitions, and discourse analysis (DA) where 
this idea was rejected, asserting talk is contextual (Smith, 1996; see 
section 2.5.2 for further details on DA).   
 
IPA can be described as having a short history. However, its 
theoretical underpinnings in phenomenology and hermeneutics 
provide it with historical roots (Eatough & Smith, 2008). 
Phenomenology encourages exploration of the existential claims and 
concerns of individuals’ experiences, whereas hermeneutics provides 
a critical interpretation of the meaning of individuals’ accounts within 
their wider social and cultural context (Smith, 2004), thus 
understanding the ‘person-in-context’ (Larkin, Watts, & Clifton., 2006, 
p. 108). Therefore, IPA considers both personal meaning making and 
the social negotiation of meaning in the individuals’ social world, 
thereby drawing on ideas from symbolic interactionism (Smith & 
Osborn, 2008).  
 
2.4.1 Phenomenology 
Phenomenology was initiated by Edmund Husserl in the early 
twentieth century (Giorgi & Giorgi, 2008). It is concerned with human 
experience in particular contexts and at particular times, as opposed 
to general assertions about the world (Willig, 2008a). IPA draws on 
Husserlian phenomenology, particularly his aim to go ‘back to the 
things themselves’ (Husserl, 1913/1982, p. 35). This allows 
‘experience to be expressed in its own terms’, rather than attempting 
to fit experience into predefined categories (Smith, Flowers, & Larkin, 
2009, p. 32). In Husserl’s pursuit to return to the things themselves, 
he advocated that in order to get to this essence of a phenomenon, 
people are required to bracket any preconceptions about the object, 
in order to see it for what it is, as opposed to what they think they 
know about it. Conversely, IPA acknowledges that it is not possible to 
bracket such information and that a researcher’s view of the world 
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will impact on the exploration process (Willig, 2008a). It is the 
acknowledgement of the role of the researcher in the research 
process that links the ‘P’ of IPA to the ‘I’ through drawing on 
hermeneutic traditions.  
 
2.4.2 Hermeneutics 
Hermeneutics is the theory of interpretation (Smith et al., 2009). IPA 
advocates that researchers engage in a double hermeneutic, as they 
try to make sense of participants making sense of their experience 
(Smith & Osborn, 2008). It recognises that researchers can only 
attempt to access participants’ personal world (Smith, 1996), as 
access is dependent on participants’ ability, as well as their wish to 
express their thoughts and feelings (Smith & Osborn, 2008). This is 
also complicated by the researcher’s perceptions, which as 
previously mentioned are an integral part of the interpretative 
process (Smith, 1996). This draws on Heidegger’s hermeneutic 
phenomenology, as Heidegger critiqued Husserl’s theories as 
abstract due to interpretation being inherent in understanding 
phenomenon and bracketing preconceptions being unachievable 
(Heidegger, 1999).   
 
2.4.3 IPA rationale 
IPA was in line with my critical realist epistemological position, in its 
appreciation that individuals can experience the same event in 
different ways; dictated by their individual beliefs and expectations 
(Willig, 2008a). IPA’s focus on lived experience has led researchers 
to explore chronic illness and the meaning made from such 
experiences, as it becomes an integral part of a person’s life world 
(Smith, 2011). Therefore, I felt the topic of SCS for CNP lent itself 
well to IPA inquiry as recognising the meaning of pain is argued to be 
central to treatment success (Eccleston, 2001). A recent evaluation 
of the corpus of IPA studies, highlighted how the experience of 
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illness has been a dominant topic of inquiry; with CP and neurology 
being the most prevalent areas of research (Smith, 2011).  
 
Additionally, IPA is distinct in offering both a strong theoretical 
underpinning alongside practical and accessible guidelines (Brocki & 
Wearden, 2006). These are seen as attractive to less experienced 
researchers (Smith et al., 2009) like myself. However, it has been 
criticised for being ‘one recipe to guide analysis’ (Braun & Clarke, 
2006, p. 78), which seems a rather concrete interpretation of what is 
seemingly a suggestion to aid novice researchers. 
Recommendations are explicit in IPA articles that researchers should 
adapt and develop these guidelines as their research unfolds (Smith, 
2004). 
 
IPA also offers professionals a foundation for intervention through 
integrating research to practice, whereas some other methods, like 
discursive approaches, can have difficulty in achieving this 
integration with the predominant focus being on the function of 
language in specific contexts (Reid, Flowers, & Larkin, 2005; see 
section 2.5.2). Making such links was pertinent in the current study in 
order to inform professionals and future SCS patients of the patient 
perspective which thus far, has been neglected.   
 
2.5 Different qualitative methods  
In this section, I aim to build a further argument of why I chose IPA 
as opposed to an alternative qualitative approach. There are various 
qualitative methods with differing, yet ‘overlapping epistemological 
underpinnings as well as theoretical and methodological emphases’ 
(Smith, 2004, p. 40), however only a selection will be outlined here. 
 
2.5.1 Grounded Theory (GT) 
GT was originally developed by Glaser and Strauss in 1967. It 
contains both positivist and interpretative elements, using systematic 
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techniques, alongside exploring how individuals construct meanings, 
intentions and actions (Charmaz, 2008). However, over time a 
number of variants have developed with different epistemological 
underpinnings (Mills, Chapman, Bonner, & Francis, 2006). Common 
to all approaches, is the exploratory, inductive nature which focuses 
on theory generation. The aim of my research was to explore the 
unique lived experiences of those who have undergone SCS surgery, 
not to develop a theory on this process. Therefore, I did not see GT 
as an appropriate methodology.   
 
2.5.2 Discourse Analysis (DA) 
DA is argued to be more than a research method. It challenges the 
understanding that language indicates individuals’ underlying beliefs, 
attitudes and intentions. Instead it proposes that individuals use 
language to construct a version of their social world, thereby 
perceiving language to serve a function, which can vary depending 
on the context (Potter & Wetherell, 1987). DA has evolved over time 
and there are now a number of different strands, however they all 
hold a similar interest in the role that language plays in the 
construction of social realities (Willig, 2008b). The aim of the current 
research was to gain insight into how participants made sense of 
their SCS experience, as opposed to solely the linguistic resources 
employed to convey their accounts. Although IPA also has a 
linguistic element, the rationale is different, as it aims to explore the 
connection between embodied experience, how this is talked about, 
and made sense of, and the emotional responses to the experience 
(Smith, 2011). Therefore, the linguistic element is part of a much 
wider objective, which was more appropriate for my research with the 
strong experiential quality. However, most importantly, DA was not in 
line with my epistemological position as it aligns with a relativist 
ontology perceiving there to be multiple constructed realities. 
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2.5.3 Thematic Analysis (TA) 
TA is a method employed to identify, analyse and report patterns 
within data (Braun & Clarke, 2006). It has been suggested that TA 
holds the core skills for all qualitative analyses and therefore should 
be learnt prior to engaging in other forms of qualitative research 
(Braun & Clarke, 2006). Braun and Clarke (2006) highlight that when 
using TA researchers are required to make a number of decisions 
prior to beginning. If researchers have a theoretical interest to 
pursue, they are likely to take a top down approach. Those wanting 
to take a more exploratory approach are more data driven, taking a 
more inductive bottom up approach. There are also two different 
levels of analysis in TA. The semantic level focuses primarily on the 
form and meaning of what the participant has said. In contrast, latent 
analysis examines the ideas and assumptions, theorising what may 
have shaped the semantic data (Braun & Clarke, 2006). Therefore, 
taking an inductive approach using a latent analysis could be argued 
to be very similar to IPA, the main difference being that TA does not 
stem from a particular theoretical underpinning (Braun & Clark, 
2006). Furthermore, similar to IPA, TA can be employed by those 
closer to a realist (e.g. critical realists) ontological position, as well as 
those working from a more relativist end of the spectrum (e.g. 
constructionists). The decision not to use TA was less about why TA 
was not appropriate and more to do with IPA being seen as more 
appropriate due to its phenomenological and hermeneutic roots 
which were key to understanding the meaning of lived experience of 
SCS surgery. Although TA, like other qualitative methods, does 
acknowledge the role of the researcher, there is less of an emphasis 
on this. I was drawn to how IPA explicitly acknowledges the double 
hermeneutic between researchers and participants, as well as the 
hermeneutic circle occurring during interview, analysis and write up 
(Smith et al., 2009). This was felt to be more in line with my 
epistemological underpinnings and beliefs than TA.  
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2.5.4 IPA critique 
I previously referred to IPA having a linguistic element and described 
the breadth of objectives within the IPA rationale [see section 2.5.2]. 
However, it could be argued that in covering such breadth during the 
analysis (description, linguistic, conceptual interpretations), an 
element of the depth is likely to be lost. This is supported by 
indications that novice qualitative researchers make basic social 
comparison as opposed to an in-depth analysis (Smith, 2004). 
Although, equally I would argue the more you use IPA, the more you 
will develop the analytical skills. Furthermore, it could be argued IPA 
brings too many theoretical underpinnings together making it difficult 
to do justice to each part.  
 
Despite these shortcomings, I felt that IPA was most appropriate for 
the research objective. In contrast, I was drawn to the theoretical 
underpinnings that focused on interpreting lived experience as well 
as the idiographic commitment of IPA and felt this was most 
appropriately aligned with my experiential focus of exploring the 
unique experiences of SCS surgery. 
 
2.6 Participants 
2.6.1 Purposive sampling 
Purposive sampling is the selection of participants based on their 
group membership or experience of a phenomenon relevant to the 
research objective (Holloway & Wheeler, 2010). This is consistent 
with IPA where participants are employed for representing a 
perspective as opposed to a population (Smith et al., 2009). 
Therefore, the aim of the current study was to explore these 
perspectives in depth, as opposed to obtaining data to be 
generalised to a specific population.    
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2.6.2 Homogenous sample 
A relatively homogenous sample is advocated for IPA research 
(Smith et al., 2009). This was achieved through purposive sampling 
as previously described. However, it is important to consider this 
concept of homogeneity. Although the current sample was 
homogeneous in that all participants had undergone SCS surgery for 
CNP, other characteristics differed such as the origin of their pain, 
their age, sex and previous treatments. The aim was not to treat the 
participants as the same, as I also wanted to capture the 
psychological variability in the group, through exploring the 
convergences and divergences between participants’ experiences 
(Smith et al., 2009). Homogeneity in a sample can focus exploratory 
research, yet it could be argued that too much homogeneity could 
constrain the findings. Therefore, I think employing participants who 
had undergone SCS surgery at the same hospital, within a specific 
time frame, was sufficiently homogenous for the research objectives.   
 
2.6.3 Sample size 
For professional doctorates conducting IPA research, four to ten 
interviews are recommended (Smith et al., 2009). The use of a small 
sample allows for a strong idiographic commitment, so that a 
detailed, nuanced analysis of each case can be undertaken before 
cross-case analysis (Smith, 2004). Therefore, it is recommended that 
novice IPA researchers avoid employing larger sample sizes, where 
the vast amount of data generated can become overwhelming and 
jeopardise the depth of the analysis (Smith & Osborn, 2008).  
 
Based on the estimated participant pool of 15-20 patients, I aimed to 
recruit between eight to ten participants. This sample size was 
chosen based on the estimated participant pool and the surgeon’s 
perception that there would be a high response rate. However, prior 
to and during the recruitment period from December 2010 to April 
2011, fewer surgeries were performed reducing the participant pool. 
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Therefore, a substantial amendment was made to the study protocol 
inclusion criteria, to increase the potential participant pool. Originally 
participants who had undergone SCS surgery 4-8 months previously 
were eligible for the study. However this was extended to 2-8 months 
[see section 2.7.1 for further details]. This allowed for a period of 
post-surgery recovery, but was a short enough time scale for 
participants to recall life leading up to and after the surgery.  
 
2.7 Participant recruitment 
2.7.1 Procedure 
Following gaining single-site ethical approval (see appendix I) and 
NHS R&D approval (see appendix J), I commenced the recruitment 
process in November 2010. To introduce the study to potential 
participants, information packs were sent out by the Department of 
Neurosurgery on my behalf (see Figure 1: Recruitment flowchart). 
Therefore, no personal information was accessed prior to 
participants’ contacting me and agreeing to take part in the study. 
The pack included a covering letter (see appendix K) and a patient 
information sheet (see appendix L). The covering letter provided an 
overview of the research and highlighted it was being conducted as 
part of my training to become a Clinical Psychologist. The patient 
information sheet provided a detailed explanation of the objectives of 
the study, the participant’s role, details of the interview, and a 
description of participant’s ethical rights.   
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Patients sent pack 
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Interviews arranged 
(n=7) 
Interviews conducted 
(n=7) 
Opportunity to receive 
study summary 
 (Yes=4 No=3) 
Figure 1:  
Recruitment 
flowchart 
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  Stage One 
Ten information packs were initially sent to potential participants, 
however there was a low response rate (n=4). During this process it 
was brought to my attention that there was some confusion over the 
email address on the patient information sheet, where the lower case 
‘L’ was being mistaken for a capital ‘i’. Therefore, a minor 
amendment was submitted and approved by ethics (see appendix 
M:A) and R&D (see appendix M:B) allowing the Department of 
Neurosurgery to send an additional letter to potential participants 
previously contacted. This letter clarified the email address (see 
appendix M:C). This resulted in the recruitment of another 
participant. 
 
Stage Two 
Four more information packs were distributed to eligible patients, 
resulting in another participant agreeing to take part. Given that an 
adequate sample had not been obtained and no more patients fitted 
the inclusion criteria, a substantial amendment was made to the 
study protocol as previously stated. 
 
  Stage Three 
Following gaining ethical (see appendix N:A) and R&D approval (see 
appendix N:B) for the substantial amendment, a further four 
information packs were sent to patients meeting the new inclusion 
criteria. Two more participants were recruited, resulting in a total of 
eight participants.   
 
  Stage Four 
Following contact from the potential participants, I provided further 
details about the study over the phone and they were given the 
opportunity to ask questions. Following agreement to take part, 
participants were given the choice to have their interview before or 
after their neuromodulation appointment at the hospital or in the 
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comfort of their own home. The neuromodulation appointments are 
scheduled 4-8 months post-surgery and last approximately 15-20 
minutes. It is provided to make any adjustments to the patient’s 
stimulator and ensure they are gaining optimal pain relief. This option 
was provided so patients would not be making any extra trips as a 
result of taking part in the study.  All but one of those who made 
contact opted to have the interview at their home. One patient 
expressed a preference to not have the interview at home. However 
he had already had his neuromodulation appointment, so this was 
not an option. He had recently had his SCS removed due to 
complications, but he still met the inclusion criteria. The patient 
agreed to have a telephone interview, however during preparation for 
applying to ethics for this amendment, the patient reported being very 
unwell. Therefore, I discussed this with the patient and we decided 
given the time it would take for ethical approval and the current 
severity and uncertainty surrounding the patient’s ill health, it would 
not be appropriate nor ethical to undertake the interview. Upon 
making this decision, the patient appeared relieved, which reinforced 
this was the most appropriate course of action.     
 
2.8 Data collection 
All participants were contacted the day prior to the interview to 
confirm the time, date and location and to ensure they still wanted to 
take part. On the day of the interview, the purpose of the study was 
reiterated to participants and the opportunity to ask question was 
again provided.  
 
I spent time going through the consent form (see appendix O), 
explaining each section to participants before obtaining written 
consent [see section 2.9.1. for further discussion on informed 
consent]. The process of using the Olympus DS-55 digital voice 
recorder was described and a sound check was completed. 
Participants were also informed they could stop the interview to take 
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a break, adjust their stimulator or to withdraw from the study. I 
collected the information on the demographic data sheet (see 
appendix P) and then proceeded with the interview schedule (see 
journal paper).  
 
Following the interview, participants were thanked for their 
involvement and given the opportunity to ask questions. I offered 
participants some leaflets with details of support services (e.g. 
Samaritans) as well as the Patient Advice and Liaison Service.  They 
were also left with the contact details of the clinical psychologist in 
the research team and advised to contact their General Practitioner if 
they required any post interview support. Lastly, participants were 
offered the opportunity to receive a summary of the study. Four 
participants signed the study request form (see appendix Q), 
whereas the remaining three participants declined this offer.  
 
For each of the interviews, I followed the lone working policy of the 
University of Nottingham and the NHS Trust Lone Working Policy. 
This entailed informing a member of university staff and my clinical 
supervisor who works for the hospital trust, of my whereabouts both 
prior to and after each interview.   
 
2.8.1 Interview  
I employed face-to-face interviews to gather more in-depth 
descriptions of participants’ life worlds and to allow interpretation of 
the meaning of the described phenomena (Kvale, 1983). These were 
chosen over telephone interviews, as face-to-face interviews allowed 
observation of social cues.  These included voice intonation and 
body language (Opdenakker, 2006); helping to put their descriptions 
into context for when analysing the data. I felt that meeting 
participants face-to-face aided the researcher/participant relationship, 
which was particularly important given the sensitivity of information 
discussed. Although focus groups have been employed when using 
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IPA (e.g. Flowers, Knussen, & Duncan, 2001), I wanted to capture 
participants’ idiographic account of their experience. I felt that using 
focus groups may have influenced what, and how much people 
disclosed.  Given they were face-to-face interviews, I felt it was 
beneficial to have the interviews in the comfort of their own home. 
This way, their identity could remain anonymous to others, which 
would have been more difficult in a hospital setting. Although, I did 
feel it was important to give participants a choice.  
  
2.8.2 Semi-structured interview schedule 
IPA literature suggests employing a semi-structured interview 
schedule to guide the interview process (Smith et al., 2009; see 
journal paper). However, this is not intended to be prescriptive 
(Biggerstaff & Thompson, 2008). During the development of the 
interview schedule, I consulted existing literature on CP and SCS 
alongside previous studies that had used IPA semi-structured 
interviews (e.g. Smith & Osborn, 2007). Following discussions with 
clinical and research supervisors, I produced a final interview 
schedule. I then liaised with members of the pubic to ensure the 
schedule was accessible and easily understood.    
 
The interview schedule followed a chronological sequence to explore 
the treatment journey comprehensively. I felt it was important to 
contextualise their SCS experience by understanding what had led 
participants to choose this treatment option. As suggested by Smith 
et al. (2009), I employed open ended questions alongside a mixture 
of the following: description questions (e.g.  describing life before and 
after the surgery); evaluative questions (e.g. related to feelings about 
the experience of pain and suggestion of SCS surgery); comparative 
questions (e.g. exploring if the experience of pain and the surgery 
had changed the way the participant felt about themselves); and 
prompts (e.g. can you tell me more about that?). Prior to the 
interviews, I had learnt the schedule to avoid distracting the 
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participant by reading the questions. I also used prompts when 
interesting claims or concerns were raised.  
 
2.8.3 Contextualising interview 
Notes were made during the interview and afterwards, to provide 
initial reflections and observations (Smith et al., 2009). They not only 
acted as a reminder of topics I wanted to return to during the 
interview, but allowed me to document when there were changes in a 
participants’ participation or if they were referring to items in the room 
such as the remote for the stimulator. This contextualised the topic 
under discussion and acted as a prompt when transcribing and 
analysing the data. I also found that having demographic information 
(e.g. about past operations and current medications) helped to 
contextualise the content of participants’ accounts.  
 
2.9 Ethical considerations 
Ethical approval was sought and granted from the Leicestershire, 
Northamptonshire & Rutland Research Ethics Committee 1 (LNR 
REC 1; see appendix I) and the University of Nottingham. R&D was 
sought and approved by a NHS trust hospital (see appendix J). As 
previously stated, a minor and substantial amendment were 
submitted and approved by ethics and R&D during the recruitment 
process. An annual report was also submitted to ethics which 
informed the committee the study was being written up (see 
appendix R).  
 
2.9.1 Informed consent 
All participants received the patient information sheet with details 
about the purpose of the study and details of what would be involved. 
Participants were given the opportunity to ask questions about the 
study when arranging the interview, the day before the interview and 
prior to commencing it. Prior to obtaining written consent, I informed 
participants that every effort would be made to maintain their 
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anonymity and confidentiality. It was explained that I would be using 
direct quotes from the interview in the write up but that pseudonyms 
would be employed. Participants were made aware that the thesis 
would be submitted to the university to be marked and that the 
research, or part of it may be published.  
 
Participants were informed of their right to withdraw from the study 
up to one week after the interview. It was explained that withdrawal 
after this time could result in their data still being included in the 
analysis. I also highlighted the reason for the time limit being 
because if participants withdrew their data, it would impact on the 
analysis. Additionally, it was explained that even if they chose to 
withdraw, their data could not be erased, in line with the University 
research policies. I re-iterated that their participation was voluntary 
and would not impact on their routine medical care. There was no 
evidence during this process to suggest that any participants lacked 
capacity to consent (Mental Capacity Act [MCA], 2007) other than the 
case previously described [see section 2.7.1, stage four].  
 
2.9.2 Confidentiality and anonymity  
All participants were assigned a participant number prior to interview 
and a gender specific pseudonym. The former was used on interview 
transcripts and the latter was used in the write up. All third party 
information including names of healthcare professionals, family 
members, hospital names, wards and locations were omitted. These 
were noted in the transcript as [wife’s name] or [hospital 1].  
 
2.9.3 Data storage 
Following the interviews, the data was transferred onto a University 
computer and then onto an encrypted memory stick, the data was 
then deleted from the computer. The encrypted memory stick was 
stored in locked filing cabinets at the University of Nottingham. 
Identifiable information (consent forms, study summary request 
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forms, audio recordings and a sheet matching participant name to 
the pseudonyms and identification number) was stored separately to 
the non-identifiable information (transcripts and demographic 
information sheet).  
 
2.9.4 Risk of harm 
It was important to think about potential benefits and risks for the 
study. Although, adverse events were not expected these were 
prepared for, given the sensitive nature of the topic under discussion. 
Therefore, these were clearly outlined in the patient information sheet 
to help prepare participants.  
 
  Benefits 
The patient information sheet acknowledged that there were no 
specific benefits for participants other than their account potentially 
helping inform future practice. However, research suggests that 
following interviews with CP patients, participants have expressed 
feeling grateful at having someone listen to their story (Walker, 
Sofear, & Holloway, 2006). This is important as the literature 
indicates individuals suffering with CP often feel dismissed by 
services (Walker, Holloway, & Sofear, 1999). However, I am equally 
aware that the benefits of having the opportunity to discuss 
difficulties can vary across cultures (Fuentes, 2004). I recognise that 
the value of emotional expression in one culture may be in contrast 
to the value of stoicism in another (Fuentes, 2004).  
 
  Risks 
Given that IPA is an iterative process, the interview schedule only 
served as a guide. This meant that questions were formulated at the 
time of the interview depending on the information participants 
disclosed. Therefore, the depth and detail of information discussed 
was dependent on participants’ answers to the questions. This was 
detailed in the patient information sheet alongside the potential that 
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the topic of discussion could evoke distress. Three participants 
became emotional when discussing how their life had changed due 
to their neuropathic pain. On these occasions I offered the 
participants the opportunity to take a break or stop the interview 
altogether. These participants reported being surprised at their 
reaction to the interview. I was mindful at these times of my role 
being that of a researcher, however I felt my clinical skills were useful 
in helping the participants feel contained and supported. 
  
2.10 Analysis 
During the analysis I was interested in learning about my participants’ 
psychological experience and meaning-making of their SCS 
treatment journey. This involved a cyclical process of moving from 
description to interpretation, from particular personal examples to 
more general categorisations of converging and diverging themes, 
both within and across transcripts (Smith & Osborn, 2008; Smith et 
al., 2009). During the analysis, I experimented with different ways 
suggested to organise the data; using post-it notes and word 
documents until I found a process that suited both me personally and 
my data. I completed an audit trail to record the interpretation 
process as it occurred which involved documenting my thoughts at 
each stage of the analysis (see appendices S-W for an example of 
the audit trail). I broadly worked within the framework advocated by 
Smith et al. (2009). This aims to aid novice IPA researchers. 
However, I attempted to be flexible in my use of these guidelines.  
 
2.10.1 Stage One: Transcription 
Following each interview, I transcribed the digital recording. I found 
this to be an important part of the analytic process as it allowed me to 
engage closely with participants’ accounts and use my notes made in 
the interview to contextualise their narratives. During this process, I 
made use of my reflective diary to note any assumptions, 
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observations or interesting ideas. This way, I could refer back to 
these at a later stage, when required.  
 
2.10.2 Stage two: Initial engagement with the text 
The first stage involved reading and re-reading the first transcript of 
data. I also listened to the digital recording. This aided my memory 
on how certain things were said, providing further context to claims 
and concerns. In addition, I was able to reflect upon richer parts of 
the data and more challenging parts of the interview for me or the 
participant. In order to make the participant the focus of this process, 
I again made notes of any interesting observations to help redirect 
my attention to the meaning of what the participant was conveying 
(Smith et al., 2009).  
 
During this active engagement with the data, I paid attention to the 
shifts from more generic explanations to detailed descriptions given 
of particular events. This helped me to focus on different parts of the 
interview in relation to the underlying narrative. This was helpful in 
moving away from the chronological order of the interview schedule 
(Smith et al., 2009).  
 
 2.10.3 Stage three: Exploratory coding 
I completed a close, line by line, analysis of the transcript (Larkin et 
al., 2006). In order to do this, I created four columns on a page which 
were titled: Initial themes (for next stage of analysis), line numbers, 
transcription and exploratory coding. Although there are no specific 
rules as to how to undertake this, I drew on Smith et al. (2009) 
guidelines and completed three levels of exploratory coding: 
Descriptive (Blue), linguistic (red) and conceptual (purple) coding 
(see appendix T for example of exploratory coding).  
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  Descriptive 
The descriptive comments aimed to describe the content of the 
account in relation to participants’ CNP and SCS surgery. Key words 
or explanations were noted alongside assumptions and emotional 
responses, for both participant and analyst (Smith et al., 2009). I 
aimed to focus on their relationship to the important things that made 
up their experience of pain and SCS, but very much taking these at 
face value, as advised by Smith et al. (2009).  
 
  Linguistic 
The linguistic comments focus on participants’ use of language. At 
times when the language and content were related, this was noted. 
For example, I made comments on participants’ use of pronouns, as 
a few participants moved from using ‘I’ to ‘you’ within their accounts. 
Noting these examples allowed me to reflect on what this change 
may represent. Also, any pauses, laughter, repetition, metaphors and 
changes in tone and fluency were also noted (Smith et al., 2009). 
  
Conceptual 
Conceptual comments formed the more interpretative, and 
interrogative aspect of the exploratory coding (Smith et al., 2009). 
This draws on the descriptive and linguistic comments, to think on a 
more abstract level about the data. It encouraged me to think about 
what participants were saying, how they were saying it, and also 
what they were not saying. I often took an interrogative approach, 
questioning what certain claims meant to the participants. For 
example, when Maya repeatedly asserted her need to ‘carry on as 
normal’ (said a total of 24 times), I wondered what it would mean to 
Maya to stop and not carry on as normal? It took time to reflect on 
this and refine my ideas. It also involved drawing on personal 
reflections at a micro and macro level. For example, when 
participants talked about avoidance, I reflected on times that I have 
avoided certain tasks or thoughts. I also reflected on a broader level 
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as to how I previously understood SCS and my new developing 
understanding the experience (Smith et al., 2009).  
 
Examples of this coding were taken to supervision and to a peer 
review support group, in order to ensure the exploratory coding was 
sufficiently embedded within the original data.  
 
2.10.4 Stage Four: Developing initial themes 
The aim at this stage was to reduce the volume of the coding, whilst 
maintaining the complexity of associations within the coding (Smith et 
al., 2009). This involved fragmenting participant stories and re-
organising the data. Thereby, my role became more central during 
this interpretative process (Smith et al., 2009). The aim was to 
capture an understanding based on the participants’ original account 
but also my interpretations of this account. This was captured 
through pithy statements which were noted in the left-hand column of 
my table (see appendix U for example of initial themes). 
 
I again sought supervision in this process to ensure the audit trail 
was clear as I moved further into the interpretative process of IPA. Of 
note, I chose to change the term emergent themes to initial themes, 
as suggesting that themes emerge from the data could be interpreted 
as minimising the researcher’s role in interpretation (Braun & Clarke, 
2006) which is inconsistent with the hermeneutic underpinnings of 
IPA.  
 
2.10.5 Stage Five: Searching for connections across 
themes 
Thus far, the themes were in the chronological order of the transcript 
(Smith et al., 2009). Therefore, I listed the themes in alphabetical 
order; this allowed me to see similar themes that could be collapsed 
or removed. Any themes removed were placed into a table of 
removed themes, alongside a reason why I felt they should not be 
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included. At this point, I documented how many times a theme had 
occurred within the transcript. This is referred to as a numeration 
analysis (Smith et al., 2009). The aim is not to perceive frequency as 
representing the only indicator of importance but it aided the 
conceptualisation process of how relevant it was to the participant 
(Smith et al., 2009; see appendix V).   
 
I then began to think creatively about how the themes may fit 
together. At this point, I experimented with different ways of doing 
this. I tried looking at the list and how themes converge and diverge, 
but also tried using post-it notes to display the themes so I could 
visually map out the connections. I found the former to be more 
manageable and appropriate to identify the relationships between the 
initial themes.  
 
During the process of trying to identify the super-ordinate themes that 
captured how the initial themes linked together, I employed three 
techniques: Abstraction, subsumption and polarisation (Smith et al., 
2009). Abstraction involves clustering initial themes together that are 
similar and subsumption is when an initial theme becomes the super-
ordinate theme. Lastly, polarisation is where oppositional 
relationships between themes were captured (Smith et al., 2009). For 
example, the re-occurring polarisation within the transcripts was the 
positive and negative aspect of SCS.  
 
During this process, I made a number of entries in my reflective 
diary, as I wanted to ensure that the interpretation process was 
sufficiently documented to help me reflect on my decisions to retain 
or discard themes. This was also aided by the removed themes 
table. Once I had finished exploring the connections and patterns, I 
created a table of the super-ordinate themes and relevant initial 
themes (see appendix W).  
 
107 
 
2.10.6 Stage six: Moving to the next transcript 
The next stage involved moving on to the next transcript and 
repeating this process. In line with IPA’s idiographic commitment, as 
far as possible, I tried to bracket previous ideas from the other 
transcripts. However, I also acknowledge that this cannot completely 
be achieved. I found using my reflective diary helped with remaining 
true to each individual account. I reflected on times I felt I was being 
influenced by other transcripts so I could return to these notes later 
when I brought them together, if relevant. 
 
2.10.7 Stage seven: Pattern across transcripts 
I then began to look for the connections between the transcripts. I 
laid out each table and scanned them for connections and potency 
which led to some re-labelling of themes.  I completed a recurrent 
theme table as for larger samples; this is suggested to be a useful 
means to see where themes were applicable to more than half the 
participants (Smith et al., 2009; see appendix X for recurrent theme 
table). I sought supervision for a critical voice on my analytic process, 
to see that my reasoning was clear and embedded in the original 
data. The analytic process continued as I wrote up the results, where 
I included a table to represent the whole analysis (see journal paper).  
 
2.11 Quality assurance measures 
A number of quality assurance criteria have been developed for 
qualitative research methods (see Denzin & Lincoln, 2011; Elliott, 
Fischer, & Rennie, 1999; Yardley, 2000). These criteria aim to 
ensure the quality and credibility of qualitative research given the 
subjective nature of these methods. For the current study, I 
employed a number of strategies aiming to convey trustworthiness 
(Denzin & Lincoln, 2011). I also followed Yardley’s (2000; 2008) 
criteria of being sensitive to context, showing commitment and rigour, 
demonstrating transparency and coherence and ensuring the 
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research has an impact and importance. The ways this was achieved 
will now be outlined. 
 
2.11.1 Study preparation 
During planning the study, I familiarised myself with the SCS 
treatment process in the hospital undertaking the SCS surgery 
(Sheldon, 2004). This was to ensure I understood relevant details of 
the process. This helped me be sensitive to context during the 
interview so I understood, and could be responsive to, what 
participants were referring to, and descriptions of any specific SCS 
events. I also thought about the context within which the interviews 
would take place. Therefore, I offered participants the option of 
having them at home or in the hospital environments, which were 
both familiar places, inherent to their CNP experiences.  
 
 2.11.2 Audit trail 
An audit trail was kept of all analytical decision making so that there 
was documentation of the rationale of my choices. In addition to this, 
during the write up of the study, I provided sufficient details of the 
procedure and analysis, employing participant quotes to establish an 
audit trail for the reader. This contributes to the coherence, rigour 
and trustworthiness of the findings (Denzin & Lincoln, 2011). 
However, I acknowledge that certain details of changes to the 
procedure could not be included in the journal paper due to word 
limitations.  
 
2.11.3 Supervision and peer support 
Regular supervision and peer support (IPA peer support group) was 
sought during different stages of the analysis. This was to increase 
the credibility and plausibility of my coding and interpretations (Smith 
et al., 2009), ensuring they were reflective of the original data. 
Gaining convergence of interpretation was not the aim of this 
process, as accuracy and objectivity were not the focus. This also 
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was a useful means to develop my analytical skills throughout the 
process.  
 
2.11.4 Reflective diary 
The reflective diary was employed to reflect on decision making, 
challenges during recruitment, the analysis and the final write-up.  
Initial reflections following the interviews were also digitally recorded 
(see appendix S). Through noting preconceptions and observations 
during the analysis, I was able to refer back to these during the write 
up. These strategies contributed toward demonstrating transparency 
and coherence (Yardley, 2000, 2008).  
 
2.11.5 Impact and importance 
There are clinical implications that have been identified, which can 
increase professionals and future SCS candidates understanding of 
the experience of this procedure. Therefore, it has potential for 
impact and importance for those in the neurosurgical and pain 
management fields. 
 
2.12 Quality assurance methods not employed 
There were also methods of quality assurance not employed in the 
current study. The technique and reason for exclusion will now be 
discussed.  
 
2.12.1 Triangulation 
Triangulation is mixing data methods to gather diverse viewpoints to 
validate claims being made about data (Olsen, 2004). It is used by 
those working within a realist framework and can be used to assess 
‘reliability’ of qualitative analysis (Madill et al., 2000). It can also be 
employed to corroborate researchers’ perspectives of the data to 
strengthen the understanding of the findings (Yardley, 2008). 
However, this can be perceived as trying to find a ‘truth’ in 
participants’ accounts or attempting to gain external verification of the 
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analysis (Ponterotto, 2005). In the current study, I did not aim to find 
a ‘truth’, therefore did not need evidence of ‘accuracy’ or ‘objectivity’ 
(Madill et al., 2000, p.3) of the participants’ accounts. In line with my 
critical realist epistemological position, I believe there are multiple 
perspectives of reality at any given time. It would also be adding 
another level of interpretation from a different person which is 
inconsistent with the double hermeneutic central to the IPA process. 
It was for these reasons I did not employ triangulation in the current 
study.  
   
2.12.2 Participant validation 
Participant validation is another process used to validate qualitative 
data. This involves clarifying with participants that the information 
yielded is a true reflection of their account. I did not employ this 
method as it again is not in with my epistemological position. I 
recognise the accounts captured are specific to time and context and 
they are likely to change if I interviewed them at a different time and 
place. This is reflected by one of my participant’s comments at the 
end of his interview: ‘it’s been nice to get it out, and in fact I might 
feel a lot different now I’ve actually sat down and phuff (noise with 
mouth) and brought it out’. Therefore, I did not feel that participant 
validation would achieve the purpose of validating claims made in the 
interview. Instead, it would add new reflections to the account, 
changing the double hermeneutic of that time and context. 
Furthermore, participant validation makes considerable demands on 
participants’ time (Barbour, 2001) and potentially their physical as 
well as emotional well-being. This further reinforces it not being 
appropriate for the current participants who are often in discomfort 
and pain. 
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2.13 Researcher characteristics 
As part of the reflexive component of qualitative research it is 
important to identify any personal influences on the research and to 
convey characteristic about myself. I am a trainee clinical 
psychologist, who takes an integrative approach to my clinical 
practice, drawing on a range of psychological theories such as 
systemic, narrative, cognitive-behavioural, attachment and 
psychodynamic. All my previous clinical experience has been 
working in mental health. However, I had recently developed an 
interest in the area of physical health, which has increased since 
undertaking this research. I do not have experience of CNP or SCS 
surgery. Prior to this research, I had not conducted any research 
employing qualitative methods. This was another novel avenue of 
exploration. Although I have previously found the structured nature of 
quantitative research comforting, this is not necessarily consistent 
with the integrative approach to my clinical practice. Therefore, the 
flexibility in qualitative methods provided a learning opportunity to 
broaden my research skills and deviate from more structured 
thinking.    
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3.0 Extended Results 
The following section is an extended version of the themes 
previously identified in the journal paper.  It aims to provide a more 
comprehensive understanding of participants’ experiences, providing 
more details of the commonalities and divergences between 
participants.   
 
3.1 Diminished control and coping 
This theme reflects coping with the psychological, physical and social 
impact of CNP alongside the diminished sense of control that 
occurred at multiple levels as participants worked their way through 
the system. It draws on the coping processes utilised both before and 
after SCS surgery.  
 
3.1.1 Battling the system and managing expectations 
All participants described a battle through the system, managing 
expectations, and trying various unsuccessful treatments. However, 
for some, it was also a battle with the system. During the course of 
their treatment journey, four participants described not being believed 
and feeling stereotyped by professionals. These participants did not 
only have to cope with the impact of their pain, but also others 
responses to this invisible illness, leading to low mood, hopelessness 
or anger. Nicole’s extract indicates the initial response she received 
from services at the beginning of her treatment journey:  
 
Nicole: ‘...went to doctor (hesitation, inhales), which was a bit of 
waste of time, cos he thought I was just trying to skive off work...I 
suppose back pain, it’s er, a common one’ 
 
For Nicole, she initially experienced this by her doctor, however she 
continued to experience these reactions years later, in other 
contexts. Such experiences contextualise the battle for these CNP 
patients, depicting the numerous challenges presented; it becomes 
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clear how they can end up in a desperate and hopeless position in 
trying to cope with the internal experience of pain and external 
pressures related to CNP. This was particularly depicted by Sally and 
Sarah in their fight to gain SCS which dominated their interviews. 
Both participants found themselves in a waiting game, where they felt 
punished and let down by the system as they struggled to secure 
funding. Sally’s first stimulator had to be removed, however, it had 
provided four and half months of pain relief, which motivated her to 
fight for another: ‘I really missed that four and half month, and it was 
that four and half month that thought, yeah, you’ve got to go and, and 
fight to get it back’. For Sally, her attempts to gain control changed as 
her desperation increased. She went from bargaining, to pleading, to 
pestering HCPs as illustrated in the following extracts:  
 
Sally: ‘Just kind of get me the money, the funding to get it done, let 
me have it done, and I’ll walk away and you’ll never hear from me 
again’ 
 
This turned into pleading: 
 
Sally: ‘I said to them ‘look you know, just let me have this one 
chance, another one chance, it wasn’t my fault in the first place it 
[SCS] had gone wrong, if the machine had of been working perfectly, 
you wouldn’t have had all this trouble’ 
 
This then changes to pestering: 
 
Sally: ‘I knew at some stage that if I kept pestering and pestering and 
pestering (laughing) they would either say clear off or yeah we’ll give 
you the money...which obviously succeeded’  
 
Although the process for Sally and Sarah had happened over the 
course of years, their experiences appeared quite vivid in their mind 
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as well as their associated emotions. Although anger was a common 
emotion amongst participants, some participants presented with an 
enforced passivity, like a learned helplessness as they struggled with 
the devastation of returning ‘back to square one' (Mike and Pete). 
This impacted on participants’ expectations of SCS in different ways. 
Sally and Mike both had a previous SCS removed due to 
complications. Therefore, they talked about keeping their 
expectations low, although not all participants were able to do this. 
For Mike, despite maintaining awareness of his previous 
disappointments, he continued to describe hope and gratitude for this 
opportunity: 
 
Mike: ‘I couldn’t wait for it [second SCS], you know, cos I thought, it’s 
surely not gona happen twice and it didn’t... I was great, grateful at 
the chance to have it done again’ 
 
Mike alluded to some worries about gaining another infection with his 
second implant, but like most other participants he described a faith 
in SCS. Sadly for Mike, his replacement SCS had recently stopped 
providing adequate pain relief six months post implant. Mike likened 
his SCS experience to a rollercoaster:  
 
Mike: ‘it’s been a rollercoaster really, mentally it’s been ‘oh great, this 
is gona be good and...this works, be positive er, physically it was 
good [SCS], but now it’s not good, so again, it’s a rollercoaster’. 
 
This rollercoaster meant uncertainty for Mike, or perhaps certainty of 
needing to accept this was the end of his treatment journey (as 
presented in the sub-theme disappointment, adaptation and 
acceptance). However, this metaphor represents well the 
unpredictable nature of patients’ treatment journey, like an emotional 
rollercoaster.  
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3.1.2 Multiple levels of powerlessness 
A sense of powerlessness was experienced on many levels at 
different points throughout participants’ treatment journey. Four 
participants described particularly negative experiences in hospital, 
however only three of these were related to their SCS experience. 
These three participants described feeling dismissed by hospital 
staff and feeling there was a lack of organisation which negatively 
impacted on their care. Two participants had difficulties gaining 
pain relief post-operation. Sarah’s treatment journey was saturated 
with powerlessness, not only in her struggle to secure SCS funding, 
but also in getting an appointment for the operation and her 
subsequent time in hospital. As Sarah told her story of problems 
with her post-operation pain relief, she was sarcastic in tone in the 
interview, indicative of her underlying anger and disbelief at her 
treatment. Her desperation for someone to listen was apparent as 
illustrated in the extract below: 
 
Sarah: ‘She [nurse] keeps telling me to click the hand [on morphine 
drip], I say ‘I am clicking’ she goes ‘it’s going through’, she kept 
checking the monitor, so I said ‘well I’m obviously not getting 
enough pain relief’ I said ‘so go and get someone to make sure I’m 
getting enough pain relief’...she said ‘just let me check’, she went 
‘oh dear it’s not in your hand’ (sniffs). So I hadn’t had any pain 
relief’. 
 
The demanding demeanour of Sarah’s pain identity alluded to here, 
came across in the interview as she recalled the events. Sarah 
made reference to an unhealthy dynamic between her and the 
staff. As her pain increased, her behaviour became more 
demanding, increasing staff frustration. This led to them being less 
likely to listen to her concerns and complaints, leaving Sarah 
feeling not listened to and lacking control. Others described a 
similar cycle, Nicole felt ‘the staff just weren’t, weren’t interested’ as 
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she tried to explain she needed the morphine pump as paracetamol 
just would not do. 
 
This powerlessness was also experienced in relation to medication 
and SCS side-effects. Four participants reported unpleasant SCS 
side-effects which heightened their awareness of their movements.  
The way these side-effects were experienced differed amongst 
participants, apart from Jack and Maya who both described 
experiencing intense shocks. This extract highlights not only the 
powerlessness, but the associated anxiety: 
 
Jack: ‘you get a little bit paranoid about what you’re doing next 
(pause), if you get what I mean, because you don’t want it to do it 
again. So you-you know sometimes, I feel like I’m sat there like a 
doll, I don’t want to move, because if I scratch that bit, bang I’ve got it 
again’. 
 
The lack of control over the side-effects placed further cognitive 
demands on these participants, making them more vigilant. In 
contrast, Nicole and Pete also experienced physical difficulties from 
the side-effects. Nicole lost her balance and Pete lost the feeling in 
his leg, which placed him in some dangerous situations: 
 
Pete: ‘I suddenly lost all feeling in my left leg, and I’m driving, and I 
ended having to drive for the last (inhales) 5 or 6 miles...literally 
picking my leg up and pushing it down on the clutch to change gear 
and lifting it back up again and that’s how I, that’s the only way I got 
home’. 
 
Participants described adapting to this powerlessness and 
consequently feeling ambivalent about their SCS. This links with 
disappointment, adaptation and acceptance sub-theme.  
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3.1.3. Coping with symptoms of depression 
All but one participant explicitly talked about coping with symptoms of 
depression however, the remaining participant Maya, presented as 
emotional throughout the interview. Maya did not explicitly report 
feeling down; rather, repeatedly talked about needing to ‘carry on as 
normal’. This seemed to be a coping mechanism, a way of avoiding 
her sadness, pain and losses. Becoming emotional in the interview 
was not isolated to Maya; two other participants were surprised by 
their tearful reaction to telling their stories. The content of their 
accounts indicated transitional emotions, but also this underlying 
more long standing low mood and/or negative thinking, which was 
evident in other accounts. 
 
The depressive symptoms varied amongst participants, however all 
described low mood such as feeling ‘miserable’, ‘very low’, ‘at a low 
eb’ or ‘depressed’. Additionally, participants explicitly described or 
alluded to cognitive and behavioural symptoms of depression, such 
as negative or ruminative thinking or loss of motivation. Sally and 
Pete spoke specifically of a cycle of depression reporting losing 
motivation to attend to self care and appearance due to not going out 
or seeing anyone, as illustrated below:  
 
Sally: ‘...just downright miserable.... I thought, oh why bother, you’re 
not going out, you’re not doing anything, erm, and that did carry on 
right through the time, erm, I bunged on a hell a lot of weight, I didn’t 
particularly care, I wasn’t bothered, and just kind of let myself go’. 
 
Similarly, Pete described previously falling into a downward 
depressive spiral due to having to give up his career. This resulted in 
loss of identities and friends, thereby overlapping with the identity 
loss and impact on pain sub-themes:  
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Pete: ‘you lose all your dignity...you’ve not got a job, you’ve got er all 
you friends who you had in the job were in, don’t want to know you, 
because their working, you’ve got nothing to do, nobody wants to go 
out with you, because, you know they’ve got other things to do, you 
lose all your friends, you lose all contact with everybody else and as I 
say, you get into this mind-set that, erm, why should I bother? I’m not 
going anywhere today, I’ve got nobody to see and so, you end up not 
having a shave...you just sit about all day’    
 
Pete alludes to experiencing learned helplessness; he no longer had 
control over many aspects of his life, leading to loss of motivation to 
self care. It is a critical period for Pete during the interview, as his 
SCS had not met his expectations. This, coupled with potentially 
having to give up work led Pete to think about how he would cope 
with his motivation loss and lack of change in his pain relief. Pete and 
Mike were in many ways in a similar position due to their SCS not 
currently working for them and having the knowledge ‘there’s nothing 
else, if this doesn’t work’ (Mike). Both described a similar way of 
active coping, through bringing meaningful activities to each day. As 
Mike described: 
 
Mike: ‘I could lay down all day, no one here would moan [family]...but 
there’s no way mentally I want to do that, so as long I can do one 
thing a day, whether it’s one drawing or (inhales), something, erm I 
feel quite happy, if I can do one thing a day, then lay down...I erm 
(pause), like to do something, er, otherwise you waste your life away 
laying in bed and I don’t like that’. 
 
It seemed Pete, went from employing more passive, avoidant coping 
strategies to more active strategies (e.g. meaningful activities), 
having learnt from previous experience. Shifting between the two 
forms of coping was evident in all accounts. This theme inter-relates 
with other themes, particularly the SCS disappointment, adaptation 
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and acceptance sub-theme. Coping with such symptoms have been 
an ongoing process for all but one participant. In contrast, Sally’s low 
mood dissipated following SCS with her speaking only of happiness 
and positive change since her implant.  
 
3.1.4. Impact of pain and the non-able body  
This theme encompasses the profound impact participants’ CNP had 
on them psychologically, socially and financially, as well as the 
impact it had on those close to them. This feeling of being physically 
restricted seemed to be at the core to all other difficulties, as 
highlighted by Sarah: 
 
Sarah: ‘you can handle the pain to a certain extent, but not being 
able to do is the (pause), is the killer really’. 
 
Three participants explicitly described an on ongoing conflict 
between what they wanted to do and what they were physically 
capable of doing. It seemed these participants had 
compartmentalised their lived experience in line with a dualistic view 
of a separate mind and body ‘Your mind wants to do things, but your 
body can’t do things’ (Nicole). This was the source of much 
frustration, which can be likened to the aging process where the body 
can slow down faster than the mind. There is a sense that 
participants were aging prematurely as indicated by others 
responses to them ‘I’m not young, but I don’t want to be treated like 
an old man’ (Mike). Therefore, trying to cope with this appeared to 
focus around trying to get on with things and adapting their lifestyle 
accordingly. In contrast, Maya reported knowingly pushing herself too 
far and suffering as a result.  
 
Additionally, participants reported being aware of the impact their 
condition had on others.  Five participants described how their 
restrictions had negatively impacted on their relationships; this 
120 
 
included relationships with partners or/and families. For Sally, she felt 
her reluctance to go out, due to her tired body, put a strain on her 
relationship: 
 
Sally: ‘it did put strain on things...he’d say you know, shall we go out, 
shall we go here, or whatever, and I’d say well no I feel tired and I 
want to go to bed, I can’t’. 
 
Whereas for Maya, it was more related to physically not being 
capable:  
 
Maya: ‘...you want to keep up with everybody else and, you know 
you want to do things with your kids and have fun un, you know, do 
what they want you to do, and join in, but knowing you’re not capable 
of it, I think it spoils it’. 
 
This inability to keep up with others and join in, often led to 
participants to feeling or actually being excluded from social events 
with family and friends. For Jack, he describes his experience as 
being in an observer role, an outsider looking in but unable to be a 
part of it:  
 
Jack: ‘you sit in the side lines all of the time and it’s a really horrible 
feeling, it really is, cos you feel like, you, even though they-they don’t 
make me feel like that, but you feel like you’re at the edge of your 
family all the time, you can never get into the middle of it’ 
 
This physical barrier appears to induce a mental partition where 
participants felt separated from the world around them. This was 
echoed in three other accounts, where they felt excluded by not 
being able to drink alcohol and join in. These negative effects of 
medication were not restricted to participants’ social life; a total of five 
participants described various unpleasant medication side-effects. 
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Nicole and Pete reported their medication impacted on their cognitive 
abilities. For Nicole, her reduction in concentration negatively 
impacted on her ability to do her job, isolating her from work 
colleagues who she felt did not understand her pain. Participants 
appeared to generally not feel themselves on medication. This 
concept of presenting with a medicated self was captured by Jack in 
his account about the impact of his excessive sleeping: 
 
Jack: ‘if I took some [medication] of that in morning, I use to sleep 
until 5/6 o clock in-in the evening...Then I use to be awake in a little 
bit, bit dopey for a couple of hours...It’d be time to have some more, 
sleep all night, and then, so I didn’t get to see the kids really. It upset 
the kids because obviously I-I wasn’t me, if you know what mean 
(pause)...it was like everything seemed slowed down if you know 
what I mean, when people were talking to me and everything, and I 
think that frightened the kids slightly cos it was like, what you being 
like this for?’ 
 
This demonstrates the impact of his medication on his family life and 
how his children were unable to understand how he was when 
medicated. The sense of guilt associated with this left Jack in an 
awkward position, of being in pain or scaring his children, hence his 
preference for his SCS.  
 
All participants described the different ways they coped with these 
changes. They reported becoming dependent on their medication or 
others or on physical aids. They also made various lifestyle 
modifications; behaviourally, environmentally and cognitively as a 
means to prevent pain. Behaviourally, participants avoided certain 
movements, whereas environmentally they adapted their homes (e.g. 
banister on stairs) or at work got ergonomic chairs or supports to 
accommodate their pain. Three participants talked about cognitive 
adaptations in relation to having to plan everything they did. They 
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described or alluded to loss of spontaneity and freedom due to 
having to think about their capabilities, as illustrated by Pete in the 
extract below: 
 
Pete: ‘‘Now I have to think, I’m going there, what do I do when I get 
there? How am I going to get about?...You have plan everything you 
do, otherwise you’re gona end up in a lot of pain’. 
 
Such adaptations were not restricted to prior to the SCS surgery as 
demonstrated by Maya: 
 
Maya: ‘...It doesn’t matter what you do in life, in your everyday life, 
you have to (pause) consider, am I capable of doing that?...But 
you’ve got to consider, I’ve got to take all of my pills with me, I’ve 
got to take my, you know, my stimulator with me [remote], and 
everything, it’s like, it’s like a baggage’. 
 
Such measures act as an additional pressure and constant reminder 
to participants of their restrictions and changes they have had to 
make for their pain. Participants also described adapting to living with 
the stimulator which is described later. The most pronounced impact 
for this group of participants seemed to be on the relational aspects 
of their identities, which is captured in the next theme.  
 
3.2 Identity transitions  
All participants talked about experiencing loss of meaningful aspects 
of their lives, particularly significant roles, thereby fragmenting their 
sense of self and impacting negatively on their self-esteem and 
mood. An additional part of the process is self-acceptance of this 
new aspect of themselves; their pain identity. 
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3.2.1 Identity loss 
This theme depicts the loss of the social self and subsequent group 
identities. Common to all participants, was this loss of belonging to a 
group whether this be related to friendship groups, family, work, 
group sports or activities. All participants referred to their past active, 
functional selves, often detailing the sports and activities they 
previously were involved in. There was a sense of associated grief in 
not being able to do them anymore. For Nicole, her life was full of 
different activities where she led teams in competitions, providing her 
with purpose, friendship groups and a sense of achievement: 
 
Nicole: ‘I use to do an awful lot of sub-aqua diving, cos I’m an 
advance diver, cross country orienting, fair walking...I got involved in, 
a lot with the dogs with doing erm, agility courses...But that’s all 
running around and that’s out the window now’. 
 
And later she describes how she gradually lost such roles and 
consequent group identities: 
 
Nicole: ‘I was with, a very active group of people aannd initially it 
was ok, a little bit of time and you end up back up with them and then 
you turn, you end up with a stick and then crutches, and as things 
gets worse and then you are just not wanted because you’re an 
embarrassment’. 
 
The meaning she once gained from the group was lost as her pain 
identity and associated disability became more established. This loss 
of her active role in this friendship group in conjunction with feeling 
rejected by those she valued appeared to reduce her feelings of self 
worth. This led to a learned helplessness with Nicole giving up on 
feeling angry about their perceptions and accepting it: ‘You give up 
having feelings (pauses, eyes filling up), you just learn to accept it 
(cries)’.  
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The sense of belonging yielded from these group identities was 
prevalent in relation to work roles as well. The four participants who 
were no longer working talked about the loss of their work roles and 
the implications of this. Common to most was again this sense of 
having a purpose and the social aspects of working. Sally described 
her job as a hair dresser as all she wanted to do but had to give up 
due to the standing involved. When talking about why she missed her 
job, she explained: 
 
Sally: ‘...I suppose the going out, the meeting people, erm (pause), 
and feeling as though you are doing something in your life’ 
 
Similarly, Jack commented: 
 
Jack: ‘it’s like going to work, when you, cos obviously you get 
relationships at work as well, friends and stuff, you miss out on all 
that’ 
 
Jack also alluded to feeling he was not fulfilling his role as a husband 
in providing for his family ‘l feel like I should be supporting me family’, 
which was an emasculating experience alongside being dependent 
on his wife to shower and dress him. In contrast, for Sarah not being 
able to work meant she could not fund social activities, therefore lost 
these social roles.  
 
For the three participants who continued to work, they had to adapt 
their roles to accommodate their pain, which for Pete and Maya 
induced a sense of loss. For Pete, his career was an enormous part 
of his current and future identity, a disruption that had been difficult to 
accept, resulting in depressed mood as previously described. This is 
illustrated in the following quote where he describes the impact of 
having to change work roles which was a loss of a role he valued:  
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Pete: ‘I’d got my (cough), my career planned out, that this is the route 
I’m gona take and this is where I’m going to go, but, that suddenly 
came to a halt...you go down in that spiral, your life’s ruined’ 
 
And later... 
 
Pete: ‘it rips your heart out, you know, this is the job, this is the 
vocation you’ve set your heart on and somebody’s taken it away 
(hesitation) and (pause) it, you lose, you lose all your dignity, 
because you know, you’ve got nothing now, you’ve not got a job, 
you’ve got er all you friends who you had in the job were in, don’t 
want to know you, because they’re working, you’ve got nothing to 
do’.  
 
There was a sense of mourning the loss of their roles and few 
references to developing new ones. It seemed that SCS had great 
significance to these role and identity losses as the outcome of the 
SCS surgery for many participants would determine whether any 
could be re-claimed or adapted. This links with the disappointment, 
adaptation and acceptance sub-theme which captures this 
acceptance process of losses that did not change and the pain 
identity. 
 
 3.2.2.  Managing the unwanted pain identity 
Five participants referred to their pain identity in a predominantly 
negative manner due to perceiving these aspects of themselves as 
particularly undesirable and shameful, such as being ‘bad-tempered’, 
‘aggressive’, ‘unresponsive’, ‘short-tempered’ and having ‘no 
patience’. Maya talked explicitly about her embarrassment of being 
someone with a disability and her attempts to avoid this label.  
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Maya:  ‘I had to use the stick for a while and I wouldn’t go out the 
house, I would never go out the house and use the stick cos I felt 
embarrassed... 
..R (Researcher): What would you say that you felt embarrassed 
about? 
I (Interviewee): Feeling hu-, that I had a disability and it was affecting 
me, erm (sniffs, pause) but I try not to think about it’ 
 
For Maya, it was not only the label that was upsetting; it was how it 
affected her and her ability to cope with it. In order to dispel the 
negative emotions associated with attending to this part of her, she 
avoids thinking about it. Thinking about this, perhaps meant 
accepting this aspect of herself, which she was finding hard to do. 
Since her SCS she described learning her limits and seemed to be 
trying to accept her capabilities. There was a contradiction in Maya’s 
account suggesting she was in some kind of identity transition. She 
struggled with the visibility of her disability and being treated 
differently by others, yet she equally yearned for validation of the 
distress that it brought her:  
 
Maya: ‘it’s more because people look at me and think there is 
nothing wrong with me, and then they don’t know...what’s within do 
they so? They don’t know what you’ve been through...I think 
sometimes I can’t come to terms with that [disability label], even 
you know this far on, this far down the line (sniffs), that still bothers 
me, that I’m classed as having a disability now’. 
 
This heightened awareness of how their pain and disability were 
visible was evident in five other accounts. Exactly how it was visible 
was unique to each participant, for example physical aids (e.g. 
walking stick), body language (e.g. behaviours in response to pain 
such as hobbling), or mood. Participants appeared to feel that others 
defined them by their pain so they masked the visibility of their 
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disability and associated emotions or avoided situations. Mike and 
Jack also explicitly talked about not wanting to be treated differently 
and how the visibility of this aspect of their identity conflicted with this 
wish.  For Mike, the stimulator had given him hope that a reduction in 
his pain behaviours would inadvertently impact on others responses 
to him. He talked about finding it frustrating being put into a sick role 
and being treated differently to others: 
 
Mike: ‘...looking forward to being without, hobbling about and people 
sort of, asking how I was, cos I get fed of, I hate sympathy (laughs, 
hesitation)...they all mean very well, but er, I hate it, being sort of 
fussed over... I don’t want to be treated like an old man...I’m not a 
macho man, by any means, but I-I hate being fussed over’. 
 
The latter part of this description suggests others’ response to the 
visibility of his pain, were emasculating, a threat to his sense of self 
which perhaps was already threatened by his pain identity. 
Therefore, Mike used humour as a coping mechanism and hope, 
hope that SCS would ‘bring him back to normality’. Similarly, Maya 
repetitively expressed her desire to be normal, which for Maya was 
being her pre-pain self. This desire for ‘normality’ was referred to in 
all accounts. However, for some participants the meaning of 
normality adapted over time.  For Jack, when his pain was 
significantly reduced by the SCS, it was a traumatic experience due 
to experiencing a sense of loss. His experience of pain had become 
his normality, part of him. This again centralises pain as shaping 
participants’ experience and sense of self, representing a conflict for 
Jack between his unwanted pain identity and what had been a 
consistent experience for 20 years:   
 
Jack: ‘I don’t know why I was so upset about it not hurting, I think it 
was more because it should have been, I’m that use to it being that 
way, it was quite upsetting because I thought there was something 
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wrong because it wasn’t hurting, but it wasn’t, it was cause 
something was right and it wasn’t hurting, which after a while, it was 
brilliant’. 
 
3.3  SCS Conflict 
This sub-theme captures what the SCS surgery outcome meant to 
the participants. Most participants were ambivalent about SCS and 
were weighing up the positive and negative aspects of it. In contrast, 
one participant felt solely positive about its effects, another felt a 
conflict between feeling grateful for his stimulator but disappointed in 
the lack of change.   
 
3.3.1  Positive change 
This encompassed the positive impact the pain relief had on six 
participants. Interestingly, four participants used the same phrase to 
describe the pain relief they gained, reporting it ‘takes the edge off it’ 
which had a positive impact on their mood. In contrast, Nicole 
experienced greater benefits from her stimulator as illustrated in this 
extract where she compares her current pain relief to the past:  
 
Nicole: ‘it’s getting on for a eight years now from when it all started, 
so you’re talking about, six months ago, so seven and a half years 
with not been out of pain, to the pain being reduced by something 
like 90%’  
 
In addition to pain relief, four participants reported being able to do 
more. However, the level of change differed amongst participants. 
Most described numerous smaller changes that had a significant 
impact on some aspect of the participant’s life. For example, for Mike 
being able to sit for longer periods meant a lot to him on a social level 
as he did not like exhibiting pain behaviours, nor being treated 
differently: 
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Mike: ‘I could sit and eat a meal, without having to get up half way 
through it, I could sit on an ordinary chair....when I use to visit friends, 
I could sit there a while without having lay down’ 
 
Similarly, being able to stand for longer had made Nicole’s working 
life easier. In contrast, the changes for Sally were profound resulting 
in significant changes in her lifestyle and in her sense of self.  
 
Sally: ‘going about more, and do more things.... just the total image 
of me, has totally changed, because I’m caring more about myself 
now, because I feel more confident, I feel more happier’. 
 
Being in less pain, meant Sally was happier, going out more and 
taking care of her appearance. She became less self-focused and 
was able to attend to her husband and parents more which appeared 
to increase her sense of self worth. Sally, Sarah and Jack remarked 
that others had commented on the change in their appearance and 
mood which was a validating experience for them. A couple of 
participants made reference to having hope about future roles. 
However, for most it was more about recognising the importance of 
having roles to help cope with their symptoms of depression. For 
Sally, she had started to look and plan ahead: 
 
Sally: ‘I’d like to get back to work’ 
 
However, it appeared that in order to be able to consider re-
establishing identities, participants needed to have reached some 
level of acceptance of their situation. The amount of change 
achieved by the SCS seemed to dictate where participants were in 
this acceptance process.   
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3.3.2 Disappointment, adaptation and acceptance 
This theme encompasses participants’ feelings about their stimulator 
post-operation. It demonstrates that SCS meant far more than a form 
of pain relief to these participants. It represented hope for change in 
various aspects of their lives. This sub-theme captures the ways in 
which expectations were not met and associated disappointment, 
adaptation to the device and acceptance of the extent of change 
experienced.  
 
For three participants their disappointment was in contrast to their 
gratitude for the stimulator, which for Sarah evoked a sense of guilt. 
 
Sarah: ‘I shouldn’t be disappointed in any of it...Cos it’s took the pain 
away’ 
 
Sarah felt given the stimulator had reduced her pain; she should be 
content, but she was not, demonstrating her higher expectations. In 
contrast, Pete denied feeling disappointed about his SCS. However, 
he alluded to disappointment when describing how his SCS had not 
met his expectations gained from the trial and how he was 
unprepared for the side-effects. There was a sense Pete feared 
negative evaluation for describing his dissatisfaction, as illustrated in 
the extract below: 
 
Pete: ‘I’m starting to sound ungrateful, I’m not ungrateful, I’m grateful 
to everything everybody’s has done, I appreciate this operation’s 
probably cost a lot of money to the tax payer and everybody’s tried 
their hardest...But (pause) I’m no different now than I was in 
2002...which I thought I would be...’ 
 
Although Pete felt there was no change, he still used the stimulator 
and was adapting to living with it like the other participants. Pete, 
alongside four other participants, particularly described adapting to 
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having the battery inside. A predominant concern was the visibility of 
the battery, as Nicole asserts: 
 
Nicole: ‘it does stick out, whereas, I, my idea of an implant was it 
would go in and you wouldn’t notice it. 
 
Due to this internal battery being felt externally, most participants 
described catching it on clothing and experiencing discomfort in 
certain positions, particularly whilst sleeping. Consequently, it was 
more cognitively demanding than anticipated. Some participants 
talked about adapting to changing their settings on their SCS. For 
Jack, he changed his setting depending on whether he was walking 
or sitting so it would give different levels of stimulation that were 
comfortable and suited to the task: 
 
Jack: ‘So it’s quite hard to remember, if I’m sitting and I’ve got it on 
the sit one [setting], if I want to stand up and go and pick a cup up, 
I’ve got to turn it off a second, sit back down turn it back on’ 
 
Maya also described the time and consideration required to operate 
the stimulator: 
 
Maya: ‘you have to set that up (pointing to stimulator) to 
accommodate what you are doing for the day...You know, if you’re 
doing a lot of stretching, you have to lower it, you know, I’ve had it, 
tweaked a few times, you know, but, cos you get like different 
stimulations...there’s a lot of consideration’ 
 
This was not the only way the stimulator preoccupied Maya’s and 
Jack’s attention, as they also talked more in-depth about this idea of 
having a ‘foreign body’ inside, which for Jack evoked paranoia and 
catastrophic thinking:  
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Jack: ‘...the-the thought of having like unnatural things inside you is 
scary anyway. It’s like It’s probably literally impossible for it to do, but 
you think what would happen if the battery leaks’. 
 
I wandered at this point, whether this statement was a form of 
reassurance seeking. Unlike most participants, Jack experienced 
excessive worry about his stimulator which left him with mixed 
feelings about his stimulator. In summary, this shows the various 
ways participants were adapting to and accommodating their 
stimulator.  
 
Another predominant process in all accounts was acceptance of no 
change or the level of change achieved. Following Mike’s SCS not 
working, he contemplated possible causes for this change and 
oscillated between hope and a forced acceptance:  
 
Mike: ‘I’m just hoping that it’s a phase, erm, like it’s not working now, 
but maybe, erm it will pick up and it will work... I’m sort of clutching at 
straws now, but erm, you know, and maybe there is another 
operation... or this is it, if I’ve gotta learn to live with it, I’ll have to 
learn to live with it, make the most of it’ 
 
Mike, like all other participants, had previously referred to SCS as 
being his last treatment option but when faced with the prospect of 
his SCS not working, it was difficult to embark on this process of 
acceptance. Although, other participants’ stimulators had 
successfully provided pain relief (excluding Pete), they were also 
making this transition to accepting the level of pain relief and 
capabilities, which for most participants meant accepting the loss of 
certain activities and their old selves: 
 
Nicole: ‘I’m realistic, I won’t be doing the things I was use to be 
doing’ 
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Similarly... 
 
Sarah: ‘So regardless of the operation [SCS], erm, things are not 
gona change to what they were before’ 
 
Despite an improvement in Jack’s sense of self, he still felt like he 
could not move forward: 
 
Jack: ‘I’m literally just stuck in a rut now, you know, and I think it’s a 
case, you’ve just got to make the best of what, what you’ve got at the 
time I think. You know, because I know for a fact there isn’t gona be 
a miracle cure’ 
 
This idea of being ‘stuck in a rut’ is suggestive of a mundane lifestyle 
that cannot be changed. It portrays a sense of being trapped, a need 
to resign himself to his situation, or even accept it.  
 
3.4  Summary 
All participants were caught up in this conflict of SCS, either through 
a positive or negative experience of SCS or both. The outcome of 
SCS, adaptations and acceptance processes were indicative of a 
number of simultaneous transitions underway. For Sally, she was 
moving forward, establishing new identities, however most 
participants were accepting losses and adapting to life with their 
SCS.  
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4.0 Extended Discussion 
The current study aimed to explore CNP patients’ experiences of the 
SCS surgery treatment journey, considering life prior to, and after the 
surgery. It would not have been possible to understand participants’ 
experiences of SCS without consideration to their journey leading up 
to the surgery. The themes generated from the analysis will be 
discussed in relation to the wider CP and SCS surgery literature 
alongside clinical implications, study limitations and suggestions for 
future research.  
 
4.1  Diminished control and coping 
The first theme illustrates how participants experienced a sense of 
powerlessness as they simultaneously coped with the devastating 
impact of pain, whilst managing hopes and disappointments 
associated with battling the system to gain treatments and eventually 
SCS. This will be discussed in relation to existing literature.  
 
 4.1.1  Battling the system and managing expectations 
All participants described experimenting with different treatments, 
however some participants also experienced not being believed and 
stereotyped by healthcare professionals (HCPs) during this process. 
These findings are consistent with research indicating CP patients 
experience both felt and enacted stigma from HCPs and wider 
society (Newton, Southall, Raphael, Ashford, & LeMarchland, 2010; 
Snelgrove & Liossi, 2009). Such discrimination is often in response to 
there being no obvious physical cause for the pain, or as a result of 
patients not responding to pain treatments (Holloway, Sofaer-
Bennett, & Walker, 2007). These types of responses from others can 
have a detrimental impact on patients’ feelings about themselves and 
hope for rehabilitation. Conversely, it is also suggested that repetitive 
treatment failures and associated distress can trigger CP patients 
anger towards HCPs (Morley, 2008) resulting in difficult relations 
between patients and services. 
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During this treatment journey, two participants in the current study 
spoke at length about their struggle with services in securing SCS. 
These findings provide novel insights into patients’ experiences of 
barriers to gaining a SCS. Existing research has focused on 
assessment criteria and patient suitability (e.g. Celestin, Edwards, & 
Jamison, 2010; Doleys, 2006; Sparkes, Raphael, Duarte, 
LeMarchand, Jackson, & Ashford, 2010) as opposed to the 
experience of going through the process. In the current research, the 
barrier to funding resulted in distress and anger. The research into 
finances related to SCS focuses on the cost-effectiveness of SCS 
(see Manca et al., 2010; Simpson, Duenas, Holmes, Papaioannou, & 
Chilcott, 2009; Turner et al., 2004). However, given that SCS for 
CNP was recently recommended by the National Institute of Health 
and Clinical Excellence (NICE, 2008) and The British Pain Society 
(BPS, 2009), there is likely to be an increase in funding for suitable 
patients over the next few years. Therefore, difficulties in this process 
should be explored and addressed and the emotional well-being of 
the patient in this process should be paramount. As previously 
identified (see journal paper) patients may be at a critical point in 
their treatment journey, having had numerous failed treatments. 
Therefore, delays and difficulties could be disempowering, 
disappointing and result in further low mood, frustration and a 
consequent increase in pain. Further qualitative research is required 
to build on these initial insights of the experience of the SCS 
assessment process and how patients get SCS. 
 
Another important aspect of this journey for current participants was 
their experience of having past expectations of treatments and 
current expectations of SCS. Research suggests that SCS 
expectations can impact on treatment satisfaction (Doleys, 2006), 
which was apparent in the current study. The influence of 
expectations can be demonstrated by an RCT whereby patients 
assigned to the SCS and physical therapy treatment reported 
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significant pain reduction, even before the stimulator had been 
implanted (Kemler et al., 2000). Doleys (2006) highlights how patient 
satisfaction is likely to depend on whether expectations have been 
fulfilled, but also patients’ perceptions of the effort of medical 
practitioners involved. Some participants in the current study talked 
about being informed SCS is not a cure, but culturally there is often 
the expectation that doctors and surgeons will eliminate disease 
demonstrating the need for a change in perspective with SCS 
(Beltrutti et al., 2004). In practice, it is important that expectations 
and goals are explicitly identified (e.g. how much further a patient 
wants to walk, how much pain relief they expect, activities they want 
to improve, Van Dorsten, 2006). It is also recommended that 
practitioners maintain an awareness of their expectations (Doleys, 
2006) as these are likely to influence how patients perceive SCS.  
 
4.1.2  Multiple levels of powerlessness 
Throughout the treatment journey participants described multiple 
ways in which they experienced feelings of powerlessness. This was 
experienced whilst battling the system to gain treatments including 
SCS, but also in hospital when having the SCS implanted. Some 
participants reported feeing dismissed by HCPs when trying to 
ascertain pain relief post-surgery. Research indicates that some 
nurses report finding it hard to cast aside their own judgements of 
patients’ pain (Richards & Hubbert, 2007). It suggests stereotypes of 
pain patients may influence nurses understanding of patients’ 
presenting behaviour when pressured on the ward, as opposed to 
considering the way they are acting in the context of them being in 
pain. Lack of understanding of the impact of pain on patients 
emotionally and behaviourally could contribute to negative 
interactions between patients and HCPs. Therefore, this warrants 
further research.  
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Participants also felt powerless to SCS side-effects (e.g. losing 
balance, loss of feeling in a limb and unpredictable shocks). This 
experience of SCS side-effects is documented in the literature (e.g. 
Kemler et al., 2004). However, the current study is the first to provide 
initial insights on patients’ perspectives of these experiences. Kemler 
et al. (2004) reported that all SCS patients who still had an implant at 
two years follow-up reported side-effects.  The two most prevalent 
side-effects were change in amplitude of stimulation by bodily 
movements in 19 out of 22 participants, and paresthesia 
(numbing/tingling of the skin) in other body parts in 13 out of 22 
participants (Kemler et al., 2004). Despite providing quantitative data, 
there was no qualitative information to inform how patients coped 
with, or adjusted to these experiences. In the wider literature, 
qualitative studies on Implantable Cardioverter Defibrillators (ICDs), 
have provided insights into the impact of perceived control and 
adjusting to this implant (Deacon, Dunbar, Moloney, Sears, & Ujhelyi, 
2003; Hallas, Burke, White, & Connelly, 2009; Morken, Severinsson, 
& Karlsen, 2009). The function of this device is different to SCS, as it 
regulates the patient’s heart beat by issuing a shock. However, the 
perceived lack of control over unpredictable shocks associated 
anxiety, catastrophic thinking and depression due to the experience 
of lack of control (Goodman & Hess, 1999; Hallas et al., 2009) 
echoes some accounts in the current study.  Further research is 
required on the impact of SCS side-effects on psychological well-
being, as well as the adjustment to SCS in order to build on the 
current study’s initial insights. This information could inform psycho-
education during pre-surgery preparation and also post-surgery 
support during the adaptation process.  
 
4.1.3  Coping with symptoms of depression 
Throughout the treatment journey, both pre and post SCS, 
participants described coping with depressive symptoms. The 
reciprocal relationship between CP and depression is well 
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established (Beltrutti et al., 2004). Research suggests that a person’s 
beliefs about the meaning of their symptoms, their ability to control 
their pain and the impact it has on their life play a central role in CP 
(Turk & Okifuji, 2002), which is also associated with depressive 
symptoms (Richardson et al., 2009). This reinforces the importance 
of understanding patients’ beliefs and how in control they feel of the 
pain and their stimulator, as this can impact on patient pain 
perception and subsequent mood, which is discussed later [see 
section 4.3.1 and 4.3.2].  
 
The way that participants coped with depressive symptoms is 
intrinsically linked to coping with the impact of their pain. Literature 
provides different ways to conceptualise coping with chronic pain and 
depression such as active or passive (avoidance) coping (see Snow-
Tyrek, Norris, & Tan, 1996) or assimilative or accommodative coping 
(Schmitz, Saile, & Nilges, 1996). The current participants showed 
evidence of assimilative coping (e.g. active attempts at seeking 
treatments) and accommodative coping (e.g. accommodating pain by 
changing their goals). The latter of which is associated with 
preventing depressive symptoms (Schmitz et al., 1996). However, 
participants in the current study appeared to fluctuate between these 
modes of coping depending on life events as opposed to adapting a 
specific coping style. Potentially now participants have the SCS, they 
may reduce their assimilative strategies related to seeking treatments 
due to SCS being the last option for most. This is supported by 
participants reporting changing their goals (e.g. doing one meaningful 
thing a day) and learning the limits of their capabilities, which 
indicates the initial stages of a process of acceptance and potentially 
accommodation to their new pain levels and capabilities which could 
eventually impact on their mood. [see section 4.3.2. for further 
discussion of adaptation and acceptance post-SCS surgery].   
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4.1.4  Impact of pain and the non-able body 
Participants detailed various ways their CP had negatively impacted 
on their lives, particularly the physical restrictions, activity limitations 
and subsequent social losses. The influence of pain on CP patients 
quality of life (QoL) is extensively documented (e.g. Miles, Curran, 
Pearce, & Allan, 2005; Morley, 2008; Snelgrove & Liossi, 2009). The 
impact of pain was present both prior to, and following SCS surgery. 
However, specific changes post-SCS will be addressed in the SCS 
conflict theme. 
 
A key finding in the current study was the discrepancy between 
participants’ desire to do things and their physical capabilities. This is 
consistent with research indicating the painful body as central to 
everything and preventing spontaneous engagement with the 
environment (Bullington, 2009; Miles et al., 2005; Smith & Osborn, 
2007; Snelgrove & Liossi, 2009). This experience is described as a 
disruption in the ‘mind-body-world’ experience which prevents those 
suffering with CP from ‘being-in-the-world’ (Bullington, 2009, p. 107). 
CP patients’ attention is focused on their painful body resulting in 
their bodies becoming the ‘object of action’ as opposed to a means 
that facilitates action (Miles et al., 2005, p. 438). Leder (1990) 
emphasises how our attention to our bodies is generally absent, but 
that pain becomes a ‘force that stands opposed to the self’ (Leder, 
1990, p. 4), thereby creating this mind and body divide depicted in 
the current findings. Such a divide is perceived as a central target of 
rehabilitation to help patients see their physical body as more than 
just a source of pain that restricts them and that they are more than a 
person in pain (Bullington, 2009). Although, pain may not be 
eliminated, individuals with CP can be helped to interact more with 
their environment (Bullington, 2009). This can be achieved through 
various treatments such as behavioural strategies which focus on 
reducing the threat posed by pain, by reducing avoidance of certain 
activities and gradually increasing engagement with activities (Belrutti 
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et al., 2004). Increasing engagement in activities could reduce the 
influence of lack of social engagement that was reported by 
participants in the current study. Such strategies may be an 
important adjunct treatment to SCS when adapting to their 
capabilities post-surgery. [see section 4.4.3 for further discussion]. 
 
4.2  Identity transitions 
The second theme illustrates how participants have experienced 
multiple identity losses as well as learning to cope with their 
unwanted pain identity.  
 
 4.2.1  Identity loss 
Participants experienced loss of their social roles and group identities 
and made few references to developing new ones. Similarly, 
literature indicates CP patients experience role loss, and subsequent 
attribute loss, as opposed to identity development (Harris et al., 
2003). Harris et al. (2003) perceived roles as external expressions of 
a person’s social interaction, and attributes were defined as 
‘internalised cognitive representations of the self in relation to others’ 
(p. 363). The authors suggested roles consist of certain attributes; 
some attributes could be retained by their presence in multiple roles. 
However for some, the loss of a role meant the loss of a set of 
attributes. In the current study, the loss of attributes and the sense of 
purpose associated with roles within group activities (e.g. leadership 
roles) altered participants’ sense of who they were due to them 
perhaps defining aspects of themselves through their belonging to 
the group. This was associated with symptoms of depression which 
was supported by Harris et al. (2003) who found that such role losses 
were associated with depression even when other factors known to 
contribute were controlled.  
 
This concept of losing aspects of the social self is extensively 
referred to in the CP literature (Hellström, 2001; Miles et al., 2005; 
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Smith & Osborn, 2007). The social self in the present study included 
work roles, where participants either had to adapt/change work roles 
due to their pain or were not able to work. Occupation is an important 
way in which people express and define themselves (Henare, 2003), 
and also provides another social arena for engagement with others. 
Therefore, there was a void or sense of emptiness for those not 
working in the current study. There was also a sense of mourning 
past, pre-pain active selves, which is consistent with literature 
suggesting CP patients often make comparisons to their pre-pain 
selves (Hellström, 2001; Smith & Osborn, 2007); particularly, the 
threat of not being able to do things or not being able to do them to 
the same proficiency challenges peoples’ identity (Miles et al., 2005). 
There was a sense of idealisation and nostalgia of the strong and 
active former self (Hellström, 2001) which made it more difficult for 
participants in the current study to embrace their new pain identity. 
Holding onto lost identities is seen as counterproductive due to it 
preventing people from adapting to their new situation (Hellström, 
2001). Therefore, being able to integrate their pain identity into how 
they see themselves is an important part of rehabilitation (Smith & 
Osborn, 2007). Psychological treatments could assist in facilitating 
this process for SCS patients as it may impede the benefits yielded 
from their stimulator. 
 
4.2.2  Managing the unwanted pain identity 
Literature suggests CP patients feel more conscious of their pain and 
disability in the social domain due to the fear of judgement by others 
(Smith & Osborn, 2007). This was prevalent in the current study with 
participants being acutely aware of the visibility of their disability and 
how this impacted on others perceptions and reactions to them. The 
associated shame led participants to mask their pain and associated 
behaviours. Gustafsson, Ekholm and Ohman (2004) suggested that 
moving on from shame to self respect, by reducing the divide 
between the self and the body can facilitate rehabilitation. 
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Therapeutic interventions for targeting identity have been suggested 
to be important for CP patients especially in cases where sensory 
modulation has not been successful and patients are trying to live 
with their pain (Morley 2008). However, I would argue such 
interventions would still be useful for patients gaining successful 
sensory modulation from devices such as SCS. Even though the 
stimulator provides pain relief, this study indicates SCS patients still 
struggle with the same identity challenges as they learn to accept 
their pain and capability levels as is depicted in the next theme.  
 
4.3  SCS conflict 
The final theme illustrates how most participants were experiencing 
conflict in relation to experiencing both positive and negative aspects 
of the stimulator. All but one participant alluded to going through a 
process of acceptance of their post-SCS pain relief and capabilities 
alongside adjusting to living with the stimulator.  
 
 4.3.1  Positive change 
Comparable with existing literature, participants in the current study 
reported SCS reduced their pain and improved their mood (Jamison 
et al., 2008; Kumar et al., 2008; North & Shipley, 2007). It also 
indicates that previous physical challenges and restrictions improved 
for some participants as a result of their SCS (e.g. sitting longer, 
standing longer). This is consistent with existing literature suggesting 
improvements in quality of life, particularly improving functional status 
are sought prior to SCS (Anderson et al., 2001) and improved 
following SCS (Kumar et al., 2008). For one participant, her SCS 
experience had a profound positive impact on her confidence, sense 
of self, social life and optimism about the future. This offers new 
insights into the positive impact of SCS, as there is no other literature 
providing such detail. This highlights the importance of more 
qualitative research being undertaken in this area to gather further 
insights about what SCS means to patients post-surgery.  
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 4.3.2  Disappointment, adaptation and acceptance 
In contrast to the above, most participants also alluded to feeling 
disappointed about some aspects of their stimulator, often due to it 
not meeting certain expectations as previously discussed. In previous 
SCS research, structured questions have been asked to ascertain 
patient satisfaction (e.g. ‘are you satisfied with the pain relief 
provided by your treatment?’ and ‘based on your experience so far, 
would you have agreed to this treatment?’ Kumar et al., 2007, p.181). 
In contrast to the current findings, this RCT (n=100) found 33 out of 
50 participants in the SCS treatment group reported being satisfied 
with their pain relief (66%), and 43 out of 50 participants felt they 
would have agreed with the treatment knowing the outcome (86%; 
Kumar et al., 2007, p. 185). Participants in the current study are likely 
to have responded positively to the above questions as all but one 
reported being happy with their pain relief and some explicitly 
commented that they did not regret their SCS decision (e.g. ‘I am 
pleased I’ve got it and I don’t think I would turn back the clock of 
saying no I don’t want it’ – Maya). However, such measures of 
satisfaction fail to capture the ambivalence and difficulties in adapting 
to the SCS which was also discussed in the current study. This 
highlights the importance of further research into patient satisfaction 
with SCS using multiple methods of evaluation which give patients 
the opportunity to expand on their SCS experiences. 
 
Participants in the current study described adapting to the presence 
of the stimulator and living with it. Participants reported discomfort 
from the positioning of the battery, side-effects and adapting to 
changing the settings. They specifically emphasised the cognitive 
demands of the stimulator. These findings provide novel insights into 
SCS adjustment. Previous research has yielded information through 
questionnaires post-SCS or quantification of interview data, 
restricting the depth of information gained. These cognitive demands 
of the stimulator are an important consideration. Pain can be seen as 
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an interruptive signal, an alert for threat, however when chronic and 
unable to control this interruption, if perceived as threatening, it can 
increase distress and depression (Linton et al., 2011). Therefore, 
depending on how the cognitive demands of the stimulator are 
perceived, this could also have a negative impact on patients’ mood. 
In the current study, there were a couple of participants who talked 
more extensively about associated paranoia and anxieties related to 
certain aspects of the stimulator. Therefore, further research is 
warranted to explore patients’ perceptions of their stimulator, as it 
could potentially act as an additional interference to daily activities 
having a negative impact on mood which will inevitably impact on the 
SCS efficacy. It is such cognitive and behavioural adaptation that 
may warrant evaluation post-SCS to increase SCS adjustment.  An 
American article on psychological considerations for implantable 
procedures draws on the SCS and wider surgical literature to 
consider post-surgical support (Van Dorsten, 2006). It emphasises 
the role of the psychologist both pre and post-SCS, advocating 
behavioural strategies be employed to gradually increase activity 
levels with the new level of pain. It also recommends relaxation, 
stress management and sleep hygiene strategies all to aid the 
adaptation process to SCS (Van Dorsten, 2006). This article is 
consistent with the current research in the suggestion that some SCS 
patients may require cognitive or behavioural post-surgical support 
whilst adjusting to their stimulator. This may be particularly relevant 
for those patients whose expectations were not met. In many ways, 
the current research brings together the CP and SCS literature 
providing further multidisciplinary insights that could improve SCS 
efficacy. Although, SCS side-effects were discussed in relation to the 
feelings of powerlessness in the extended paper, this demonstrates 
the inter-related nature of the themes, as they were also an important 
part of adjusting to the stimulator as previously discussed.  
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Lastly, six participants described the process of accepting their level 
of pain relief and capabilities post-SCS. This was significant to this 
group of participants as most had been informed SCS was their last 
treatment option, placing a lot of pressure on the success of SCS. 
For these participants the restrictions and subsequent losses were 
most important to them. Arguably if participants are not able to 
accept their activity and capability levels post-SCS, this could have a 
negative impact on individuals’ mood. Given that mood can alter a 
person’s pain perception this could result in a perceived decrease in 
pain relief, which may account of the reduction of SCS pain relief 
over time that is described in the SCS literature (Ohmeiss & 
Raubaum, 2001). Therefore, the current study indicates CP patients 
using SCSs may need to go through a process of adaptation to SCS 
and acceptance of their level of functioning and pain identity (Smith & 
Osborn, 2007) prior to re-establishing or forging new identities and 
engaging in new activities. This process is likely to be different for 
each individual depending on what their pain means to them, how it 
impacts on their life and the adaptation to the SCS.  As Nicole 
reflected: ‘it’s too early to say really how much of an impact it’s-it’s 
going to make [SCS], the reduction in pain i-is the big one, all the 
(hesitation) emotional, psychological things that go with it, they’re 
probably going to take longer’ (four months post SCS). This again 
highlights the importance of post-SCS support, particularly evaluating 
how well patients are adapting psychologically as well as practically 
to their SCS. The aim should be to mitigate interference in 
functioning and encouraging identity and pain acceptance (Morley, 
2008). For some patients, they may benefit from an adjunct 
psychological treatment during the acceptance and adaption 
process. It is argued in the literature that both cognitive behavioural 
therapy (CBT) and acceptance and commitment therapy (ACT) are 
effective psychological interventions in managing CP (Wetherell, 
Afari, Rutledge, Sorrell, Stoddard, & Petkus, 2011). They take two 
quite different approaches with CBT being perceived as a form of 
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controlling pain through modifying physical sensations, catastrophic 
thinking and unhelpful behaviours (e.g. avoidance), whereas ACT 
focuses on accepting pain. In a recent RCT, both treatments were 
effective in reducing pain interference, depression, pain-related 
anxiety, but ACT was seen as a more satisfactory treatment to 
patients (Wetherell et al., 2011). ACT seems more relevant to the 
current research findings where the focus has changed from 
previously trying to control their pain, which they now have through 
SCS, to now accepting their pain and capability levels. Also, the 
effects of CBT on patients’ level of disability due to their CP are 
reported to be limited (Eccleston et al., 2009), whereas ACT is 
associated with better functioning (McCracken & Eccleston, 2005), 
which seemed a primary concern for current participants. Therefore, 
ACT may be an appropriate psychological intervention that could 
assist patients struggling during the acceptance and adaptation 
process post-SCS. Interestingly, two decades ago, practitioners were 
expressing the view that psychological treatment should be 
considered post-SCS to address the psychological factors related to 
pain (Daniel, Long, Hutcherson, & Hunter, 1985). Therefore, perhaps 
what is of most interest is the factors preventing research being 
translated into practice.    
 
4.4  Clinical implications 
The current study illustrates the significance of attending to process 
alongside SCS assessment and outcomes. Given the potential 
challenges in obtaining SCS, when such issues arise patients should 
be offered additional support during this critical period in their 
treatment journey. Psychological assessment and goal setting in 
relation to expectations may prevent unrealistic goals and could 
improve treatment satisfaction.  
 
The current study also demonstrates that despite some 
improvements in mood and activities of daily living, patients were 
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adapting to their levels of pain relief and capabilities as well as the 
stimulator. Post-surgery psychological evaluation/monitoring could 
assist in identifying any unmet expectations, beliefs about the 
presence of the stimulator, adjustments to living with the device, 
assistance in increasing activity levels, all of which could help in 
increasing mood and acceptance of any changes in identities. 
Support in accepting their pain, and changes or lack of changes, 
could potentially help patients start to forge new identities and 
engage with their environment to improve their sense of self and 
mood.   
 
4.5  Study limitations 
The study inclusion criteria specified recruitment of participants 2-8 
months post-SCS surgery. This was to ensure that the interview was 
close enough to the surgery for participants to recall their life prior to 
SCS and life post-operation. However, given that the effects of SCS 
can reduce over time often at approximately 12 months (Cameron, 
2004; Ohnmeiss & Rashbaum, 2001; Taylor, Van Buyten, Buchser, 
2006), the current results may be restricted to the short-term impact 
of SCS. However, one participant in the sample had experienced 
such effects, but at 6 months. Despite this, widening the sample to 
include patients 12 months post-SCS surgery would have reduced 
the sample homogeneity. Also, the current study yielded a wealth of 
information, so it would be more beneficial to complete a separate 
piece of research investigating SCS post 12 months to capture the 
necessary depth of information.  
 
Furthermore, when developing the interview schedule I was aware 
that my interpretation of what constitutes a treatment journey may be 
different to those I interviewed, so I wanted to keep the questions as 
open as possible. I was mindful that I did not want the schedule to 
solely focus on the practicalities of the treatment journey, as the 
purpose of IPA is to capture the psychological experience, in terms of 
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the connection between their embodied experience, how this is 
talked about and made sense of, and the emotional responses to this 
experience (Smith, 2011). This is why I chose to ask about any 
changes in terms of how they thought or felt about themselves since 
their pain onset and life after the surgery. However, in hindsight, it is 
important to deliberate whether asking about change directly may 
have led participants to feel they needed to talk about change even if 
this was not present or important to them. However, the findings 
indicate participants were able to say when they felt nothing had 
changed, for example Pete explicitly stated ‘my life is no different to 
before the surgery’. Also, the ‘SCS conflict’ theme captured 
participants views of aspects of their lives that had, or had not 
changed as much as expected. This indicates the lack of change was 
important to them and this was expressed. 
 
4.6  Future research 
In light of this being the first qualitative piece of research on SCS, it 
would be useful for further qualitative studies to explore particular 
parts of the treatment journey in more depth. Future research is 
warranted on the assessment process for patients, how they 
experience the selection process, the panel where they present their 
case for SCS and whether they feel supported in their decision 
making. Also further qualitative studies on patients’ perceptions of 
the stimulator post-surgery and experience of adjusting to living with 
the stimulator would help to delineate any further support required in 
this process as suggested by the current study.  
 
This study highlights the wealth of information on patient satisfaction 
with SCS that has not been captured by current evaluation methods. 
Therefore, future research would benefit from broadening the 
evaluation measures, using interviews or open-ended questions in 
questionnaires to gain more comprehensive feedback. It would also 
be useful to survey how frequently multidisciplinary working, 
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specifically the use of psychological support, is offered, required and 
employed post-SCS in the United Kingdom (UK).  
 
Lastly, there appears to be a discrepancy between what takes place 
in clinical practice and the recommendations in the evidence-base/ 
SCS guidelines (e.g. BPS, 2009; European Federation of 
International Association for the Study of Pain [IASP] Chapters, 
Gybels et al., 1998; NICE, 2008). This is supported by a survey 
indicating only 61% of UK pain management centres employed 
psychological assessment in their SCS selection process (Ackroyd, 
Bush, Graves, McVey, & Horton, 2005). As previously suggested 
there is no such data on post-SCS evaluation. It would be useful to 
build on this research to understand why this is not taking place, 
identifying any challenges or barriers to implementing such 
recommendations and the risks of not doing so. Potentially, 
unsuitable candidates may be selected skewing beliefs about SCS 
efficacy. 
 
4.7.  Conclusion 
The lack of qualitative, in-depth exploration of the treatment journey 
of SCS formed the rationale for the current research. It has 
demonstrated the importance of using qualitative methods to gain 
further insights of patients’ experiences of SCS to inform existing 
quantitative research. The current study has highlighted the lack of 
understanding of patients’ beliefs about SCS, patients’ perspectives 
on the assessment process and adjusting to living with the device in 
existing literature. This research offers insights into these processes 
and questions if psychological assessment and evaluation could aid 
the assessment process and help with identifying individuals who 
require additional support in accepting their levels of pain relief and 
capabilities and adjusting to the SCS. This can inform future research 
in SCS, with the hope of continuing to combine the SCS and CP 
literature to convey a holistic understanding of the SCS experience. It 
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is hoped that the insights about SCS expectations and post-SCS 
surgery conflicts will increase neurosurgical and pain management 
teams’ understanding of the potential challenges for SCS patients 
during assessment and when adapting to living with the stimulator. 
This could encourage these teams to draw on psychological 
therapies, when appropriate, as an adjunct to SCS. On a broader 
scale, it is hoped that more qualitative studies will be completed to 
continue to build on these findings and to deepen the understanding 
of what it means to have SCS surgery from those who matter, the 
patients.    
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5.0 Critical Appraisal 
In this section, I aim to summarise my research journey, conveying 
my reflections of the different stages in the research process. Within 
this, I will refer to scientific, ethical and theoretical issues.  
 
5.1 Planning 
The research stemmed from a neurosurgeon who had an interest in 
the psychological experience of SCS surgery. SCS was novel to me, 
however I soon became engrossed in the extensive evidence-base 
for this surgical procedure. This process in itself was particularly 
challenging due to trying to learn the medical terminology, whilst 
simultaneously trying to identify what had already been completed 
and what needed to be explored. I was struck by the lack of 
qualitative research in the area or any research related to patient 
satisfaction that was not in the form of a questionnaire. Throughout 
this process I liaised closely with the neurosurgeon who assisted in 
my learning experience of medical concepts. Once I had formulated 
my research objectives, it was important to explain to the team why I 
had chosen a qualitative project as well as the value of this 
approach, in what was, a very quantitative field. However, when I 
presented my research proposal, they seemed positive about 
something different being undertaken.    
 
During the planning, I took time to learn about the process patients 
went through, to truly grasp their treatment journeys. I attended 
multidisciplinary meetings regarding patient selection and obtained 
documentation employed in the assessment process to gain an 
understanding of the patient journey. During this process I was 
surprised by the lack of psychological assessment in the service as it 
is advocated in SCS guidelines, but the neurosurgeon assured me 
referrals were made for those where psychological concerns were 
highlighted in the SCS screening process.  
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5.2 Recruitment process 
The recruitment process was challenging for both practical and 
ethical reasons. The participant pool ended up being smaller than 
first predicted. Therefore I had to amend my inclusion criteria to 
increase my participant pool. [see section 2.7.1 for details of 
difficulties recruiting participants]. Re-applying to ethics and the trust 
was a stressful process however one that I came to learn was a 
reality of conducting research in the National Health Service. During 
the recruitment process, there was some confusion about the 
recruitment protocol within the research team so it was important to 
regularly communicate and reiterate the protocol. However, this 
again presented me with the reality of working in a multidisciplinary 
research team with busy clinicians whose priority, unlike mine, was 
not my research. It highlighted the importance of me being proactive 
in communicating information in different formats to make sure all 
team members were aware of protocols and rationale for decision 
making.  
 
In addition to this, during recruitment a patient contacted me 
regarding the study. However, he reported being physically unwell at 
the time following the removal of his SCS due to complications. 
During the conversations, it appeared his central motivation for 
participating was his experience of the difficulties in recruiting for 
research. Although there were practical difficulties as well, my priority 
was my ethical commitment to the patient. I considered his capacity 
to consent in line with the MCA (2007) during this period of 
disappointment and felt the interview may not be appropriate at this 
time. Supervision was also helpful during this process. [see section 
2.7.1, stage four for further details]. 
 
5.3 Interviews  
I found conducting the interviews enlightening, but equally 
challenging as I was not there in my capacity as a clinician, I was 
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there as a researcher, yet was required to provide support to 
emotional participants. Although, it was initially a strange experience, 
I soon was able to support participants in my researcher role, helping 
them feel contained by allowing them time to stop the interview when 
required and letting them know it was ok to feel emotional given the 
sensitive information being discussed. During this process I think I 
truly came to understand what phenomenologists mean when they 
talk about empathically entering and reflecting on the participant’s 
lived world (Wertz, 2005). Following interviews, I found myself lost in 
thought and reflections about what it would be like to live in their 
world, with so many restrictions, having gone from normal life to 
losing so much, to then adapting to a machine inside of them. What 
would it mean to me to not be able to walk for long periods, not be 
able to go to the gym, to go out spontaneously? How would this 
make me feel about myself? I was saddened even by thought of this, 
as alluded to in my reflective diary: 
 
‘Having had this interaction, I can’t help but 
reflect on my life, it makes me think about the 
bigger picture of what I have. I have a bigger 
picture beyond this experience, yet that sense 
making of his experience, his painful existence, 
that was it, raw in front of me, where was his 
bigger picture? Did he have a bigger picture 
than pain? It seemed all consuming.’ 
 
During the course of my second interview, as the interpretative 
process began, I became aware of preconceptions I never realised I 
had. A process alluded to by Gadamer (1990) whereby only in the 
process of interpretation do you truly start to see the influences of 
your thoughts. I felt surprised at the sheer disappointment I was 
sensing from this participant. I realised, perhaps I had been more 
influenced than I thought by the surgeon’s positivity about SCS, 
154 
 
despite my awareness of the mixed results in the literature. I was 
thankful to learn this early as it was useful to be mindful of in future 
interviews. Additionally, I previously had concerns that participants 
may hold back information, knowing the neurosurgeon who 
completed their surgery was involved in the research. Conversely, I 
felt that participants felt relieved they’d had the opportunity to talk 
about their experiences and seemed eager to provide feedback to 
help future SCS patients. This was evident in the way that some 
participants spoke out, as if they were talking to potential SCS 
patients ‘I think people just got be, not too hopeful’ (Sally). 
 
5.4 Analysis 
The analysis was mentally and physically exhilarating and 
exhausting. I found myself oscillating between the concern of being 
too descriptive or too interpretative. I recalled an article I had read 
where Gee (2011), had highlighted the importance of remembering 
that as long as the interpretations were grounded in the data, that in-
depth interpretations actually elucidate IPA’s objective to see ‘the 
things themselves’. This encouraged me to have faith in my instinct. 
Generating new insights was anxiety provoking as it re-organised the 
chronological flow of the narratives into a new form, however it was 
equally exciting and motivating. An experience I had never had from 
quantitative research.  
 
On a personal level, this was in contrast from my usual structured 
way of working. This, in many ways, was a personal challenge. It 
encouraged me to increase the flexibility of my thinking and sit with 
the uncertainty that qualitative analysis can evoke. Such uncertainty 
was particularly prominent when I was working across the transcripts. 
Despite some obvious commonalities between my data, I was 
overwhelmed by the amount of diversity. During times when finding 
commonality is difficult, Smith, Flowers and Larkin (2009) encourage 
researchers to think on a higher level to find the shared experience. 
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After much thought and reflection I began to see more subtle 
similarities than I originally thought. I reframed my feeling about this 
and felt confident I had achieved the shared higher order quality, 
whilst showing within the theme the participants’ unique idiosyncratic 
experience. I came to understand the balance of convergence and 
divergence as being a sign of good IPA (Smith, 2011).  
 
5.5 Writing up 
My research journal paper is for submission to a neurosurgery 
journal. Therefore, I felt it was important to reflect on my rationale for 
this choice and my experience of developing a qualitative piece of 
work for a medical journal.  
 
Given the dearth of research on the psychological experience of SCS 
surgery, I felt my target audience needed to be the surgical and pain 
management teams who work with these patients. I felt submitting to 
a neurosurgery journal would ensure the insights from my research 
were communicated to those who would benefit from it. I originally 
wanted to submit to a neuromodulation journal which would target 
predominantly neurosurgeons undertaking these procedures such as 
SCS7. However, it was difficult to communicate the depth of the 
treatment journey in the restrictive word limit. This, I felt was a 
significant point as it highlights a potential obstacle of submitting IPA 
studies to non-psychological journals which can be the most crucial 
audience. I also feel, as clinical psychologists, we should strive to 
communicate and disseminate psychological information to other 
professionals. This is why I chose to change to the Journal of 
Neurosurgery as it targeted a similar audience but also allowed for 
the depth due to a more accommodating word count. This way I 
could ensure the relevant information was conveyed.  
 
                                                 
7
 Neuromodulation is a pain control technique where pain relief is achieved by modulating 
noxious messages, changing their activity without making permanent lesion in neural tissues 
(Beltrutti et al., 2004). It can be achieved through chemical or electrical methods (Beltrutti et 
al., 2004). 
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During the write up, it was difficult to know when to stop analysing. I 
was aware that the write up was a key part of the analytical process 
but it was difficult making decisions about what to include in the 
journal paper to concisely answer the research question. Here lay a 
key conflict for me; I was trying to balance my commitment to IPA, 
alongside my intended audience who are dominated by the medical 
discourse. During this process, I found myself being aware of my use 
of language, specific terminology that is often employed during IPA 
analysis was not necessarily appropriate for the intended audience. I 
felt that by aligning with one, I was betraying the other. After much 
deliberation, I feel I managed to balance this appropriately so that the 
phenomenological and hermeneutic underpinnings were adequately 
conveyed but not at the expense of its accessibility. This example 
from my reflective diary illustrates my sense making of this 
experience: 
 
‘So I find myself questioning whether the 
neurosurgeons reading this really want to hear 
about the exhausting burden of the non-able 
body that creates a rupture between the 
patient’s body and world restricting their abilities 
to create new selves. Or do they simply want to 
hear that patients experienced activity 
limitations and physical restrictions which 
influenced how patients felt about themselves, 
how do I find the balance?’    
 
As previously mentioned, it took time to explain qualitative research 
to the SCS team. This reinforced the importance of how I conveyed 
the information in my article making sure I emphasised that the data 
was not meant to be generalised or objective in nature.  
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5.6 Multi-disciplinary team working 
In light of my journal article encouraging more multi-disciplinary 
working between neurosurgeons and the wider pain management 
teams and my systemic interests, I felt it was important to reflect on 
my experience of working in a multidisciplinary research team with 
individuals from multiple systems. Given the technical language in 
the literature, it was helpful having a neurosurgeon in the research 
team. I found his description of concepts more accessible than 
reading about them in books.   It helped me to be able to integrate a 
psychological perspective into the understanding of these concepts 
and also how to assert them in an accessible manner to others. It 
was also important to stay focused on what I was required to know 
for the purpose of the project rather than getting too distracted by 
the wider surgical literature which was not necessarily relevant. 
Significantly, I have also learnt to appreciate the difficulty in 
balancing research commitments with clinical demands, something I 
shall remember for the future.    
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Systematic Review 
Appendix A: Common neuropathic pain conditions 
 
Neuropathic Pain Condition Description 
 
Failed Back Surgery Syndrome 
(FBSS) 
FBSS describes patients 
experiencing persistent low back 
pain and leg pain as a result of 
unsuccessful back or spine surgery. 
Patients with greater leg pain as 
opposed to back pain are suggested 
to be suitable candidates for SCS. 
Many patients experience this type of 
pain following lumbar surgery 
(Medical Advisory Secretariat, 2005). 
 
Complex Regional Pain Syndrome 
(CRPS) Type I (formally known as 
Reflex Sympathetic Dystrophy; 
RSD) 
CRPS Type I is where symptoms 
(e.g. burning pain) develop in a limb, 
usually after an injury (e.g. a 
fracture) or immobilisation (e.g. 
stroke; Medical Advisory Secretariat, 
2005), but are often disproportionate 
to the inciting event (Kemler et al., 
2004). However, it can also start 
spontaneously with no precipitating 
injury. Patients experience allodynia 
which is a heightened sensitivity to 
touch and abnormal sweating. 
 
Complex Regional Pain Syndrome 
(CRPS) Type II (formally known as 
causalgia – nerve injury) 
Type II has a known nerve injury. 
 
 
 
Postherpetic Neuralgia This is a persistent pain, which 
occurs after having shingles. Some 
people experience sensory loss and 
allodynia in areas where they 
previously had shingles (Oaklander, 
1999). 
 
Diabetic Neuropathy Symmetrical sensory loss and 
burning pain in the lower leg (Gilron, 
Watson, Cahill, & Moulin, 2006). 
 
HIV-related Neuropathy Painful paresthesia (abnormal 
sensations like numbness, itching or 
tingling) which is most pronounced in 
the toes and soles of the feet (Brew, 
2003). 
Full references are in the extended paper reference list 
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Appendix B: Systematic reviews of spinal cord stimulation surgery (NP and CP conditions including NP) 
Author & Year 
 
Title Participants 
 
Frey et al., 2009 
 
Spinal Cord Stimulation for Patients with Failed Back Surgery Syndrome: A Systematic Review 
 
Failed Back Surgery Syndrome 
(FBSS) patients 
 
Simpson et al., 2009 
 
Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic 
evaluation 
 
Patients with FBSS, Complex 
Regional Pain Syndrome  
(CRPS), low back pain, Critical Limb 
Ischemia (CLI), and angina 
 
Turner et al., 2004 
 
Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: a 
systematic review of effectiveness and complications 
 
FBSS, CRPS,  
 
Celestin et al., 2009 
 
Pretreatment Psychosocial Variables as Predictors of Outcomes Following Lumbar Surgery and Spinal Cord 
Stimulation: A Systematic Review and Literature Synthesis 
 
Chronic back pain 
 
Mailis-Gagnon et al., 
2009 
 
Spinal cord stimulation for chronic pain (Cochrane Review) 
 
Chronic pain 
 
Taylor et al ., 2006 
 
Spinal Cord Stimulation in Complex Regional Pain Syndrome and Refractory Neuropathic Back and Leg Pain/Failed 
Back Surgery Syndrome: Results of a Systematic Review and Meta-Analysis 
 
CRPS and FBSS 
 
Taylor et al., 2005 
 
Spinal cord stimulation for chronic back and leg pain and failed back surgery syndrome: a systematic review and 
analysis of prognostic factors 
 
FBSS and chronic back and leg pain 
 
Grabow et al., 2004 
 
Spinal Cord Stimulation for Complex Regional Pain Syndrome: An evidence Based Medicine Review of the 
Literature 
 
CRPS 
 
Mailis-Gagnon et al., 
2004 
 
Spinal Cord Stimulation 
 
Chronic pain 
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Appendix C: Search strategy (example medline search strategy) 
1. (spinal-cord stimulat* or spinal cord stimulat*).mp  
2. exp Electric Stimulation Therapy/ 
3. exp Electric Stimulation/ 
4. neurostimulat*.mp.  
5. 1 or 2 or 3 or 4 
6. "quality of life".mp.  
7. (euroqol or euro qol or eq5d or eq 5d).mp.  
8. (hql or hqol or h qol or hrqol or hr qol).mp.  
9. ("nottingham health profile" or NHP).mp.  
10. (sf36 or sf 36 or short form 36 or shortform thirty six or short form thirty 
six).mp.  
11. anxi*.mp.  
12. depress*.mp.  
13. mood.mp.  
14. psych*.mp.  
15. (physical activit* or social activit*).mp.  
16. "activities of daily living".mp.  
17. mobility.mp.  
18. (work or employ*).mp.  
19. (pain or discomfort).mp.  
20. "self care".mp. 
21. 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 
19 or 20 
22. 5 and 21 
23. outcome*.mp.  
24. exp "Outcome and Process Assessment (Health Care)"/ 
25. exp "Outcome Assessment (Health Care)"/ 
26. exp Treatment Outcome/ 
27. 23 or 24 or 25 or 26 
28. 22 and 27 
29. neuropathic pain.mp.  
30. 28 and 29 
31. limit 30 to humans 
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Appendix D: Data extraction pro-forma  
(adapted from Torgerson, 2003) 
 
Trial & Study: 
 
Author & Year: 
 
Objectives: (Are the aims clearly stated?) 
 
Study Design: (What is the study design?) 
 
Setting & Country: (Was it a single or multicentre site? Which 
country/countries were the sites based in?) 
 
Treatment Period: (Was the period of time participants received 
treatment stated? What was this time period?) 
 
Participants: (What was the total number of participants? How many 
participants were in each group? What was the mean age of 
participants in each group? What was the age range? What is the 
neuropathic pain condition?)  
 
Pre-screening/Trial stimulation: (Was pre-screening for 
psychological factors conducted? Did patients have trial stimulation 
prior to implantation of the SCS?) 
 
Intervention and Comparator: (What was the intervention group? 
What was the comparator?) 
 
Outcomes Measures: (What outcome measures were used?) 
 
Follow up: (What was the follow up time period?) 
 
Key findings: (What were the key findings related to Quality of Life 
as evaluated using generic measures? Were there any changes in 
pain intensity?) 
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Appendix E: A: Table to show study characteristic for Prospective Randomised Controlled Trial of Effectiveness of SCS 
(PROCESS) trial 
Trial & 
Study 
Author 
& Date 
Objectives Study  
Design 
Setting & 
Country 
Treatment 
Period 
Participants Pre-screening/ 
Trial  
Intervention & 
comparator 
Outcome Measures Follow 
up 
 
A1 Kumar 
et al 
(2007) 
 
 
 
 
To assess the 
effectiveness 
of SCS+ 
CMM 
compared 
with CMM 
alone. 
 
PROCESS 
  
Multisite 
 
12 sites 
(Europe, 
Canada, 
Australia 
& Israel) 
April 2003-
2005 
 
 
100 
Baseline: 
SCS+CMM = 52, 
M = 30, F =22, 
Mean Age = 48.9 
years; CMM = 
48, M =21, F = 
27, Mean Age =  
52.0 year 
NP = Radicular 
origin 
predominantly in 
legs 
Trial stimulation 
undertaken 
SCS+CMM 
 
Vs  
 
CMM 
-VAS = At least 50% 
pain relief 
-SF36 
-ODI 
-Patient satisfaction 
-Changes in pain 
medication and non 
drug therapies 
-Employment Status 
-Complications were 
listed 
Reported 
on 6 & 12 
Months.  
 
Could 
request 
crossover 
at 
6months.  
A2 Kumar 
et al 
(2008) 
To assess the 
effectiveness 
of 
SCS+CMM, 
compared 
with CMM 
alone at 24 
month follow 
up 
 
PROCESS 
 
Multisite 
 
12 sites 
(Europe, 
Canada, 
Australia 
& Israel) 
April 2003-
2005  
 
 
 
428  
24 months: 
SCS+CMM: 
M=25, F=17, 
Mean Age = 48.8 
years; CMM 
(n=10): M=5, 
F=5, Mean Ages 
= 49.2 years 
NP same as A1. 
 
Trial stimulation 
undertaken 
SCS+CMM 
 
& 
 
CMM9 
-VAS = At least 50% 
pain relief 
-SF36 & EQ-5D 
-ODI 
-Patient satisfaction 
-Changes in pain 
medication and non 
drug therapies 
-Employment Status 
-Complications listed 
Reported 
on 24 
months 
                                                 
8 = Study based on patients in A1; however only those randomly assigned to SCS+CMM were included in A2, not patients who crossed over at 6 months 
9 = No. of patients randomised to and remaining in the CMM group were too small to use as comparison analysis (n=11); analysis performed for illustrative purposes only. 
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A3 
 
Manca 
et al. 
(2010) 
 
To quantify 
the extent to 
which 
reduction in 
leg & back 
pain & 
disability over 
time translate 
to 
improvement 
in HRQoL 
 
PROCESS 
 
 Multisite 
 
12 sites 
(Europe, 
Canada, 
Australia 
& Israel) 
 
April 2003-
2005 
 
100 
Baseline: 
SCS+CMM = 52, 
M = 30, F =22, 
Mean Age = 48.9 
years; CMM = 
48, M =21, F = 
27, Mean Age = 
52.0 years.  
-6 months N/S. 
-NP same as A1. 
 
 
 
 
Trial stimulation 
undertaken 
 
SCS+CMM 
 
&  
 
CMM 
 
-VAS = At least 50% 
pain relief 
-SF36 & EQ-5D 
-ODI 
-Patient satisfaction 
-Changes in pain 
medication and non 
drug therapies 
-Employment Status 
-Complications were 
listed 
 
Reported 
on 
Baseline 
& 6 
months 
 
A4 
 
Eldabe 
et al 
(2010) 
 
To analyse 
the sub-
dimensions of 
Health 
outcomes 
related to 
pain, 
functions and 
HRQoL 
 
PROCESS 
 
 
Multisite 
 
12 sites 
(Europe, 
Canada, 
Australia 
& Israel) 
 
April 2003-
2005 
 
100 
Baseline: 
SCS+CMM = 52, 
M = 30, F =22, 
Mean Age = 48.9 
years; CMM = 
48, M =21, F = 
27, Mean Age = 
52.0 years. 
- 6 months N/S. 
NP as A1. 
 
Trial stimulation 
undertaken 
 
SCS+CMM 
 
& 
 
CMM 
 
-VAS = At least 50% 
pain relief 
-SF36 & EQ-5D 
-ODI -Patient 
satisfaction 
-Changes in pain 
medication and non 
drug therapies 
-Employment Status 
-Complications were 
listed 
 
Reported 
on 
Baseline, 
6 months 
& 
24 
months 
 
 
KEY: CMM = Conventional Medical Management (e.g. oral medication, nerve blocks, psychological rehabilitation); EQ-5D = European Quality of Life measure; HRQoL = Health Related 
Quality of Life; NP = Neuropathic Pain; ODI = Owestry Disability Inventory; SCS = Spinal Cord Stimulation; SF-36 = Short Form-36 (HRQoL measure); VAS = Visual Analogue Scale 
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Appendix E: B: Table to show study characteristic for Kemler prospective randomised controlled trials 
 
Trial 
& 
Study 
 Author 
& Date 
Objectives Study  
Design 
Setting & 
Country 
Treatment 
Period 
Participants Pre-screening/ 
Trial  
Intervention 
& 
comparator 
Outcome Measures Follow up 
 
 
B5 
 
Kemler 
et al. 
(2000) 
 
 
 
 
 
To assess the 
effectiveness 
of SCS+PT 
compared 
with PT alone 
for chronic 
reflex 
sympathetic 
dystrophy 
(RSD). 
 
 
Prospective 
RCT 
  
 
Single site 
 
Netherlands 
 
March  
1997-  
July 1998 
 
 
 
54 
Baseline: 
SCS+PT = 36, 
M = 14, F =22, 
Mean Age = 
40.0 years 
PT = 18, M =3, 
F = 15, Mean 
Age = 35.0 
years 
 
Met Criteria 
CRPS (formally 
known as 
RSD). Disease 
restricted to 
one extremity, 
however 
affected whole 
hand or foot 
 
 
 
 
 
 
Pre- 
Screening 
For  
Psychological 
distress 
 
& 
 
Trial stimulation 
undertaken 
 
SCS+PT10 
 
Vs  
 
PT 
 
-VAS & MPQ 
-GPE scale 
-Functional Status: 
Functional test of hand 
& functional test of the 
foot. 
-A Jamar 
dynamometer was 
used to measure grip 
strength 
-A hand held myometer 
was used to measure 
strength of foot 
dorsiflexoin and plantar 
-NHP & EQ-5D 
-SIP 
-SRDS11 
-Adverse events listed 
 
Reported 
6 months 
                                                 
10 = Physical Therapy (PT) was a standardised program of graded exercises to improve strength, mobility, and function of the affected hand or foot. Administered for 30 minutes twice a 
week, with a minimum of 2 days between sessions, total duration = 6 months. Selected physical therapists were trained to do the program to ensure standardisation. 
 
11 = All questionnaires had been previously validated then translated to Dutch. 
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B6 
 
Kemler 
et al. 
(2004) 
 
To assess the 
effectiveness 
of SCS+PT 
compared 
with PT alone 
for chronic 
RSD at 2 
years. 
 
Prospective 
RCT 
 
 
Single site 
 
Netherlands 
 
March  
1997-  
July 1998 
 
 
 
 
21  
2 years: 
SCS+PT = 35 
& 
PT = 16. No 
further 
demographics 
provided 
 
As B5 met 
criteria CRPS. 
 
As in B5 
 
SCS+PT 
 
& 
 
PT 
 
As in B5 
 
Reported 
difference 
between 
baseline & 
24 months 
 
B7 
 
Kemler 
et al. 
(2008) 
 
To assess the 
effectiveness 
of SCS+PT 
compared 
with PT alone 
for chronic 
RSD at 5 
years. 
 
Prospective 
RCT 
 
 
Single site 
 
Netherlands 
 
March 
1997-  
July 1998 
 
 
 
36 
5years: 
SCS+PT = 31 
& PT = 13. No 
further 
demographic 
provided 
 
As B5 met 
criteria CRPS. 
 
As in B5 
 
SCS+PT 
 
&  
 
PT 
 
As in B5 
 
Reported 
difference 
between 
baseline 
and 60 
months 
 
 
 
KEY: CRPS = Complex Regional Pain Syndrome; GPE = Global Perceived Effect Scale; MPQ = McGill Pain Questionnaire; NHP = Nottingham Health Profile; SRDS = Self Rating 
Depression Scale; SIP = Sickness Impact Profile.  
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Appendix E: C: Table to show study characteristic of included case series 
 
Trial & 
Study 
 Author 
& Date 
Objectives Study  
Design 
Setting & 
Country 
Treatment 
Period 
Participants Pre-screening/ 
Trial  
Intervention & 
comparator 
Outcome Measures Follow up 
 
 
8 
 
Van  
Buyten 
et al. 
(2008) 
 
 
 
 
 
To assess 
patients 
ability to 
recharge 
the 
neurostimul
ator and 
clinical 
effectivenes
s of SCS. 
 
 
Case 
Series 
  
- pre & post 
treatment 
comparison 
  
 
Multisite 
 
12 sites 
 
European 
Centres 
 
Specific 
countries 
N/S 
 
October  
2004-  
March 2005 
 
 
 
45  
M = 15  
F =30 
 
Mean Age =  
51.3 years 
(ranging 31.1 to 
69.4) 
 
Chronic NP 
patients: 
55% FBSS: 
post-operative 
back or leg 
pain, 27% 
radicular pain, 
7% CRPS I, 7% 
CRPS II & 4% 
other 
 
 
 
 
 
 
 
 
 
 
 
Trial stimulation 
undertaken 
 
SCS  
 
No comparator 
 
-VAS 
-EQ-5D 
-ODI 
-1-5 rating scale of 
patient and physician 
satisfaction with 
neurostimulator 
-Complications listed 
 
Reported 
difference 
between 
baseline & 
12 months 
 
Last 12 
month 
follow up 
April 2006 
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9 
 
Spince
maille 
et al. 
(2004) 
 
To build a 
quality 
system for 
neuromodul
ation  
 
Case 
Series 
 
- pre & post 
treatment 
comparison 
 
 
Single site 
 
Netherlands 
 
April 1999-  
December 
2001 
 
 
 
 
105  
M = 43% 
F = 57% 
 
Mean Age = 
52.5 years 
 
FBSS: 
Neuropathic 
Limb Pain 
12.4 % = only 
leg pain (type 
II) 
87.6% = Pain in 
one leg and 
some back pain 
(type III) 
 
 
Pre-screening: 
SCL-90 
 
Trial stimulation 
undertaken 
 
SCS and 
regular 
treatment 
(including 
physiotherapy,  
TENS, oral 
medication 
such as anti-
depressants, 
NSAIDs and 
analgesics) 
 
No comparator 
 
-VAS 
-MPQ 
-MQS 
-EQ-5D 
-SIP 
-RD 
No complication 
reported 
 
Reported 
difference 
between 
baseline & 
12 months 
 
96 
participants 
left @ 12 
months 
 
 
KEY: MQS = Medication Quantification Scale; NSAID = Non-steroidal anti-inflammatory drugs; RD= Roland Disability Scale; TENS = Transcutaneous electrical nerve stimulation 
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Appendix F: Key findings of pain intensity and health related quality of life 
 
Study Follow Up Key Findings 
 
A1 
 
6 month 
 
 
 
 
 
12 month 
 
 
 More SCS patients achieved the primary outcome of 50% pain relief (48% of SCS group vs 9% of CMM group). 
 Compared to the CMM group, the SCS group achieved lower levels of leg pain (p<0.0001) and lower levels of back pain (p = 0.008). 
 The SCS group exhibited enhanced HRQoL on seven of the eight domains on the SF-36 (p≤0.02) except on role-emotional. CMM only improved 
significantly in one out of the eight domains compared with baseline which was ‘general health’ (p<0.007).  
 
 
 More SCS patients achieved over 50% pain relief than the CMM alone group on both an as per treatment analysis (48% of SCS group vs 18% 
CMM group, p = 0.03).  
 An intention to treat analysis was completed categorising patients who crossed over at 6 months as not meeting the primary outcome. Difference 
between groups achieving the primary outcome remained similar (34% of SCS group vs 7% of CMM, p = 0.005).  
 HRQoL results were not reported at 12 months. 
 
A2 24 months 
   
  Compared with baseline, SCS patients experienced lower levels of leg pain (p<0.0001) but there was no significant difference in back pain (p = 
0.21). 
 Compared with baseline, SCS patients experienced enhanced HRQoL on the EQ-5D (p<0.0001) and on 7 of 8 domains of the SF36 (p≤0.01) 
except for role-emotional (p = 0.11). EQ-5D sub-dimensions were not reported. 
 Illustrative analysis was completed (due to low numbers in CMM group, n=11), showed over 37% patients in SCS group and 2% in the CMM 
alone group achieved the primary outcome of 50% leg pain relief (p<0.0003). 
 No HRQoL comparisons were completed. 
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A312 6 months 
    
 The degree of association between patient’s pain levels, disability and generic HRQoL depended on the HRQoL measure and the dimensions of 
the HRQoL being investigated. 
 Pair wise correlation co-efficients revealed, at baseline, significantly greater levels of leg pain on the disease-specific measure were associated 
with lower levels of generic HRQoL, as measured by the EQ-5D (EQ-5D vs leg pain: r=-0.436, p<0.05). 
 The functional ability (ODI) showed a statistically significant negative correlation with all generic HRQoL measures (EQ-5D: r= -0.638, p<0.05, 
MCS: r=-0.301, p<0.05, PCS: r-0.462, p<0.05) indicating lower functional disability is associated with higher generic HRQoL regardless of the 
generic HRQoL measure employed. 
 Multilevel regression analyses revealed a number of baseline characteristics such as age, genders, and location of pain, were not statistically 
significant predictors of generic HRQoL in the first 6 months of the study. 
 The EQ-5D regression model indicated higher leg pain and functional disability are significantly associated with lower EQ-5D (leg pain: r= -
0.039; coefficient for ODI: r=-0.069, all p<0.001).  
 
A4 
 
Baseline,  
 
6 & 24  
 
months 
 
 More SCS patients (68%) experienced at least 30% leg pain relief in comparison to CMM alone (18%).  
 The SCS group got significantly greater scores on the PCS & MCS components of the SF-36 and there was a significant improvement from 
baseline which was sustained at 24 months. 
 The SCS group reported greater improvements when compared with CMM and baseline in 4 out of 5 dimensions: anxiety/depression, 
pain/discomfort, self care, and usual activities (all p≤0.05), which were sustained at 24 months.  
 SCS provided pain relief, improvement in most sub-dimensions of HRQoL and functional capacity, where as CMM alone provided little or no 
pain relief or other improvements.  
 Most improvement with SCS were sustained at 24 months, however 36% still reported HRQoL problems, related to pain and discomfort being an 
extreme problem. 
 
                                                 
12 = Key finding of Study A3 will report results of both generic and specific measures to fulfil the review objective as the purpose of this article was to explore 
the associations between these measures.  
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B5 6 months 
 
 ITT analysis revealed SCS patients reported a reduction in pain of 50% or more. No figure was provided for the PT group. VAS scores suggest 
SCS patients had a larger pain reduction (mean= -2.4cm) in comparison to PT alone where there was an increase in scores (mean =0.2cm. 
p<0.001). 
 The ITT analysis revealed no significant differences in HRQoL between groups. 
 A multivariate regression showed that no baseline factor other than treatment allocation influenced the size of the effect. 
   
 Per treatment analysis suggested SCS patients (n=24) experienced a larger pain reduction on VAS scores (mean = 3.6cm) in comparison to PT 
alone (mean increase = 0.2cm). HRQoL significantly improved for those affected in the hand (p=0.02) and those affected in the foot (p=0.08). 
This effect was chiefly derived from the pain component of the Nottingham Health Profile which is the primary source of distress of this patient 
population. 
 Other generic measures of HRQoL (i.e. EQ-5D) and more specific HRQoL measures (e.g. SIP) or the Self Rating Depression Scale (SRDS) 
were not reported. 
 
B6 2 years 
  
 ITT analysis revealed SCS groups showed a reduction in pain (mean VAS = 2.1cm) whereas the PT showed no reduction (Mean 0cm, p<0.001). 
 A multivariate regression showed that no baseline factor other than treatment allocation influenced the size of the effect. 
 No statistically significant changes were observed in HRQoL. 
 
 Per treatment analysis revealed improvements in pain relief only in the 24 SCS patients (mean pain relief = 3.0cm) and improvements in HRQoL 
on the pain component of the NHP for upper (p=0.02) and lover (p=0.008) extremities. 
 The EQ-5D results were not reported. 
 
B7 5 Years 
 
 Results indicated that the pain alleviating effect of SCS in patients with chronic CRPS-I diminished over time, which were no longer significant at 
3 year follow up.  
 Of the 31 patients remaining in the SCS group at 5 years, there was a reduction of pain intensity (mean -1.7cm), which was more than the 13 
patients in the PT alone group (-1.0cm; p=0.25). However, it was not statistically significant.  
 A multivariate regression showed that no baseline factor other than treatment allocation influenced the magnitude of effects. 
 HrQoL measures for the EQ-5D and NHP indicated no significant changes between groups.  
 Per treatment analysis of patients implanted with a SCS (n=20) revealed reduction in pain (mean VAS = 2.5cm) in comparison to PT alone 
(mean VAS = 1.0cm, p=0.06). SCS did not influence HRQoL scores.  
 Despite the above, 18 of the 20 patients with an implant (90%) indicated they had positively responded to treatment and 19 (95%) reported they 
would undergo the treatment again for the same outcomes. 
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8 
 
12 months 
 
 The rechargeable neurostimulator was successfully recharged by all patients meeting the primary objective to achieve between 75-95% success 
rates. 
 Favourable satisfaction ratings were observed for the neurostimulation system from both patients (97.6%) and physicians (92.7%). 
 Pain improved over the 12 month period with mean VAS scores reducing significantly (baseline = 7.2 to 12 months = 4.4, p<0.001) and 80.5% of 
patients reported at least 50% pain relief in the primary area of pain. 
 SCS resulted in improvements in HRQoL as measured by the EQ-5D with the mean scored doubling (baseline = 0.21 to 12 months = 0.46, 
p<0.001). Subscales were not reported. 
 93% reported they would undergo the same procedure to get the same results.  
 
9 12 months 
 
  Authors did not discuss the results of their statistical analyses; they presented mean scores for each outcome in a table showing baseline and 
12 months results. 
 Mean VAS scores suggested significant reductions in pain (baseline 7.3 to 12 months = 3.0, p<0.05) and the EQ-5D suggested significant 
improvements in HRQoL (baseline = 55.2 to 12 months = 12.4, p<0.05). Subscales of EQ-5D measures were not reported but SIP subscales 
were reported.   
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Appendix G: Outcome measures in reviewed studies 
 
Outcome measure 
 
Measure description 
Visual Analogue Scale 
(VAS) 
The VAS measures pain intensity. It is often a straight horizontal line 100 mm long with ‘no pain’ 
on the left hand side and ‘worse pain imaginable’ on the right hand side. The patient marks their 
pain magnitude on the scale and the physician measures the distance in mm from the left hand 
side to ascertain a number (e.g. patient mark 70mm along, so the VAS score is 70). It is noted to 
be used across cultures and relatively sensitive, with it being commonly used in research9. 
However, there are many variations of its use.  
 
McGill Pain Questionnaire 
(MPQ)7 
MPQ measures pain part one, consists of 3 major classes of word descriptors of pain: sensory, 
affective and evaluative. Part two has a scale to measure pain intensity. Part one ranged from 0-
20, higher scores indicate more pain and part two contained scores ranging from 0-63. Higher 
scores indicate more pain. 
 
Jebsen Functional test for 
the hand 
 
To measure hand function by timing the patient doing a range of tasks. 
Kemler functional test for 
the foot
5
 
 
To measure foot function by timing the patient doing a range of tasks. 
Global Perceived Effect Perception of effect is rated on a seven point scale (1, worst ever; 2 much worse; 3 worse; 4 not 
improved and not worse; 5 improved; 6 much improved and 7 best ever)4. 
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Oswestry Disability Index 
(ODI)2 
The ODI is a measure of disability which consists of 7 categories: pain intensity, personal care, 
lifting, walking, sitting, standing, sleeping, sex life (if applicable) and social life. They all contain 6 
statements (for example on the pain intensity scale the first statement ‘I have no pain at the 
moment’ and the last statement is ‘the pain is the worse imaginable at the moment’. First 
statement score 0, the last statement score 5. Scores are obtained by dividing the total score by 
the total possible score and multiplying it by 100 to obtain a percentage. If the percentage of 
change is 10% or less it is attributed to error.  
 
Nottingham Health Profile 
(NHP)3 
This HRQoL measure is divided into two parts. Part One consists of 6 components: sleep, physical 
activities, energy, pain, emotional reactions and social isolation where respondents’ rate simple 
statements. Each dimension has a range between 0-100. The second part consists of 7 
statements related to areas of life that may be affected by health problems: employment, 
housework, social life, sex life, personal relationship, hobbies and interests and holidays.  Scored 
1 = yes and 0 = no. For some groups several items do not apply, for example the elderly, 
unemployed or disabled1 
 
EuroQoL 5D (EQ-5D)6 This measures HRQoL through 5 domains: Mobility, activities, anxiety/depression, pain/discomfort 
and self care. The measure has two parts: Part One asks the respondent to rate their health state 
on the five domains described above, it provide three statements to choose from. For example, the 
mobility domain has these three statements; I have no problems walking around, I have some 
problems walking around, I am confined to bed. Part Two is a vertical scale from 0 – 100, 0 = 
worst imaginable health state and 100 = best imaginable health state. There are a number of ways 
to score the measure depending on the purpose (see 6). 
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Generic Short Form 36 
(SF36)11 
This measures HRQoL through two main scales, the physical component scale (PCS) and the 
mental component scale (MCS). It consists of eight domains: Physical functioning, Role-physical, 
bodily pain, general health, vitality, social functioning, role-emotional and mental health11.  
 
Short generic version 
Sickness Impact Profile 
(SIP) 
68 item measures of HRQoL consisting of 6 subscales measuring activities of daily life, mobility 
and complex physical activities. There are scores for different diseases with minor diseases 
averaging between 10-15 and major diseases such as stroke and spinal cord lesions between15-
25. 
 
Self Rating Depression 
Scale (SRDS)12 
A measure of depression containing 20 items relating to depression where respondents have to 
rate how they have felt in the last week. 
 
Medication Quantification 
Scale (MQS) 
This consists of two components to evaluate the use of analgesics. The first part produces a 
detrimental weight to weigh up the harm caused by long term use. The second part is related to 
the dose recommended by manufacturers which ranges from 0 (<1 dose per week) to 4 (super-
therapeutic dose). MQS scores are obtained for each medication by multiplying the detriment 
weight score by the dose level10. 
 
Roland Disability (RD)8 It is measure which asks 24 questions focusing on lower back problems. A score is calculated by 
getting the sum of the positive answers.  
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Appendix H: Quality assessment criteria (based on NHS CRD Report No.4) 
1) Quality assessment of Randomised Controlled Trials  
 
Quality Question 
 
Trial: 
PROCESS         Kemler Trials 
Was the method used to 
assign participants to 
the treatment groups 
really random? 
Yes Yes 
What method of 
assignment was used? 
1:1 
randomisation. 
Biostatistician 
prepared 
random 
computer 
generated 
blocks (of two to 
four patients) on 
a per site basis. 
After baseline 
assessment, 2:1 
randomisation to 
receive SCS+PT or 
PT alone.  
Computer generated 
table of random 
numbers was used. 
Stratified according 
to the location of the 
RSD (hand or foot). 
Was the allocation of 
treatment concealed? 
Yes Yes 
What method was used 
to conceal the treatment 
allocation? 
Randomisation 
was 
electronically 
locked and only 
accessed after a 
patient entered 
the trial 
Allocation made by 
research assistant, 
by telephone, 
concealed from study 
investigators.  
Was the number of 
participants who were 
randomised stated? 
Yes Yes 
Were the group similar 
at baseline in terms of 
prognostic factors? 
Yes Yes 
Were the eligibility 
criteria for the study 
entry specified? 
Yes. Yes 
Were details of baseline 
comparability 
presented? 
Majority 
excluding back 
pain. 
Yes 
Was an intention-to-
treat analysis included? 
Yes Yes 
Were at least 80% of the 
participants originally 
included in the 
randomised process 
followed up in the final 
analysis? 
Yes Yes 
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2) Quality assessment of case series: 
 
Quality Questions 
 
Study 8 Study 9 
Is the study based 
on a representative 
sample selected 
from a relevant 
population? 
Yes 
(3 different 
neuropathic pain 
conditions: CBLP, 
CRPS, FBSS) 
Yes 
Are the criteria for 
inclusion and 
exclusion explicit? 
Yes 
(but minimal = age, 
indication, medical 
history) 
Yes 
Did all individuals 
enter the study at 
similar points in their 
condition 
progression? 
Various diagnoses N/S but probably not 
Was follow-up long 
enough for important 
events to occur? 
Yes 
12 months 
Yes 
12 months 
Were outcomes 
assessed using 
objective criteria or 
was blinding used? 
No. Outcome 
evaluator N/S. 
No, third party 
outcome evaluator 
If comparison of 
sub-series are being 
made, sufficient 
description of the 
series and the 
distribution of the 
series and the 
distribution of 
prognostic factors? 
No subseries 
 
 
 
No subseries 
 
Key: Chronic Back and Leg Pain (CLBP); Complex Regional Pain 
Syndrome (CRPS); Failed Back Surgery Syndrome (FBSS); N/S = 
Not stated. 
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Appendix K: Covering letter sent out to participants 
 
Spinal Cord Stimulation Surgery for Chronic Neuropathic Pain: 
The Psychological Experience of the Treatment Journey 
 
Dear  
The Department of Neurosurgery at the Nottingham University 
Hospital has sent you this information pack on behalf Anna Turner. 
She is currently training to be a Clinical Psychologist for the NHS 
with the University of Nottingham. She wanted me to contact you 
because you have recently undergone spinal cord stimulation 
surgery and she would like to invite you to take part in her research 
study.   
 
The purpose of the research is to explore your experience of spinal 
cord stimulation surgery, specifically by discussing your experience 
of life before and after the surgery.  The research intends to give you 
the opportunity to voice these experiences, with the aim of enhancing 
the understanding of the treatment experience for future patients, 
families, healthcare professionals, surgeons and the wider NHS.  The 
research will be part of her Doctoral Thesis; therefore will count 
towards her qualification as a Clinical Psychologist. 
 
Please take your time to read the information sheet enclosed.  This 
provides details about the research.  If you would like to take part in 
the research or would like to contact Anna for more information 
before deciding, please call her on her research study mobile on 
07583419942 or alternatively email her 
lwxamt1@nottingham.ac.uk and she will get back to you as soon 
as possible. Thank you for your time.  
Kind Regards, 
 
Surajit Basu, Consultant Neurosurgeon 
Secretary Alison Brookfield0115249924 Extension 61105  
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Appendix L: Participant information sheet  
 
Spinal Cord Stimulation Surgery for Chronic Neuropathic Pain: The 
Psychological Experience of the Treatment Journey 
 
Researchers:   Anna Turner (Principal Investigator), Prof. Nadina 
Lincoln (Chief Investigator), Dr. Roshan das Nair (Academic 
Supervisor) and Dr. Jamie Macniven (Clinical Supervisor). 
 
I would like to invite you to take part in a research study.  Before you 
decide I will explain why the research is being done and what your 
role would be.  Please take your time to read the following 
information carefully. Please feel free to talk to others about the 
research if you wish. Also, you’re welcome to contact me if you would 
like to ask me any questions if anything is unclear or if you would like 
more information.  Take your time to decide whether or not you 
would like to take part in the research. 
 
What is the purpose of the research? 
The purpose of the research is to explore the experience of patients 
who have undergone spinal cord stimulation surgery for chronic 
neuropathic pain.   The aim is to gain an understanding of life both 
before and after the surgery. The research hopes to give patients an 
opportunity to discuss their experience, with the goal of promoting an 
understanding for other patients and families so that they can make 
an informed choice about the treatment. Additionally, the research 
could provide much needed information to define the role of 
psychological input in the patient selection and evaluation process of 
the surgery. It is hoped that information gained from the research can 
improve the support provided by healthcare teams and surgical 
teams to meet the psychological and physical needs of patients. The 
research will also be part of my Doctoral Thesis which will go towards 
my qualification as a Clinical Psychologist. 
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Why have I been invited? 
I am interested in your experience of spinal cord stimulation surgery 
and your chronic neuropathic pain.  I have contacted you because 
you have recently had spinal cord stimulation surgery.  I am hoping 
to interview a maximum of ten people to complete the research. 
 
Do I have to take part? 
It is up to you to decide, the research is voluntary.  If you do not want 
to be included in the research your regular treatment at the hospital 
will not be affected in any way.  If you decide to take part, you are still 
free to change your mind and withdraw from the research up until 
one week after the interview. If you choose to withdraw, you do not 
need to provide a reason and this will not affect the standard of care 
you receive. 
 
What will happen to me if I take part? 
You will be asked to take part in a semi-structured interview.  This 
interview will last for around one hour.  The interview will be audio 
recorded using a Dictaphone. The interview is recorded because it 
would be difficult to write detailed notes on what you were saying and 
listen to your experience at the same time. Therefore, by recording 
the interview I can write up the interview word for word and use this 
to help me complete the analysis.  The interview recording will be 
stored on a university computer and will be password protected. I will 
be the only person to access this data.  Following this, the data will 
be copied on to an encrypted data stick. This will be stored in a 
locked filing cabinet at the University of Nottingham.  All data files will 
be stored anonymously, therefore identification numbers will be used, 
not your name.  The data obtained from the interview will only be 
viewed in full by myself and my academic supervisor.  On submission 
of the Doctoral thesis, I will use quotes directly from the data in the 
analysis. However, I will make sure you cannot be identified from 
these quotes.  
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After considering the information on this sheet, I am happy to answer 
any questions you have about the research. You can contact me on 
my research study mobile on 07583419942 or via email if preferred 
at lwxamt1@nottingham.ac.uk. 
 
I have included the following diagram to demonstrate what can 
happen now:  
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Option 1: I would like to discuss  Option 2: I do not wish to take part 
                       the research    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
You have already received the information pack detailing the 
purpose of the research and what your role would be 
If you decide to take part in the research, you can have the 
interview at your neuromodulation clinic appointment at the 
Department of Neurosurgery, Queens Medical Centre or in 
your own home.  
If you would like to be interviewed at your neuromodulation 
appointment, please inform me of any seating aids (e.g. 
wheelchairs/ cushions) you may want to bring to make the 
interview more comfortable. 
If you do not make contact with me in two 
weeks, it will be noted that you do not wish to 
take part in the research. This will not affect 
your standard of care.  
Please contact me by telephone or email and 
I can provide further information about the 
research and answer any questions. 
 
I will call you the day before the interview to check the time, 
date and location of the interview are ok and you still want to 
take part  
At the start of the interview, I will ask you to sign a consent 
form and ask you some basic questions about yourself and 
your previous treatment for your chronic neuropathic pain. 
Then I will start the interview and recording. After the 
interview, you will be given the opportunity to ask any 
questions and provide feedback on your involvement in the 
research. 
If you would like a summary of the research when it is 
completed, you can sign a request form and it will be sent to 
you when the study is completed. 
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Expenses and payments 
The interview will be held at the Department of Neurosurgery in the 
Queens Medical Centre when you go for your neuromodulation clinic 
appointment 4-8 months after your surgery. Alternatively, the 
interview can be held in the comfort of your own home.  This way you 
are not making any extra journeys to be part of the research, 
therefore no expenses or payments will be offered. 
 
What are the potential disadvantages and risks of taking part? 
The research is interested in exploring your experience of the 
treatment journey of spinal cord stimulation surgery; therefore there 
is no definite interview schedule.  The interview will follow a set of 
questions; prompts related to questions will be determined by how 
you answer the questions.  Therefore, the interview could potentially 
bring about sensitive topics of conversation.  In the event that you 
feel like you need to take a break from the interview or would like to 
stop the recording, this can be done. Information leaflets of support 
services will be available on the interview day such as the 
Samaritans National Helpline (08457 90 90 90) and advice of other 
support services will be provided if required.  
 
Although, the interview will only be for an hour, the whole process will 
involve being seated for a couple of hours in total. Therefore to make 
this as comfortable as possible please bring any seating aids (e.g. 
cushions) and feel free to get up, stretch, walk around at any point 
during the interview. Also, we can take a break should you wish to 
adjust your stimulator for pain relief.  
 
What are the possible benefits of taking part? 
I cannot say that the research will help you. However, I hope that by 
discussing your experiences, this will benefit others who are making 
the decision about this surgical procedure and also provide 
information for healthcare providers. 
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What will happen if I don’t want to carry on with the study? 
Your participation is voluntary and you are free to withdraw up to one 
week after the interview, without giving any reason, and without your 
legal rights being affected. If you withdraw then the information 
collected so far cannot be erased and this information may still be 
used in the project analysis. 
 
What if there is a problem? 
If you have a concern about any aspect of the research, please feel 
free to contact me on my research study mobile on 07583419942 
and I will do my best to answer your questions. Alternatively, you can 
contact my clinical supervisor Jamie Macniven on 01158230222. If 
you remain unhappy and wish to complain, you can do this through 
the NHS Complaints Procedure for Nottingham University Hospitals 
by contacting Tracey Rose on 0115 924 9924 extension 42319. 
 
Will my taking part in this study be confidential? 
Yes.  If you join the research study, I have a duty of confidentiality to 
you as a research participant and I will do my best to meet this duty 
by following ethical and legal practice. I will store any information with 
your name on (e.g. consent form and a sheet matching you to a 
participant identification number and pseudonym) in a locked filing 
cabinet at the University of Nottingham. All other data will be 
anonymised using the above identification number so that you are 
not recognisable (e.g. demographic information sheet, recording of 
the interview and write up of the interview). These documents will 
also be stored in a locked filing cabinet. Your personal contact details 
will be destroyed after it is no longer necessary to contact you. 
 
What will happen to the results of the research study? 
The results of the research study will be written up as part of my 
Doctoral thesis with the aim of a publication in relevant journals. It 
may also be presented at conferences related to spinal cord 
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stimulation surgery.  At the end of the interview you will be asked if 
you would like to receive a summary of the research study.  You will 
not be identified in any report, publication or presentation. 
 
Who is organising and funding the research? 
The research study is being sponsored and funded by the University 
of Nottingham. 
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of 
people, called a Research Ethics Committee to protect your interest.  
This study has been reviewed and given favourable opinion by 
Leicestershire, Northamptonshire and Rutland Research Ethics 
Committee 1. 
. 
Further information and contact details 
For some general information about research, please refer to the 
National Research Ethics Service website: 
http://www.nres.npsa.nhs.uk.  
 
If you would like more specific information about the research project 
or if you require any information or advice on whether or not you 
should participate in the study, please feel free to contact me on my 
research study mobile on 07583419942 or email at 
lwxamt1@nottingham.ac.uk. 
 
Alternatively you can speak to a member of your health care team, 
your GP or to the Patient Advice and Liaison Service on 0115 
9249924 extension 65412.   
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Study Coordinator     Chief Investigator 
Anna Turner      Prof. Nadina Lincoln 
Institute of Work, Health and Organisations, Address same as  
University of Nottingham    study coordinator 
Jubilee Campus,      
Wollaton Road,      
Nottingham       
NG8 1BB       
Research Study Mobile:  
07583419942     Tel: 0115 9515315 
lwxamt1@nottingham.ac.uk     nadina.lincoln@nottingham.ac.uk 
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Leicestershire, Northamptonshire & Rutland Research Ethics Committee 1 
                                                             The Old Chapel 
                                                     Royal Standard Place 
                                                                   Nottingh                                                                                                                                                       
                                                            Tel: 0115 8839368 
                                                          Fax: 0115 8839294 
16 December 2010 
 
Ms Anna Turner 
Principal Investigator  
I-WHO, International House 
B Floor 
Jubilee Campus 
Nottingham 
NG8 1BB 
 
Dear Ms Turner, 
Study title: Spinal Cord Stimulation Surgery for Chronic  
Neuropathic Pain: The Psychological Experience  
of the Treatment Journey 
REC reference: 10/H0406/66 
Protocol number: 10063 
Amendment number: 1  
Amendment date: 03 December 2010 
Thank you for your letter of 03 December 2010, notifying the Committee of the above 
amendment. The Committee does not consider this to be a “substantial amendment” as defined 
in the Standard Operating Procedures for Research Ethics Committees.  The amendment does 
not therefore require an ethical opinion from the Committee and may be implemented 
immediately, provided that it does not affect the approval for the research given by the R&D 
office for the relevant NHS care organisation. 
 
Documents received 
The documents received were as follows: 
 Document  Version  Date  
Notification of a Minor Amendment - additional letter 
clarifying researcher's email address 
1  03 December 2010  
Letter to be sent about email  1.0  03 December 2010  
 Statement of compliance 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees (July 2001) and complies fully with the Standard Operating Procedures for 
Research Ethics Committees in the UK. 
10/H0406/66:   Please quote this number on all correspondence 
Appendix M: A: Minor amendment letter 
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Yours sincerely, 
 
 
 
 
Miss Susie Cornick-Willis 
Committee Co-ordinator 
 
E-mail: susie.cornick-willis@nottspct.nhs.uk 
 
Copy to: Paul Cartledge, Research Innovation Services 
 
R&D office for NHS care organisation at lead site – **** 
 
Professor Nadina Lincoln – Chief Investigator  
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Appendix M: B:  R&D minor amendment letter 
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Appendix M: C: Letter clarifying email address 
 
 
 
Spinal Cord Stimulation Surgery for Chronic Neuropathic Pain: 
The Psychological Experience of the Treatment Journey 
 
 
Dear  
 
The Department of Neurosurgery at the Nottingham University 
Hospital previously sent you an information pack on behalf Anna 
Turner for the above research. However, it has come to our attention 
that there has been some confusion over the email address.  
 
If you were interested in taking part in the study, the email address is 
all in lower case lwxamt1@nottingham.ac.uk, the first letter is a lower 
case L. Alternatively she can be contacted on her research mobile on 
07583419942 and she will get back to you as soon as possible.  
 
Thank you for your time, 
Kind Regards, 
 
 
 
Surajit Basu, Consultant Neurosurgeon 
Secretary Alison Brookfield 
0115249924 Extension 61105 
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Appendix N: A: Substantial amendment letter 
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Appendix N: B: R&D Substantial amendment letter 
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Appendix O: Written consent form                                
 
CONSENT FORM 
(Final version 1.0: 29.07.2010) 
 
Spinal Cord Stimulation Surgery for Chronic Neuropathic Pain: 
The Psychological Experience of the Treatment Journey 
 
REC ref: 10/H0406/66   
 
Name of Researcher:  Anna Turner       
 
Name of Participant:     
 
 
1. I confirm I have read and understand the information 
sheet final version 1.0 dated 29.07.2010 for the above 
research. I confirm I have had the opportunity to 
consider this information and ask questions. 
 
2. I understand that my participation is voluntary and that I 
am free to withdraw up to one week following the 
interview, without providing a reason, and without my 
medical care or legal rights being affected. I understand 
that should I withdraw then the information collected 
cannot be erased. 
 
3. I understand that data collected in the research may be 
viewed by authorised individuals from the University of 
Nottingham, the research group and regulatory 
authorities where it is relevant to my taking part in the 
study. I give permission for these individuals to have 
access to data and to collect, store, analyse and 
publish information obtained from my participation in 
this research. I understand that my personal details will 
be kept confidential.  
 
4. I understand the interview will be recorded and that 
anonymous direct quotes from the interview may be 
used in the research reports. 
 
5. I agree to take part in the above research. 
 
Name of Participant  Date          Signature 
_________________________    _____________       ________ 
 
Name of Principal Investigator Date          Signature 
_________________________    _____________       ________ 
Three copies will be produced: 1 for the participant, 1 for the 
research notes and 1 for the medical notes
Please initial box 
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Appendix P: Demographic information sheet  
 
DEMOGRAPHIC INFORMATION 
 
Spinal Cord Stimulation Surgery for Chronic Neuropathic Pain: The 
Psychological Experience of the Treatment Journey 
 
Participant number:     ______________ 
Gender:        M / F 
Age:          ____   years 
Ethnicity:      ______________ 
Date of Birth:      ______________ 
Location of pain:     ______________ 
Diagnosis:      ______________ 
Length of time experienced pain:   ______________ 
Previous surgery:     ______________ 
Medication:      ______________ 
Previous/current mental health difficulties: ______________ 
Previous psychological contact:   ______________ 
Date of SCS surgery:    ______________  
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Appendix Q: Study request form 
 
 
 
STUDY SUMMARY REQUEST 
 
Spinal Cord Stimulation Surgery for Chronic Neuropathic Pain: The 
Psychological Experience of the Treatment Journey 
 
 
I _____________________________________________________ 
(NAME) 
would like to receive a summary of the research when complete. 
 
Please send this to me by: 
 
Post 
 
 
 
(ADDRESS) 
 
Email 
_______________________________________________________ 
 
 
 
 
 
 
 
 
 
223 
 
Appendix R: Annual ethics report letter 
 
NRES Committee East Midlands - Leicester 
The Old Chapel 
Royal Standard Place 
Nottingham 
NG1 6FS 
 
Tel: 0115 8839368 
Fax: 0115 8839294 
09 September 2011 
 
Prof. Nadina Lincoln 
University of Nottingham 
Jubilee Campus 
Nottingham 
NG8 1BB 
 
Dear Prof Lincoln 
 
Study title: Spinal Cord Stimulation Surgery for  
Chronic Neuropathic Pain: The  
Psychological Experience of the  
Treatment Journey 
REC reference: 10/H0406/66 
Protocol number: 10063 
 
Thank you for sending the progress report for the above study dated 
08 September 2011.  The report will be reviewed by the Chair of the 
Research Ethics Committee, and I will let you know if any further 
information is requested. 
 
The favourable ethical opinion for the study continues to apply for the 
duration of the research. 
 
10/H0406/66:     Please quote this 
number on all correspondence 
 
Yours sincerely 
 
Mr Nick Brooks 
Administrative Assistant 
 
E-mail: nick.brooks@nottspct.nhs.uk 
 
Copy to: Mr Paul Cartledge,  
Ms Maria Koufali, Nottingham University Hospitals NHS 
Trust 
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Appendix S: Diary extract following interview with Pete 
 
‘....I feel exhausted after this interview. I also feel sad for Pete. He 
has had a long and testing journey and now he is trying to accept life 
as it is. I was struck by how much he appreciated talking about his 
experiences and his suggestion that this may change the way he 
thinks about his stimulator. The reason why I say this is, he had this 
demeanour, this way about him, I don’t know like there was this 
underlying anger and a desperate disappointment. It seemed he did 
not want to talk too explicitly about his disappointment, but alluded to 
it throughout, maybe in fear of being seen as ungrateful. He did 
stress he did not want to come across as ungrateful. Always feeling 
he has to manage how he comes across, that must be tiring in itself. I 
guess I was just surprised at how relaxed he appeared at the end, it 
was almost like he just wanted to be listened to, he wanted to talk 
about how the stimulator hadn’t met his expectations, how he felt 
unprepared  but feared how others would judge that’.  
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Appendix T: A: Extract of exploratory coding for Pete (Descriptive, linguistic and Conceptual) 
Line  Original Transcript Exploratory Comments 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
R: Ok, so to begin with then, can you describe what life was like before your 
surgery for me? 
I: Right (pause), prior to the-e, I, I don’t know if y-you realise I, I was a police 
officer for 20 years 
R: Oh right 
I: Erm, during that time, you’ve got to be fairly fit, you’ve got to keep yourself 
active so I use to play squash, golf, er as I said I use to walk (mentioned prior to 
interview), go walking 8-8, 9 miles a day was a good day out for me and I was 
pretty active, erm, in 1992, I was assaulted whilst at work, erm, and ended up 
being head butted which forced me, my neck back over a kerb, on th’ floor, 
caused damage to er, i-it’s cracked a vertebrae in the neck and ruptured the 
discs either side. As a result of that, I had a lot of head pain, a lot of  er pain 
down both arms, er, I was off work for quite a while, er, I got very depressed, 
very anxious, very aggressive. 
R: Humm 
I: Er, and that’s-that all comes out becos you realise, you thinking to, you sit 
down, you think to yourself, could I have done more to prevent this, you know 
what’s happened, and y-your angry with yourself and this depression, i-it’s hard 
to get out of, but eventually, I-I did eventually get out of it, and I returned back to 
work, and er, but I wasn’t allowed to go back out on the streets, the-the police 
surgeon said you know, if at any time you might get a pull then you’d end up 
being paralysed, so. 
R: Yeah 
I: So I wasn’t allowed, so I had to change my life style, I’d got my (cough), my 
career planned out, that this is the route I’m gona take and this is where I’m 
going to go, but, that suddenly came to a halt.  
R: Humm 
I: You know, you have to change your life style totally (sniffs), which I did, er 
(inhales), unfortunately 7 years later they made the decision that I couldn’t do the 
job anymore and I was medically retired.  
 
 
Police officer. Job role. Long time period – 20 years. 
 
Perception must be fit and active for job role – did variety of sports. ‘You’ve got 
to’ – ‘got to keep’ = rule? Important to him, his perception of what a police officer 
should be?  
Previously an active person. 
 
 
Assaulted at work and cracked vertebrae in neck. 
A lot of pain and off work. Repetition ‘a lot’ to emphasise pain severity. Negative 
emotions, mood and behaviour. Listed these off quickly.  
 
 
Process of thinking about assault - What he failed to do to prevent it. 
Rumination? 
Anger at self 
Depression. Rumination contribute to depression, how did he get out of it? 
Change in tone – higher pitch from eventually. ‘Eventually’ - suggesting time 
before getting out of it. ‘Wasn’t allowed’ - No choice, no control over change in 
job role. Would he have wanted to go back to his old job role, what did this mean 
to him? Vulnerability ‘a pull then...paralysed’. Repetition: ‘Wasn’t allowed’ no 
choice, no control? Adapted lifestyle. Career ‘planned’ (past tense) – valued, 
worked towards. ‘Going to go’ – (future tense) more plans? ‘Suddenly’ - speed of 
change. Career plans stopped by assault. Disruption to anticipated future self.  
Repetition of having to change lifestyle – ‘totally’ adding emphasis. Change. 
Time frame.  
‘They made the decision’ – no control, not part of decision making? – Medically 
retired.. 
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Appendix T: B: Extract from reflective diary on exploratory 
coding for second transcript - Pete 
 
‘....Given my natural tendency to be attracted towards structure, I 
have found the guidelines useful. However I do find myself 
‘checking in’ regularly with the book. It helps me focus on the main 
task, to stay close to the data, yet making sure I attend to the 
conceptual aspects of the transcript. However, I am hoping to 
become a bit more flexible as I continue coding’. 
 
‘.... This assault screams vulnerability to me and a loss of control. I 
find myself reflecting on the fact he was attacked at work, doing 
something he valued. I’m thinking about times when I have felt 
vulnerable, I can’t help but think about what it would be like for a 
man though, especially given his role in the police seems so 
important to him. I guess the event itself is irrelevant to my 
research but the impact of the consequences of this event, the loss 
and lack of control are central...I sense an underlying tone of 
anger, is this about the injustice of what happened to him or is it 
this the aggressive self he refers to? Is it his pain impacting on his 
emotions?  Why did I not ask him what he meant by aggressive, I 
really want to know - as in his demeanour? Or, as in his actions? I 
had to jot this down, as it was a temporary distraction from 
attending to the data. I have come to value the use of this reflective 
diary as it helps me refocus so I stick closely to the data and don’t 
run away too much with my thoughts’.  
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Appendix U: A: Identifying initial themes in Pete’s transcript 
Initial theme  Line Original Transcript Exploratory Comments 
 
Significant 
work role 
 
Loss of 
active self 
 
Origin of 
initial pain 
 
Negative 
impact of 
pain on 
emotions 
Aggressive 
Ruminative 
thinking 
Anger at self 
 
Physically 
vulnerable 
 
Lack of 
choice 
Disruption of 
aspirations 
 
Lack of 
control of 
decision 
making 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
 
R: Ok, so to begin with then, can you describe what life was like before 
your surgery for me? 
I: Right (pause), prior to the-e, I, I don’t know if y-you realise I, I was a 
police officer for 20 years 
R: Oh right 
I: Erm, during that time, you’ve got to be fairly fit, you’ve got to keep 
yourself active so I use to play squash, golf, er as I said I use to walk 
(mentioned prior to interview), go walking 8-8, 9 miles a day was a good 
day out for me and I was pretty active, erm, in 1992, I was assaulted whilst 
at work, erm, and ended up being head butted which forced me, my neck 
back over a kerb, on th’ floor, caused damage to er, i-it’s cracked a 
vertebrae in the neck and ruptured the discs either side. As a result of that, 
I had a lot of head pain, a lot of  er pain down both arms, er, I was off work 
for quite a while, er, I got very depressed, very anxious, very aggressive. 
R: Humm 
I: Er, and that’s-that all comes out becos you realise, you thinking to, you sit 
down, you think to yourself, could I have done more to prevent this, you 
know what’s happened, and y-your angry with yourself and this depression, 
i-it’s hard to get out of, but eventually, I-I did eventually get out of it, and I 
returned back to work, and er, but I wasn’t allowed to go back out on the 
streets, the-the police surgeon said you know, if at any time you might get a 
pull then you’d end up being paralysed, so. 
R: Yeah 
I: So I wasn’t allowed, so I had to change my life style, I’d got my (cough), 
my career planned out, that this is the route I’m gona take and this is where 
I’m going to go, but, that suddenly came to a halt.  
R: Humm 
I: You know, you have to change your life style totally (sniffs), which I did, 
er (inhales), unfortunately 7 years later they made the decision that I 
couldn’t do the job anymore and I was medically retired.  
 
 
Police officer. Job role. Long time period – 20 years. 
 
Perception must be fit and active for job role – did variety of sports. 
‘You’ve got to’ – ‘got to keep’ = rule? Important to him, his perception 
of what a police officer should be?  
Previously an active person. 
 
 
Assaulted at work and cracked vertebrae in neck. 
A lot of pain and off work. Repetition ‘a lot’ to emphasise pain severity. 
Negative emotions, mood and behaviour. Listed these off quickly.  
 
 
Process of thinking about assault - What he failed to do to prevent it. 
Rumination? 
Anger at self.Depression. Rumination contribute to depression, how 
did he get out of it? Change in tone – higher pitch from eventually. 
‘Eventually’ - suggesting time before getting out of it. ‘Wasn’t allowed’ 
- No choice, no control over change in job role. Would he have wanted 
to go back to his old job role, what did this mean to him? Vulnerability 
‘a pull then...paralysed’. Repetition: ‘Wasn’t allowed’ no choice, no 
control? Adapted lifestyle. Career ‘planned’ (past tense) – valued, 
worked towards. ‘Going to go’ – (future tense) more plans? ‘Suddenly’ 
- speed of change. Career plans stopped by assault. Disruption to 
anticipated future self.  
Repetition of having to change lifestyle – ‘totally’ adding emphasis. 
Change. Time frame.  
‘They made the decision’ – no control, not part of decision making? – 
Medically retired.. 
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Appendix U: B: Reflective diary extract on identifying initial 
themes 
 
 
‘....So at this stage I need to write pithy statements, but I am 
struggling to do that. It is hard trying to capture the understanding 
interpretatively in a short statement. Also I guess I am aware of my 
audience, I don’t think it will be helpful using too abstract statements 
like I have read in some IPA studies...I am mindful of this, but I 
equally want to remain true to the IPA approach’.  
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Appendix V: Abridged table of numeration analysis for Pete 
 
Initial Theme Frequency 
Acceptance II 
Adaptation to physical restrictions II 
Aggressive II 
Anger at professionals 
Anger at self 
Behavioural modifications III 
Behavioural modifications to SCS 
Cheated 
Chronicity of pain 
Cognitive modifications 
Conflict: Grateful vs disappointment II 
Containing undesirable self 
Decreased mobility 
Dependence (others II/stick) 
Depleting motivation 
Depression cycle II 
Desire to be alone II 
Disruption of aspirations 
Environment modifications 
Expectations II/faith in SCS  
Expectations not met 
External locus of control II 
Group identity 
Hope 
Hopelessness IIII 
Increased disability 
Job as a commitment 
Lack of choice II 
Lack of communication III 
2 
2 
2 
1 
1 
3 
1 
1 
1 
1 
2 
1 
1 
3 
1 
2 
2 
1 
1 
3 
1 
2 
1 
1 
4 
1 
1 
2 
3 
 
Reflective diary extract: 
 
‘....So I find the numeration analysis interesting as it has drawn my 
attention to the negativity present within this transcript, particularly 
the negative emotions and his efforts to cope.’ 
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Appendix W: Theme table for Pete 
 
Super-ordinate theme Initial theme 
Battling through the 
system 
Anger at professionals 
Back to square one 
Lack of communication  
Lack of consideration from hospital staff 
No mention of operation risks 
Past treatment failures 
Persistence with various treatments 
Process of diagnosis 
 
Managing expectations Expectations not met 
Expectations of SCS panel 
Faith in SCS  
Hope  
Painless mobility of trial  
Past expectations led to disappointment  
Selling self to get SCS 
 
Loss of identities Group identity 
Job as a commitment 
Loss of active self 
Loss of job identity 
Loss of non-pain self 
Significance of work role 
 
Managing the unwanted 
pain identity 
Aggressive 
Anger at self 
Desire to be alone 
Lack of control of self 
Miserable 
Pain severity 
Persistence of pain 
Personality change  
Rejection of dependence/others 
Self –focused  
Undesirable/unwanted self 
Visibility of disability 
 
Impact of non-able body Decreased mobility 
Restricted movement / Restrictions of 
immobility 
Restrictions of medication 
Physical restrictions 
Dependent on other/ stick 
Social exclusion/isolation/withdrawal 
Increased disability 
Adaptations to physical restrictions 
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Impact of pain Behavioural modifications 
Cognitive modifications 
Disruption of aspirations 
Environment modifications 
Negative impact of medication on 
memory 
Negative impact of pain on emotions 
Pain Impact on Everything 
Planning 
Relationship adaptation 
 
Battle to cope with 
depressive symptoms 
Cycle of depression 
Hopelessness 
Lacked opportunity to discuss problems 
with HCPs 
Learning process 
Loss of motivation  
Loss of purpose 
Ruminative thinking 
Sense of release from expressing 
experience 
Significance of a sense of purpose  
Significance of re-establishing identities 
Significant support  
Struggle to keep going 
Wife protector and motivator  
Worrying about future 
 
Conflict of SCS: Grateful 
Vs Disappointment 
 
Acceptance 
Adaptation to SCS 
Behavioural modifications to SCS 
Change from pain to squeezing 
sensation 
Coping with side effects/ Not prepared 
for side effects 
Increased disability 
Last hope 
Loss of control of leg  
No change  
Querying disappointment 
 
Powerlessness Cheated 
External locus of control  
Lack of choice  
Lack of control of decision making 
Powerless  
 
NB: BOLD text shows the audit trail from the initial themes in 
appendix U. 
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Appendix X: Abridged recurrent theme table 
 
Super-ordinate 
theme 
Sub-ordinate theme Participant (pp) No.of 
pps Sally Pete Nicole Mike Jack Maya Sarah 
 
Transitions of the 
self 
Loss of identities 
 
       7 
Managing the unwanted 
pain identity 
       7 
Diminished 
control and 
coping 
Impact of pain 
And the non-able body 
  
 
    
 
 7 
Coping with symptoms of 
depression 
       6 
Battling the system and 
managing expectations 
       7 
Multiple levels of 
powerlessness  
       6 
Conflict of SCS Positive change 
 
       6 
Disappointment, 
adaptations and 
acceptance 
       6 
 
There were other themes, however they only applied to one or two participants transcripts and were not strong enough within the 
transcripts to be included in the analyses. 
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Appendix Y: Reflective diary extract on organising themes 
across transcripts 
 
‘I am thinking on a higher level now to identify the overall 
commonalities alongside the more subtle similarities. I am struck by 
the divergences too. This is an exciting but equally overwhelming 
experience trying to make sense of such a vast amount of data. I 
have been grappling with this concept of powerlessness. It is making 
me feel powerless in trying to do it justice in the analysis! I feel it is 
inherent in every transcript and for some, it underlined their whole 
account. Yet, their powerlessness seems to have been experienced 
in so many different ways – in response to their pain, the stimulator, 
the system so how can I convey this. It’s like similarity with a 
difference.’  
